WO2021255170A1 - 1,3,4-oxadiazole pyrimidines en tant que fongicides - Google Patents

1,3,4-oxadiazole pyrimidines en tant que fongicides Download PDF

Info

Publication number
WO2021255170A1
WO2021255170A1 PCT/EP2021/066410 EP2021066410W WO2021255170A1 WO 2021255170 A1 WO2021255170 A1 WO 2021255170A1 EP 2021066410 W EP2021066410 W EP 2021066410W WO 2021255170 A1 WO2021255170 A1 WO 2021255170A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
halogen atoms
cycloalkyl
difluoromethyl
methyl
Prior art date
Application number
PCT/EP2021/066410
Other languages
English (en)
Inventor
Jeremy Dufour
Anne-Sophie Rebstock
Philippe Desbordes
Aurelie MALLINGER
Jacopo NEGRONI
Vincent Thomas
Sophie DUCERF
Christoph Andreas Braun
Ruth Meissner
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Priority to BR112022025755A priority Critical patent/BR112022025755A2/pt
Publication of WO2021255170A1 publication Critical patent/WO2021255170A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • the present invention relates to the use of 1,3,4-oxadiazol-2-ylpyrimidine compounds for controlling phytopathogenic microorganisms, in particular phytopathogenic fungi, in crop protection.
  • 1.2.4-oxadiazoles derivatives are well known to be useful as crop protection agents to combat or prevent microorganisms’ infestations.
  • WO-2019/122323, WO-2018/118781 and WO-2018/080859 disclose 1.2.4-oxadiazol-3-ylpyrimidines and 1,2,4-oxadiazol-3-ylpyridines derivatives that may be used for the control of microbial pests, particularly fungal pests, on plants.
  • Fungicidally active 1,2,4- oxadiazoles are further known from US 2018/317490.
  • 1.3.4-oxadiazoles derivatives are far less common and seldomly used for the control of microbial pests.
  • WO-2018/165520, WO-2017/065473 and WO-2017/023133 disclose 1.3.4-oxadiazol-2-ylpyrimidines and 1.3.4-oxadiazol-2-ylpyridines derivatives that may be used as metalloenzyme (histone deacetylase) inhibitors for the treatment of human diseases.
  • metalloenzyme histone deacetylase
  • Some fungicidally active 1,3,4-oxadiazoles are disclosed in WO-2020/127974 and WO-OO/15637.
  • fungicidal agents Numerous fungicidal agents have been developed until now. However, the need remains for the development of further fungicidal compounds, so as to provide compounds being effective against a broad spectrum of fungi, having lower toxicity, higher selectivity, being used at lower dosage rate to reduce or avoid unfavorable environmental or toxicological effects whilst still allowing effective pest control. It may also be desired to identify further fungicidal compounds to prevent the emergence of fungicides resistances. Furthermore, it may be desired to provide further fungicidal compounds having an improved storage stability and/or a higher weather stability, for example an improved photostability.
  • the present invention provides a new use of 1.3.4-oxadiazol-2-ylpyrimidine compounds for controlling phytopathogenic microorganisms in crop protection, which has advantages over known uses of fungicidal compounds in at least some of these aspects.
  • the present invention relates to the use of compounds of formula (I) for controlling phytopathogenic microorganisms, in particular phytopathogenic fungi, in crop protection: wherein R 1 , R 2 and X are as recited herein as well as their salts, N-oxides and solvates.
  • the present invention also relates to a composition
  • a composition comprising at least one compound of formula (I) as defined herein and at least one agriculturally suitable auxiliary.
  • the present invention relates to a method for controlling phytopathogenic microorganisms in crop protection which comprises the step of applying at least one compound of formula (I) as defined herein or a composition as defined herein to the phytopathogenic microorganisms and/or their habitat.
  • halogen refers to fluorine, chlorine, bromine or iodine atom.
  • oxo refers to an oxygen atom which is bound to a carbon atom or sulfur atom via a double bound.
  • C 1 -C 8 -alkyl refers to a saturated, branched or straight hydrocarbon chain having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms.
  • Examples of CVCValkyl include but are not limited to methyl, ethyl, propyl (n-propyl), 1-methylethyl (iso-propyl), butyl (n-butyl), 1-methylpropyl (sec-butyl), 2-methylpropyl (iso-butyl), 1,1-dimethylethyl (tert-butyl), pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2- dimethylpropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, hexyl, 1-methylpentyl, 2- methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-d
  • said hydrocarbon chain has 1, 2, 3 or 4 carbon atoms (“C 1 -C 4 -alkyl”), e.g. methyl, ethyl, propyl, iso- propyl, butyl, sec-butyl, iso-butyl or tert-butyl.
  • C 1 -C 4 -alkyl e.g. methyl, ethyl, propyl, iso- propyl, butyl, sec-butyl, iso-butyl or tert-butyl.
  • C 2 -C 8 -alkenyl refers to an unsaturated, branched or straight hydrocarbon chain having 2, 3, 4, 5, 6, 7 or 8 carbon atoms and comprising at least one double bond.
  • Examples of CVCV alkenyl include but are not limited to ethenyl (or "vinyl"), prop-2-en-1-yl (or “allyl”), prop-1-en-1-yl, but- 3-enyl, but-2-enyl, but-1-enyl, pent-4-enyl, pent-3-enyl, pent-2-enyl, pent-l-enyl, hex-5 -enyl, hex-4-enyl, hex-3-enyl, hex-2 -enyl, hex-1-enyl, prop-1-en-2-yl (or “isopropenyl”), 2-methylprop-2-enyl, 1- methylprop-2-enyl, 2-methylprop-1-en
  • C 2 -C 8 -alkynyl refers to a branched or straight hydrocarbon chain having 2, 3, 4, 5, 6, 7 or 8 carbon atoms and comprising at least one triple bond.
  • Examples of C 2 -C 8 -alkynyl include but are not limited to ethynyl, prop-1-ynyl, prop-2-ynyl (or “propargyl"), but-l-ynyl, but-2-ynyl, but-3- ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2 -ynyl, hex-3 -ynyl, hex-4-ynyl, hex-5-ynyl, 1-methylprop-2-ynyl, 2-methylbut-3-ynyl, 1-methylbut-3-ynyl, 1-methylmethylbut-3-y
  • C 1 -C 8 -halogenoalkyl refers to a C 1 -C 8 - alkyl group as defined above in which one or more hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 -halogenoalkyl comprises up to 9 halogen atoms that can be the same or different.
  • C 1 -C 8 - halogenoalkyl having 1 to 5 halogen atoms refers to a C 1 -C 8 -alkyl group as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 2 -C 8 -halogenoalkenyl refers to a C 2 -C 8 -alkenyl group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • C 2 -C 8 -halogenoalkenyl comprises up to 9 halogen atoms that can be the same or different.
  • C 2 -C 8 -halogenoalkynyl refers to a C 2 -C 8 -alkynyl group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • C 2 -C 8 -halogenoalkynyl comprises up to 9 halogen atoms that can be the same or different.
  • C 1 -C 4 -hydroxyalkyl refers to a C 1 -C 4 -alkyl group as defined above in which at least one hydrogen atom is replaced with a hydroxyl group.
  • Examples of C 1 -C 4 -hydroxyalkyl include but are not limited to hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl,l,2-dihydroxyethyl, 3-hydroxypropyl, 2-hydroxypropyl, 1-hydroxypropyl, 1-hydroxypropan-2-yl, 2-hydroxypropan-2-yl, 2,3-dihydroxypropyl and 1,3-dihydroxypropan-2-yl.
  • C 1 -C 6 -cyanoalkyl refers to a C 1 -C 6 -alkyl group as defined above in which at least one hydrogen atom is replaced with a cyano group.
  • C 1 -C 8 -alkoxy refers to a group of formula (C 1 -C 8 -alkyl)-O-, in which the term “C 1 -C 8 -alkyl” is as defined herein.
  • C 1 -C 8 -alkoxy examples include but are not limited to methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, n-pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, n-hexyloxy, 1-methylpentoxy, 2-methylpentoxy, 3- methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2- dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2- trimethylpropoxy, 1,2,2-trimethylpropoxy, 1 -ethyl- 1-methylpropoxy and 1 -e
  • C 1 -C 8 -halogenoalkoxy having 1 to 5 halogen atoms or " C 1 -C 8 - halogenoalkoxy” as used herein refers to a C 1 -C 8 -alkoxy group as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 -halogenoalkoxy examples include but are not limited to chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2- difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2- dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and 1,1,1-trifluoroprop-2-oxy.
  • C 1 -C 8 -alkylsulfanyl refers to a saturated, linear or branched group of formula (C 1 -C 8 -alkyl)-S-, in which the term “C 1 -C 8 -alkyl” is as defined herein.
  • Examples of C 1 -C 8 -alkylsulfanyl include but are not limited to methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, sec-butylsulfanyl. isobutylsulfanyl, tert-butylsulfanyl, pentylsulfanyl, isopentylsulfanyl, hexylsulfanyl group.
  • C 1 -C 8 - halogenoalkylsulfanyl having 1 to 5 halogen atoms refers to a C 1 -C 8 - alkylsulfanyl as defined above in which 1 to 5 hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 - alkylsulfinyl include but are not limited to saturated, straight-chain or branched alkylsulfinyl radicals having 1 to 8, preferably 1 to 6 and more preferably 1 to 4 carbon atoms, for example (but not limited to) methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfmyl, butylsulfinyl, 1-methylpropyl- sulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1-methylbutylsulfinyl, 2- methylbutylsulfinyl, 3-methylbutylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, 1,1- dimethylpropyl
  • C 1 -C 8 -halogenoalkylsulfinyl having 1 to 5 halogen atoms refers to a C 1 -C 8 alkylsulfinyl as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 - alkylsulfonyl examples include but are not limited to methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1 -methyl - ethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1- dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3- methylbutylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, 1, 1-dimethylpropylsulfonyl,
  • C 1 -C 8 -halogenoalkylsulfonyl having 1 to 5 halogen atoms refers to a C 1 -C 8 - alkylsulfonyl as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 -halogenoalkylsulfonylamino having 1 to 5 halogen atoms refers to a C 1 - C 8 -alkylsulfonylamino as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • CVCValkylsulfamoyl refers to a sulfamoyl radical having one C 1 -C 8 -alkyl group as defined herein.
  • di-(C 1 -C 8 -alkyl)sulfamoyl refers to a sulfamoyl radical having two independently selected CVCValkyl groups as defined herein.
  • C 1 -C 8 -alkylcarbamoyl refers to a carbamoyl radical having one C 1 -C 8 -alkyl group as defined herein.
  • di-(C 1 -C 8 -alkyl)carbamoyl refers to a carbamoyl radical having two independently selected C 1 -C 8 -alkyl groups as defined herein.
  • C 1 -C 8 -halogenoalkylcarbonyl having 1 to 5 halogen atoms refers to a C 1 -C 8 - alkylcarbonyl as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 -halogenoalkylcarbonyloxy having 1 to 5 halogen atoms refers to a C 1 - C 8 -alkylcarbonyloxy as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 -halogenoalkylcarbonylamino having 1 to 5 halogen atoms refers to a C 1 - C 8 -alkylcarbonylamino as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 -halogenoalkoxycarbonylamino having 1 to 5 halogen atoms refers to a C 1 -C 8 -alkoxycarbonylamino as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 -halogenoalkoxycarbonyl having 1 to 5 halogen atoms refers to a C 1 -C 8 - alkoxycarbonyl as defined above in which one to five hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 1 -C 8 -alkylamino refers to an amino radical having one C 1 -C 8 -alkyl group as defined herein.
  • Examples of C 1 -C 8 -alkylamino include but are not limited to N -methylamino. N -ethyl- amino, N -isopropylamino. N -n-propylamino. N -isopropylamino and N -tcrt-butylamino.
  • di-(C 1 -C 8 -alkyl)amino refers to an amino radical having two independently selected C 1 -C 8 -alkyl groups as defined herein.
  • di-(C 1 -C 8 -alkyl)amino include but are not limited to N', N -dimethylamino, N , N -diethylamino. N , N -diisopropylamino .
  • N-(C 1 -C8-alkyl)-N-(C 3 -C 7 -cycloalkyl)amino refers to a N,N-disubstituted amino radical having one C 1 -C 8 alkyl group as defined herein and one C 3 -C 7 -cycloalkyl group as defined herein.
  • non-aromatic C 3 -C 12 -carbocycle or “C 3 -C 12 -carbocycle” as used herein refers to a nonaromatic, saturated or partially unsaturated, hydrocarbon ring system in which all of the ring members, which vary from 3 to 12, are carbon atoms.
  • the ring system may be monocyclic or polycyclic (fused, spiro or bridged).
  • Non-aromatic C 3 -C 12 -carbocycles include but are not limited to C 3 -C 12 -cycloalkyl (mono or bicyclic), C 3 -C 12 -cycloalkenyl (mono or bicyclic), bicyclic system comprising an aryl (e.g.
  • phenyl fused to a monocyclic C 3 -C 7 -cycloalkyl (e.g. tetrahydronaphthalenyl, indanyl), bicyclic system comprising an aryl (e.g. phenyl) fused to a monocyclic C 3 -C 8 -cycloalkenyl (e.g. indenyl, dihydronaphthalenyl) and tricyclic system comprising a cyclopropyl connected through one carbon atom to a bicyclic system comprising an aryl (e.g.
  • the non-aromatic C 3 -C 12 -carbocycle can be attached to the parent molecular moiety through any carbon atom.
  • C 3 -C 1 2-cycloalkyl refers to a saturated, monovalent, mono- or bicyclic hydrocarbon ring which contains 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms.
  • C 3 -C 7 -cycloalkyl designates monocyclic C 3 -C 7 -cycloalkyls which include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl.
  • C 3 -C 5 -cycloalkyl designates monocyclic C 3 -C 5 -cycloalkyls which include cyclopropyl, cyclobutyl and cyclopentyl.
  • Examples of bicyclic Cg-C 12-cycloalkyls include but are not limited to bicyclo[3.1.1]heptane, bicyclo[2.2.1 ]heptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, bicyclo[3.3.1]nonane, bicyclo[4.2.0]octyl, octahydropentalenyl and bicyclo[4.2.1 ]nonane.
  • C 3 -C 7 -halogenocycloalkyl having 1 to 5 halogen atoms refers to a C 3 -C 7 - cycloalkyl group as defined above in which 1 to 5 hydrogen atoms are replaced with halogen atoms that may be the same or different.
  • C 3 -C 7 -cycloalkylsulfanyl refers to a group of formula (C 3 -C 7 -cycloalkyl)-S-, in which the term “C 3 -C 7 -cycloalkyl” is as defined herein.
  • C 3 -C 7 -cycloalkylcarbamoyl refers to a carbamoyl radical having one C 3 -C 7 - cycloalkyl group as defined herein.
  • N-(C 1 -C 8 -alkyl)-N-(C 3 -C 7 -cycloalkyl)carbamoyl refers to a N,N-disubstituted carbamoyl radical having one C 1 -C 8 -alkyl group as defined herein and one C 3 -C 7 -cycloalkyl group as defined herein.
  • C 3 -C 7 -cycloalkylamino refers to a (C 3 -C 7 -cycloalkyl)-NH-group, in which the term “C 3 -C 7 -cycloalkyl” is as defined herein.
  • C 3 -C 7 -cycloalkylsulfamoyl refers to a sulfamoyl radical having one C 3 -C 7 - cycloalkyl group as defined herein.
  • aromatic C 6 -C 14 -carbocycle or “aryl” as used herein refers to an aromatic hydrocarbon ring system in which all of the ring members, which vary from 6 to 14, preferably from 6 to 10, are carbon atoms.
  • the ring system may be monocyclic or fused polycyclic (e.g. bicyclic or tricyclic).
  • aryl examples include but are not limited to phenyl, azulenyl, naphthyl and fluorenyl.
  • the aryl can be attached to the parent molecular moiety through any carbon atom. It is further understood that when said aryl group is substituted with one or more substituents, said substituent(s) may be at any positions on said aryl ring(s). Particularly, in the case of aryl being a phenyl group, said substituent(s) may occupy one or both ortho positions, one or both meta positions, or the para position, or any combination of these positions.
  • non-aromatic 3- to 10-membered heterocycle refers to anon- aromatic, saturated or partially unsaturated non-aromatic ring system comprising 1 to 4, or 1 to 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur. If the ring system contains more than one oxygen atoms, they are not directly adjacent.
  • Non aromatic heterocycles include but are not limited to 3- to 7-membered monocyclic non-aromatic heterocycles and 6- to 10- membered polycyclic (e.g. bicyclic or tricyclic) non-aromatic heterocycles.
  • the non-aromatic 3- to 10- membered heterocycle can be connected to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle.
  • non-aromatic 3- to 7-membered monocyclic heterocycle refers to a 3-, 4-, 5-, 6- or 7-membered monocyclic ring system containing 1, 2 or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur where the ring system is saturated or unsaturated but not aromatic.
  • the heterocycle may comprise one to three nitrogen atoms, or one or two oxygen atoms, or one or two sulfur atoms, or one to three nitrogen atoms and one oxygen atom, or one to three nitrogen atoms and a sulfur atom or one sulfur atom and one oxygen atom.
  • saturated non-aromatic heterocycles include but are not limited to 3-membered ring such as oxiranyl, aziridinyl, 4- membered ring such as azetidinyl, oxetanyl, thietanyl, 5-membered ring such as tetrahydrofuranyl, 1,3- dioxolanyl, tetrahydrothienyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, triazolidinyl, isoxazolidinyl, oxazolidinyl, oxadiazolidinyl, thiazolidinyl, isothiazolidinyl, thiadiazolidinyl, 6-membered ring such as piperidinyl, hexahydropyridazinyl, hexahydropyrimidinyl, piperazinyl, triazinanyl, hexahydrotriazin
  • unsaturated non-aromatic hererocyles include but are not limited to 5-membered ring such as dihydrofuranyl, 1,3-dioxolyl, dihydrothienyl, pyrrolinyl, dihydroimidazolyl, dihydropyrazolyl, isoxazolinyl, dihydrooxazolyl, dihydrothiazolyl or 6-membered ring such as pyranyl, thiopyranyl, thiazinyl and thiadiazinyl.
  • 5-membered ring such as dihydrofuranyl, 1,3-dioxolyl, dihydrothienyl, pyrrolinyl, dihydroimidazolyl, dihydropyrazolyl, isoxazolinyl, dihydrooxazolyl, dihydrothiazolyl or 6-membered ring such as pyranyl, thiopyranyl, thiazinyl and thiadiaziny
  • non-aromatic 6- to 10-membered polycyclic heterocycle refers to a 6-, 7-, 8-, 9-, 10-membered polycyclic (e.g. bicyclic or tricyclic) ring system containing 1, 2 or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur where the ring system is saturated or unsaturated but not aromatic.
  • Non-aromatic bicyclic heterocycles may consist of a monocyclic heteroaryl as defined herein fused to a monocyclic C 3 -C 7 -cycloalkyl, a monocyclic C 3 -C 8 -cycloalkenyl or a monocyclic non-aromatic heterocycle or may consist of a monocyclic non-aromatic heterocycle fused either to an aryl (e.g. phenyl), a monocyclic C 3 -C 7 -cycloalkyl, a monocyclic C 3 -C 8 -cycloalkenyl or a monocyclic non-aromatic heterocycle.
  • aryl e.g. phenyl
  • nitrogen atom may be at the bridgehead (e.g. 4, 5,6,7- tetrahydropyrazolo[l,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1.2.4]triazolo[l,5-a]pyridinyl, 5, 6, 7, 8- tetrahydroimidazo[l,2-a]pyridinyl).
  • Non-aromatic tricyclic heterocycles may consist of a monocyclic cycloalkyl connected through one common atom to a non-aromatic bicyclic heterocycle.
  • aromatic 5- to 14-membered heterocycle or “heteroaryl” as used herein refers to an aromatic ring system comprising 1 to 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur. If the ring system contains more than one oxygen atom, they are not directly adjacent.
  • Aromatic heterocycles include aromatic 5- or 6-membered monocyclic heterocycles and 6- to 14- membered polycyclic (e.g. bicyclic or tricyclic) aromatic heterocycles.
  • the 5- to 14-membered aromatic heterocycle can be connected to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle.
  • aromatic 5- or 6-membered monocyclic heterocycle or “monocyclic heteroaryl” as used herein refers to a 5- or 6-membered monocyclic ring system containing 1, 2, 3 or 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur.
  • Examples of 5-membered monocyclic heteroaryl include but are not limited to fiiryl (furanyl), thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, isoxazolyl, oxazolyl, oxadiazolyl, oxatriazolyl, isothiazolyl, thiazolyl, thiadiazolyl and thiatriazolyl.
  • Examples of 6-membered monocyclic heteroaryl include but are not limited to pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl.
  • 6- to 14-membered polycyclic aromatic heterocycle or “polycyclic heteroaryl” as used herein refers to a 6-, 7-, 8-, 9-, 10-, 11-,12-, 13- or 14-membered polycyclic (e.g. bicyclic or tricyclic) ring system containing 1, 2 or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur.
  • Aromatic bicyclic heterocycles may consist of a monocyclic heteroaryl as defined herein fused to an aryl (e.g. phenyl) or to a monocyclic heteroaryl.
  • bicyclic aromatic heterocycle examples include but are not limited to 9-membered ring such as indolyl, indolizinyl, isoindolyl, benzimadozolyl, imidazopyridinyl, indazolyl, benzotriazolyl, purinyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl and benzisoxazolyl or 10-membered ring such as quinolinyl, isoquinolinyl, cinnolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, naphthyridinyl, pteridinal and benzodioxinyl.
  • 9-membered ring such as indolyl, indolizinyl, isoindolyl, benzimadozolyl, imidazopyridinyl, indazolyl, benzotriazolyl,
  • nitrogen atom may be at the bridgehead (e.g. imidazo[l,2-a]pyridinyl, [1.2.4]triazolo[4,3- ajpyridinyl, imidazo[l,2-a]pyridinyl, imidazo [2, 1-b] oxazolyl, furo[2,3-d]isoxazolyl).
  • Examples of tricyclic aromatic heterocyle include but are not limited to carbazolyl, acridinyl and phenazinyl.
  • C 3 -C 7 -cycloalkyloxy designates a group of formula -O-R wherein R is a C3- Cvcycloalkyl as defined herein.
  • partially aromatic bicyclic C 8 -C 10 -carbocycle designates a bicyclic system comprising one non-aromatic monocyclic C 4 -C 6 -carbocycle as defined herein which is fused to a phenyl ring.
  • partially aromatic bicyclic 8- to 10-membered heterocycle designates a 8-, 9- or 10-membered bicyclic system comprising a non-aromatic monocyclic C/rCg-carbocycle as defined herein which is fused to a monocyclic heteroaryl as defined herein, a non-aromatic monocyclic heterocyclyl as defined herein which is fused to a phenyl ring or a non-aromatic monocyclic heterocyclyl as defined herein which is fused to a monocyclic heteroaryl as defined herein.
  • substituents refers to a number of substituents that ranges from one to the maximum number of substituents possible based on the number of available bonding sites, provided that the conditions of stability and chemical feasibility are met.
  • leaving group as used herein is to be understood as meaning a group which is displaced from a compound in a substitution or an elimination reaction, for example a halogen atom, a trifluoromethanesulfonate (“triflate”) group, alkoxy, methanesulfonate, p-toluenesulfonate, etc.
  • variable xxxx incorporates by reference the broad definition of the variable as well as preferred, more preferred and even more preferred definitions, if any.
  • the present invention relates to the use of compounds of formula (I) for controlling phytopathogenic microorganisms, in particular phytopathogenic fungi, in crop protection: wherein
  • X is hydrogen or fluorine
  • R a is independently selected from the group consisting of hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 - halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 -halogenoalkynyl, C 3 -C 7 - cycloalkyl, aryl, heterocyclyl, heteroaryl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 -alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R aX substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R ay substituents;
  • R b is independently selected from the group consisting of hydrogen, hydroxy, C 1 -C 8 -alkoxy, C 1 - C 8 -alkyl, C 1 -C 8 -halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 - halogenoalkynyl, C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 - alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R bx substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R by substituents; or R a and
  • R 2 is aryl or heteroaryl, wherein R 2 is unsubstituted or substituted with one or more R 2y substituents; or R 1 and R 2 can form together with the carbon atom to which they are linked, a partially aromatic bicyclic Cs-C 1 o-carbocycle or a partially aromatic bicyclic 8- to 10-membered heterocycle comprising 1 to 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur, wherein the aromatic part of the bicyclic Cs-C 1 o-carbocycle or bicyclic 8- to 10-membered heterocycle may be substituted with one or more R 2y substituents and wherein the non-aromatic part of the bicyclic Cs-C 1 o- carbocycle or bicyclic 8- to 10-membered heterocycle may be substituted with oxo and/or one or more R 1y substituents;
  • R ax and R bx are independently selected from the group consisting of halogen, nitro, hydroxyl, cyano, carboxyl, amino, sulfanyl, pentafluoro - ⁇ 6 -sulfanyl, formyl, carbamoyl, carbamate, C 3 -C 7 - cycloalkyl, C 3 -C 7 -halogenocycloalkyl having 1 to 5 halogen atoms, CVCValkylamino.
  • C 1 -C 8 - halogenoalkoxycarbonylamino having 1 to 5 halogen atoms C 3 -C 7 -cycloalkoxycarbonylamino, C 1 -C 8 - alkylsulfmyl, C 1 -Cs-halogcnoalkylsulfmyl having 1 to 5 halogen atoms, C 3 -C 7 -cycloalkylsulfmyl, C 1 -C 8 - alkylsulfonyl, C 1 -C 8 -halogenoalkylsulfonyl having 1 to 5 halogen atoms; C 3 -C 7 -cycloalkylsulfonyl, C 1 - C 8 -alkylsulfonylamino, C 1 -C 8 -halogenoalkylsulfonylamino having 1 to 5 halogen atoms, C 3 -C 7 -cycloalkylsulf
  • R 1y , R ay and R 1y are independently selected from the group consisting of halogen, nitro, hydroxyl, cyano, carboxyl, amino, sulfanyl, pentafluoro - ⁇ 6 -sulfanyl, formyl, carbamoyl, carbamate, CVCValkyl.
  • C3- C7-cycloalkyl C i-Cs-halogcnoalkyl having 1 to 5 halogen atoms, C 3 -C 7 -halogenocycloalkyl having 1 to 5 halogen atoms, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 8 -alkylamino, N-(C 1 -C 8 -alkyl)-N-(C 3 -C 7 - cycloalkyl)amino, C 3 -C 7 -cycloalkylamino, di-(C 1 -C 8 -alkyl)amino, C 1 -C 8 -alkoxy, C 1 -C 8 -halogenoalkoxy having 1 to 5 halogen atoms, C 3 -C 7 -cycloalkyloxy, C 1 -C 8 -alkylsiilfanyl.
  • R 2y is selected from the group consisting of halogen nitro, hydroxyl, cyano, carboxyl, amino, sulfanyl, pentafluoro- ⁇ 6 -sulfanyl, formyl, carbamoyl, carbamate, CVCValkyl.
  • C 1 -C 8 -halogenoalkylsulfanyl having 1 to 5 halogen atoms C 3 -C 7 -cycloalkylsulfanyl, C 1 -C 8 -alkylcarbonyl, C 1 -C 8 halogenoalkylcarbonyl having 1 to 5 halogen atoms, C 3 -C 7 -cycloalkylcarbonyl, C 1 -CValkylcarbamoyl.
  • R x is independently selected from the group consisting of nitro, hydroxyl, cyano, carboxyl, amino, sulfanyl, pentafluoro- ⁇ - 6 sulfanyl, formyl, carbamoyl, carbamate, C 3 -C 7 -cycloalkyl, C 3 -C 7 - halogenocycloalkyl having 1 to 5 halogen atoms, C 1 -C 8 -alkylamino, N-(C 1 -C 8 -alkyl)-N-(C 3 -C 7 - cycloalkyl)amino, C 3 -C 7 -cycloalkylamino, di-(C 1 -C 8 -alkyl)amino, C 1 -C 8 -alkoxy.
  • C 1 -C 8 -halogenoalkoxy having 1 to 5 halogen atoms, C 3 -C 7 -cycloalkyloxy, C 1 -C 8 -alkylsulfanyl, C 1 -C 8 -halogcnoalkyl sulfanyl having 1 to 5 halogen atoms, C 3 -C 7 -cycloalkylsulfanyl, C 1 -C 8 -alkylcarbonyl.
  • C 1 -C 8 - halogenoalkylcarbonyl having 1 to 5 halogen atoms, C 3 -C 7 -cycloalkylcarbonyl, C 1 -C 8 -alkylcarbamoyl.
  • the compounds of formula (I) can be used for controlling harmful microorganisms, in particular phytopathogenic fungi, in crop protection.
  • the phytopathogenic fungi are selected from the group consisting of the Puccinia species, for example Puccinia recondita, Puccinia graminis or Puccinia striiformis ; the Uromyces species, for example Uromyces appendiculatus; and the rust disease pathogens, in particular selected from the group consisting of the Gymnosporangium species, for example Gymnosporangium sabinae Hemileia species, for example Hemileia vastatrix, and Phakopsora species, for example Phakopsora pachyrhizi or Phakopsora meibomiae .
  • the rust disease pathogens in particular Phakopsora pachyrhizi and Phakopsora meibomiae.
  • the compounds of formula (I) can suitably be in their free form, salt form, N-oxide form or solvate form (e.g. hydrate).
  • the compound of formula (I) may be present in the form of different stereoisomers. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. Accordingly, the invention encompasses both pure stereoisomers and any mixture of these isomers. Where a compound can be present in two or more tautomer forms in equilibrium, reference to the compound by means of one tautomeric description is to be considered to include all tautomer forms.
  • the compound of the formula (I) can be present in the form of the enantiomer (T), in the form of the enantiomer (I”) or any mixture thereof
  • the compound of formula (I) may be present in the form of the free compound and/or a salt thereof, such as an agrochemically active salt.
  • Agrochemically active salts include acid addition salts of inorganic and organic acids well as salts of customary bases.
  • inorganic acids are hydrohalic acids, such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, sulfuric acid, phosphoric acid and nitric acid, and acidic salts, such as sodium bisulfate and potassium bisulfate.
  • Useful organic acids include, for example, formic acid, carbonic acid and alkanoic acids such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, and also glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, saturated or mono- or diunsaturated fatty acids having 6 to 20 carbon atoms, alkylsulfuric monoesters, alkylsulfonic acids (sulfonic acids having straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), arylsulfonic acids or aryldisulfonic acids (aromatic radicals, such as phenyl and naphthyl, which bear one or two sulfonic acid groups), alkylphosphonic acids (phosphonic acids having straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), arylphosphonic
  • the compounds of the invention may exist in multiple crystalline and/or amorphous forms.
  • Crystalline forms include unsolvated crystalline forms, solvates and hydrates.
  • Solvates of the compounds of the invention or their salts are stoichiometric compositions of the compounds with solvents.
  • X is hydrogen or fluorine, preferably, X is hydrogen.
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C 3 -C 4 -cycloalkyl and phenyl, wherein the phenyl may be substituted with one to three substituents selected from the group consisting of cyano, C 1 -C 4 -alkyl, halogen, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenoalkoxy; and each R b is independently selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and C 3 -C 4 -cycloalkyl.
  • R a is selected from hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 -halogenoalkyl.
  • R 1 is selected from the group consisting of n-propyl, iso-propyl, n-propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, trifluoromethyl, difluoromethyl, fluoromethyl, 2,2,2-trifluoroethyl, ethynyl, prop-l-ynyl, prop- 2-ynyl, cyclobutyl, cyclopropyl, cyclopropylmethyl, cyclobutylmethyl, trifluoromethoxymethyl, [(4- methylphenyl)sulfonylamino]methyl, [(tert-butoxycarbonyl)amino]methyl, acetyl, carboxy, tert- butoxycarbonyl, (cyclopropylamino)carbonyl and l-(methoxyimino)ethyl.
  • R 1 is selected from the group consisting of n-propyl, isopropyl, n-propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, difluoromethyl, fluoromethyl, 2,2,2- trifluoroethyl, ethynyl, prop-l-ynyl, prop-2 -ynyl, cyclobutyl, cyclopropyl, cyclopropylmethyl, cyclobutylmethyl, trifluoromethoxymethyl, [(4-methylphenyl)sulfonylamino]methyl, [(tert- butoxycarbonyl)amino]methyl, acetyl, carboxy, tert-butoxy carbonyl, (cyclopropylamino)carbonyl and 1- (methoxyimino)ethyl .
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C3-C4-cycloalkyl and phenyl, wherein the phenyl may be substituted with one to three substituents selected from cyano, C 1 -C 8 - alkyl, halogen, C 1 -C 8 -alkoxy and C 1 -Cs-halogcnoalkyl :
  • R b is selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and C 3 -C 4 -cycloalkyl.
  • R 2 is aryl or heteroaryl, wherein R 2 is substituted with one or more R 2y substituents, preferably one to three R 2y substituents.
  • R 2 is an aryl selected from phenyl and naphthyl; or a heteroaryl selected from the group consisting of fu ryl (furanyl), thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, isoxazolyl, oxazolyl, oxadiazolyl, isothiazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, indolyl, isoindolyl, quinolinyl and isoquinolinyl; wherein said aryl or heteroaryl is substituted with one to three R 2y substituents, preferably selected from the group consisting of halogen, nitro, cyano, C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -halogeno
  • R 2 is phenyl or pyridinyl, in particular phenyl, wherein the phenyl or pyridinyl is substituted with one to three R 2y substituents, preferably selected from the group consisting of halogen, nitro, cyano, C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -halogenoalkyl having 1 to 5 halogen atoms, C 1 -C 4 -alkoxy, C 1 -C 4 -halogenoalkoxy having 1 to 5 halogen atoms and C 1 -C 4 - alkoxycarbonyl, more preferably selected from the group consisting of fluorine, chlorine, bromine, nitro, cyano, methyl, ethyl, iso-propyl, n-propyl, n-butyl, iso-butyl, tert-butyl,
  • R 2 is substituted with one R 2y substituent.
  • R 2 is substituted with two or three, preferably two R 2y substituents.
  • R 2 is phenyl, which is substituted with one to three halogen atoms selected from fluorine and chlorine, preferably one or two fluorine atoms.
  • R 1 and R 2 form, together with the carbon atom to which they are linked, a partially aromatic bicyclic Cs-Cm-carbocyclc or a partially aromatic bicyclic 8- to 10- membered heterocycle comprising 1 to 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur, wherein the aromatic part of the bicyclic Cs-Cm-carbocyclc or 8- to 10- membered heterocycle may be substituted with one or more R 2y substituents and wherein the non-aromatic part of the bicyclic Cs-Cm-carbocyclc or 8- to 10-membered heterocycle may be substituted with one or more R 1y substituents.
  • the aromatic part of the bicyclic Cs-Cm-carbocyclc or 8- to 10- membered heterocycle is unsubstituted or substituted with one or two substituents selected from the group consisting of halogen, C 1 -C 4 -alkyl, cyano, C 1 -C 4 -halogenoalkyl having 1 to 5 halogen atoms, C 1 -C 4 - alkoxy, C 1 -C 4 -halogenoalkoxy having 1 to 5 halogen atoms
  • the non-aromatic part of the bicyclic Cs- Cm-carbocyclc or 8- to 10-membered heterocycle is unsubstituted or substituted with oxo and/or one or two R 1y substituents selected from the group consisting of C 1 -C 4 -alkyl, halogen, cyano, C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms, C 1
  • the partially aromatic bicyclic C 8 -C 10 -carbocyclc or bicyclic 8- to 10-membered heterocycle is selected from the group consisting of
  • R 1 and R 2 form, together with the carbon atom to which they are linked, a partially aromatic bicyclic C 8 -C 10 -carbocycle selected from A1 and A28 or a partially aromatic bicyclic 8- to 10- membered heterocycle selected from the group consisting of A6, A7, A16, A17, A30, A31, A32, A33, A34, A46, A47, A63 and A64.
  • the compounds used according to the present invention are compounds of the formula (I) or salts, N-oxides or solvates thereof: wherein
  • X is hydrogen or fluorine, preferably hydrogen
  • R 1 is selected from the group consisting of cyano, C 2 -C 8 -alkyl, C 1 -C 8 -halogenoalkyl, C 1 -C 8 - cyanoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 -halogenoalkynyl, C 3 -C 7 - - - -C 8 -alkyl-aryl, -C 1 -C 8 -alkyl-heterocyclyl, -C 1 -C 8 -alkyl-heteroaryl, -C 1 -C 8 -alkyl-Cg-C ?
  • R a is independently selected from the group consisting of hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 - halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 -halogenoalkynyl, C 3 -C 7 - cycloalkyl, aryl, heterocyclyl, heteroaryl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 -alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R ax substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R ay substituents;
  • R b is independently selected from the group consisting of hydrogen, hydroxy, C 1 -C 8 -alkoxy, C 1 - C 8 -alkyl, C 1 -C 8 -halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 - halogenoalkynyl, C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 - alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R bx substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R by substituents; or R a and
  • R 2 is an aryl selected from phenyl and naphthyl; or a heteroaryl selected from the group consisting of fu ryl (furanyl), thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, isoxazolyl, oxazolyl, oxadiazolyl, isothiazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, indolyl, isoindolyl, quinolinyl and isoquinolinyl; wherein said aryl or heteroaryl is substituted with one to three R 2y substituents selected from the group consisting of halogen, nitro, cyano, C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -halogenoalkyl having 1 to 5 halogen atoms
  • the compounds used according to the present invention are compounds of the formula (I) or salts, N-oxides or solvates thereof: (I) wherein
  • X is hydrogen or fluorine, preferably hydrogen
  • R a is independently selected from the group consisting of hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 - halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 -halogenoalkynyl, C 3 -C 7 - cycloalkyl, aryl, heterocyclyl, heteroaryl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 -alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more Ra xubstituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R ay substituents;
  • R b is independently selected from the group consisting of hydrogen, hydroxy, C 1 -C 8 -alkoxy, C 1 - C 8 -alkyl, C 1 -C 8 -halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 - halogenoalkynyl, C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 - alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R bx substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R by substituents; or R a and
  • the compounds used according to the present invention are compounds of the formula (I) or salts, N-oxides or solvates thereof: wherein
  • X is hydrogen or fluorine, preferably hydrogen
  • CVCValkenyl and CYCValkynyl may be substituted with, respectively, one or more R 1x substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R 1y substituents;
  • R a is independently selected from the group consisting of hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 - halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 -halogenoalkynyl, C 3 -C 7 - cycloalkyl, aryl, heterocyclyl, heteroaryl, wherein said CVCValkyl.
  • C 2 -C 8 -alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R ax substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R ay substituents;
  • R b is independently selected from the group consisting of hydrogen, hydroxy, C 1 -C 8 -alkoxy, C 1 - Cs-alkyl, C 1 -C 8 -halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 - halogenoalkynyl, C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 - alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R bx substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R by substituents; or R a and R
  • R 2 is an aryl selected from phenyl and naphthyl, preferably phenyl; wherein the aryl is substituted with one to three R 2y substituents selected from the group consisting of halogen, nitro, cyano, C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -halogenoalkyl having 1 to 5 halogen atoms, C 1 -C 4 -alkoxy, C 1 -C 4 -halogenoalkoxy having 1 to 5 halogen atoms and C 1 -C 4 -alkoxycarbonyl, preferably selected from the group consisting of fluorine, chlorine, bromine, nitro, cyano, methyl, ethyl, iso-propyl, n-propyl, n-butyl, iso-butyl, tert-butyl, cyclopropyl, trifluoromethyl, difluoro
  • R a is selected from hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 -halogenoalkyl, C 3 -C 7 -cycloalkyl and aryl, wherein the aryl may be substituted with one to three substituents selected from cyano, C 1 -C 8 - alkyl, halogen, C 1 -C 8 -alkoxy and C 1 -C 8 -halogenoalkoxy; and each R b is independently selected from hydrogen, C 1 -C 8 -alkoxy, C 1 -C 8 -alkyl, C 1 -C 8 -haloalkyl and C 3 -C 7 -cycloalkyl.
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C3-C4-cycloalkyl and phenyl, wherein the phenyl may be substituted with one to three substituents selected from the group consisting of cyano, C 1 -C 4 -alkyl, halogen, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenoalkoxy; each R b is independently selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C3-C4-cycloalkyl and phenyl, wherein the phenyl may be substituted with one to three substituents selected from the group consisting of cyano, C 1 -C 4 -alkyl, halogen, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenoalkoxy; each R b is independently selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and
  • R 1 is selected from the group consisting of n-propyl, iso-propyl, n- propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, trifluoromethyl, difluoromethyl, fluoromethyl, 2,2,2- trifluoroethyl, ethynyl, prop-l-ynyl, prop-2 -ynyl, cyclobutyl, cyclopropyl, cyclopropylmethyl, cyclobutylmethyl, trifluoromethoxymethyl, [(4-methylphenyl)sulfonylamino]methyl, [(tert- butoxycarbonyl)amino]methyl, acetyl, carboxy, tert-butoxy carbonyl, (cyclopropylamino)carbonyl and 1- (methoxyimino)ethyl .
  • n-propyl iso-propyl, n-
  • R 1 is selected from the group consisting of n-propyl, iso-propyl, n-propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, difluoromethyl, fluoromethyl, 2,2,2-trifluoroethyl, ethynyl, prop-l-ynyl, prop-2 -ynyl, cyclobutyl, cyclopropyl, cyclopropylmethyl, cyclobutylmethyl, trifluoromethoxymethyl, [(4- methylphenyl)sulfonylamino]methyl, [(tert-butoxycarbonyl)amino]methyl, acetyl, carboxy, tert- butoxycarbonyl, (cyclopropylamino)carbonyl and l-(methoxyimino)ethyl.
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C 3 -C 4 -cycloalkyl, and phenyl, wherein the phenyl may be substituted with one to three substituents selected from the group consisting of cyano, C 1 -C 4 -alkyl, halogen, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenoalkoxy; and each R b is independently selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and C 3 -C 4 -cycloalkyl.
  • R 2 is not a phenyl, which is substituted in para-position with fluorine.
  • the compounds used according to the present invention are compounds of the formula (I) or salts, N-oxides or solvates thereof: wherein
  • X is hydrogen
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C 3 -C 4 -cycloalkyl and phenyl, wherein the phenyl may be substituted with one to three substituents selected from the group consisting of cyano, C 1 -C 4 -alkyl, halogen, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenoalkoxy; each R b is independently selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and C3-C4-cycloalkyl;
  • R 2 is phenyl or pyridinyl, which is substituted with one to three R 2y substituents independently selected from the group consisting of fluorine, chlorine, bromine, nitro, cyano, methyl, ethyl, iso-propyl, n-propyl, n-butyl, iso-butyl, tert-butyl, cyclopropyl, trifluoromethyl, difluoromethyl, methoxy, ethoxy, trifluoromethoxy, difluoromethoxy, methoxycarbonyl, ethoxycarbonyl and tert-butoxycarbonyl, preferably one to three R 2y substituents independently selected from the group consisting of fluorine, chlorine, bromine, methyl and methoxy; provided that compound of formula (I) is not :
  • the compounds used according to the present invention are compounds of the formula (I) or salts, N-oxides or solvates thereof: wherein
  • X is hydrogen
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C3-C4-cycloalkyl and phenyl, wherein the phenyl may be substituted with one to three substituents selected from the group consisting of cyano, C 1 -C 4 -alkyl, halogen, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenoalkoxy; each R b is independently selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and C3-C4-cycloalkyl; and
  • R 2 is phenyl which is substituted with one to three substituents independently selected from fluorine and chlorine; provided that the compound of formula (I) is not 5-[5-(difluoromethyl)-1.3.4-oxadiazol-2-yl]-N- [2,2,2-trifluoro- 1 -(4-fluorophenyl)ethyl]pyrimidin-2-amine .
  • the compounds used according to the present invention are compounds of the formula (I) or salts, N-oxides or solvates thereof: wherein
  • X is hydrogen
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C 3 -C 4 -cycloalkyl and phenyl, wherein the phenyl may be substituted with one to three substituents selected from the group consisting of cyano, C 1 -C 4 -alkyl, halogen, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenoalkoxy; each R b is independently selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and C 3 -C 4 -cycloalkyl;
  • R 2 is phenyl, which is substituted with one or two fluorine atoms; provided that the compound of formula (I) is not 5-[5-(difluoromethyl)-1.3.4-oxadiazol-2-yl]-N- [2,2,2-trifluoro-l-(4-fluorophenyl)ethyl]pyrimidin-2-amine and not ( ⁇ 5-[5-(difluoromethyl)-1.3.4- oxadiazol-2-yl]pyrimidin-2-yl ⁇ amino)(4-fluorophenyl)acetonitrile.
  • the compounds used according to the present invention are compounds of the formula (I) or salts, N-oxides or solvates thereof: wherein
  • X is hydrogen or fluorine, preferably hydrogen;
  • R a is independently selected from the group consisting of hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 - halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 -halogenoalkynyl, C 3 -C 7 - cycloalkyl, aryl, heterocyclyl, heteroaiyl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 -alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R aX substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaryl may be substituted with, respectively one or more R ay substituents;
  • R b is independently selected from the group consisting of hydrogen, hydroxy, C 1 -C 8 -alkoxy, C 1 - C 8 -alkyl, C 1 -C 8 -halogenoalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -halogenoalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 - halogenoalkynyl, C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaiyl, wherein said C 1 -C 8 -alkyl, C 2 -C 8 - alkenyl and C 2 -C 8 -alkynyl may be substituted with, respectively, one or more R bx substituents and wherein said C 3 -C 7 -cycloalkyl, aryl, heterocyclyl, heteroaiyl may be substituted with, respectively one or more R by substituents; or
  • R 2 is unsubstituted phenyl or unsubstituted pyridinyl; wherein R 1x , R aX , R bx , R 1y , R ay and R by are as defined herein; provided that compound of formula (I) is not :
  • R 1 is selected from the group consisting of n-propyl, iso-propyl, n-propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, trifluoromethyl, difluoromethyl, fluoromethyl, 2,2,2-trifluoroethyl, ethynyl, prop-l-ynyl, prop-2 -ynyl, cyclobutyl, cyclopropyl, trifluoromethoxymethyl, [(4-methylphenyl)sulfonylamino]methyl, [(tert- butoxycarbonyl)amino]methyl, acetyl, carboxy, tert-butoxy carbonyl, (cyclopropylamino)carbonyl and 1- (methoxyimino)ethyl .
  • R 1 is selected from the group consisting of n-propyl, iso-propyl, n-propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, difluoromethyl, fluoromethyl, 2,2,2-trifluoroethyl, ethynyl, prop-l-ynyl, prop-2 -ynyl, cyclobutyl, cyclopropyl, trifluoromethoxymethyl, [(4-methylphenyl)sulfonylamino]methyl, [(tert-butoxycarbonyl)amino]methyl, acetyl, carboxy, tert-butoxy carbonyl, (cyclopropylamino)carbonyl and l-(methoxyimino)ethyl.
  • R a is selected from hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C3-C4-cycloalkyl and phenyl, wherein the phenyl may be substituted with one to three substituents selected from the group consisting of cyano, C 1 -C 4 -alkyl, halogen, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenoalkoxy; and each R b is independently selected from hydrogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and C3-C4-cycloalkyl.
  • R 2 is substituted with one R 2y substituent. In some other embodiments, R 2 is substituted with two or three, preferably two R 2y substituents.
  • R 2 is phenyl, which is substituted in one or both ortho-position(s) with fluorine and/or chlorine, preferably fluorine atom(s).
  • R 1 is selected from the group consisting of cyano, trifluoromethyl, difluoromethyl, fluoromethyl, 2,2,2-trifluoroethyl, prop-l-ynyl, prop-2 -ynyl, cyclobutyl, trifluoromethoxymethyl, [(4-methylphenyl)sulfonylamino]methyl, [(tert- butoxycarbonyl)amino]methyl, carboxy, tert-butoxycarbonyl, (cyclopropylamino)carbonyl and 1- (methoxyimino)ethyl .
  • the said preferred features can also be selected among the more preferred features of each of X, R 1 and R 2 so as to form most preferred subclasses of compounds according to the invention.
  • the present invention also relates to intermediates for the preparation of compounds of formula (I).
  • the present invention relates to processes for the preparation of compounds of formula (I) and their intermediates.
  • the radicals and indices X, R 1 and R 2 have the meanings given above for the compounds of formula (I). These definitions apply not only to the end products of formula (I) but also to all intermediates.
  • Compounds of formula (I) can be prepared, according to process P1, by reacting intermediates of formula (II) with a dehydrating agent, such as methyl N -(triethylammoniumsulfonyl)carbamate (Burgess reagent), in a suitable solvent such as tetrahydrofurane, as previously described in WO2017065473.
  • a dehydrating agent such as methyl N -(triethylammoniumsulfonyl)carbamate (Burgess reagent)
  • Intermediates of formula (II) can be commercially available or can be prepared according to process P2, by reacting carbohydrazides of formula (III) with C 1 -C 3 -haloalkylacetic anhydride or C 1 -C 3 - haloalkylacetyl chloride (which are either commercially available or may be prepared starting from readily available compounds according to known procedures) in a suitable solvent such as tetrahydrofurane optionally in presence of a base such as triethylamine, preferably at room temperature, as previously described in WO2017065473.
  • a suitable solvent such as tetrahydrofurane
  • a base such as triethylamine
  • Carbohydrazides of formula (III) can be commercially available or can be prepared, according to process P3, by reacting a compound of formula (IV), wherein LG1 is a leaving group as for example ethoxy with hydrazine hydrate in a suitable solvent such as ethanol, as previously described in WO2017065473.
  • compounds of formula (IV) can be prepared, according to process P4, by reacting a compound of formula (V), wherein LG1 is an alkoxy like for example ethoxy and wherein LG2 is a leaving group like for example chlorine by nucleophilic substitution with a compound of formula (VI) (as described for example in European Journal of Medicinal Chemistry, 135, 531-543; 2017 or Bioorganic & Medicinal Chemistry, 25(17), 4553-4559; 2017) optionally in presence of a base (like for example N,N- diisopropylethylamine) or an acid (like for example p-toluenesulfonic acid) in a solvent such as for example dichloromethane or 1,4-dioxane.
  • a base like for example N,N- diisopropylethylamine
  • an acid like for example p-toluenesulfonic acid
  • a transition metal catalyst such as tris(dibenzylideneacetoneetone)dipalladium (as described for example in WO2012143415 or WO2019063748) or copper(I) iodide (as described for example in WO2000068198).
  • Compounds of formula (V) can be commercially available or may be prepared starting from readily available compounds according to known procedures.
  • Compounds of formula (VI) can be commercially available or may be prepared starting from readily available compounds according to known procedures.
  • compounds of formula (IV) can be prepared, according to process P5, by reacting a compound of formula (VII), wherein LG1 is an alkoxy like for example ethoxy by nucleophilic substitution with a compound of formula (VIII) wherein LG3 is a leaving group like for example chlorine, tosylate or hydroxy (as described for example in ACS Medicinal Chemistry Letters, 7(5), 502-507; 2016, Journal of Organic Chemistry, 68(11), 4527-4530; 2003, WO2002069901 or WO2007090852) optionally in presence of a base (like for example N,N-diisopropylethylamine) or an acid (like for example p- toluenesulfonic acid) in a solvent such as for example dichloromethane, 1,4-dioxane or acetonitrile.
  • a base like for example N,N-diisopropylethylamine
  • an acid like for example p- toluene
  • LG3 is an hydroxy
  • a Lewis acid like for example aluminum tris(trifluoromethanesulfonate)
  • triphenylphosphine and diisopropyl azodicarboxylate as described for example in Tetrahedron, 66(25), 4621-4632; 2010.
  • transition metal catalyst such as tris(dibenzylideneacetoneetone)dipalladium when LG3 is for example a bromine or an iodine (as described for example in WO2014058685 or ACS Catalysis, 3(11), 2536-2540; 2013) or when LG3 is an hydroxy (as described for example in (Angewandte Chemie, International
  • Compounds of formula (VII) can be commercially available or may be prepared starting from readily available compounds according to known procedures.
  • Compounds of formula (VIII) can be commercially available or may be prepared starting from readily available compounds according to known procedures.
  • compounds of formula (IV) can be prepared, according to process P6, by reacting a compound of formula (VII), wherein LG1 is an alkoxy like for example ethoxy by reductive animation with a compound of formula (IX) (as described for example in Advanced Synthesis & Catalysis, 352(16), 2815-2824; 2010, WO2011077043 or WO2018106667) in presence of a reductive reagent (like for example sodium cyanoborohydride, sodium triacetoxyborohydride or sodium borohydride), optionally in presence of an acid (like for example acetic acid) in a solvent such as for example methanol or tetrahydrofurane. It may be necessary to activate the carbonyl derivative for example with a Lewis acid (like for example titanium tetrachloride).
  • a Lewis acid like for example titanium tetrachloride
  • carbohydrazides of formula (III) can be prepared, according to process P7, by reacting a compound of formula (X) with an acid such as trifluoroacetic acid in a suitable solvent such as dichloromethane, preferably at room temperature, as previously described in Bioorganic & Medicinal Chemistry, 20(1), 487-497; 2012.
  • Process P7 Compounds of formula (X) can be commercially available or may be prepared, according to process P8, by reacting an acid of formula (XI) with tert- butyl carbazate in presence of a coupling agent like for example ( 1 -
  • a coupling agent like for example ( 1 -
  • 2,2-Difluoroacetohydrazide and 2,2,2-trifluoroacetohydrazide can be commercially available or may be prepared, according to known processes, as previously described in Synlett, (12), 1939-1941; 2005, Journal of Organic Chemistry, 78(16), 8054-8064; 2013, Chemistry of Heterocyclic Compounds (New York, NY, United States), 52(2), 133-139; 2016 or WO 2018233633.
  • compounds of formula (I) can be prepared, according to process P10, from a compound of formula (XII), wherein LG4 is a leaving group by nucleophilic substitution with a compound of formula (VI) (as described for example in European Journal of Medicinal Chemistry, 135, 531-543; 2017 or WO2017065473) optionally in presence of a base (like for example triethylamine) or an acid (like for example p-toluenesulfonic acid) in a solvent such as for example dichloromethane or 1,4-dioxane. It may be necessary to activate the leaving group for example by oxidation with 3-chloroperbenzoic acid when LG4 is SMe.
  • a base like for example triethylamine
  • an acid like for example p-toluenesulfonic acid
  • solvent such as for example dichloromethane or 1,4-dioxane. It may be necessary to activate the leaving group for example by oxidation with 3-ch
  • Compounds of formula (XII) can be commercially available or may be prepared starting from readily available compounds analogously to process P1 and P2 or P3 and P4 or P9.
  • compounds of formula (I) can be prepared, according to process P11, by reacting a compound of formula (XIII) by nucleophilic substitution with a compound of formula (VIII) with reaction conditions similar to process P5.
  • compounds of formula (I) can be prepared, according to process P12, by reacting a compound of formula (XIII) by reductive amination with a compound of formula (IX) with reaction conditions similar to process P6.
  • compounds of formula (I) can be prepared, according to process P13, by reacting a compound of formula (XIV) with C 1 -C 3 -haloalkylacetic anhydride (which is either commercially available or may be prepared starting from readily available compounds according to known procedures) in a suitable solvent such as dichloromethane, preferably at 0 °C, as previously described in WO2018165520.
  • a suitable solvent such as dichloromethane, preferably at 0 °C, as previously described in WO2018165520.
  • Compounds of formula (XIV) can be prepared, according to process P14, by reacting a compound of formula (XV) with an azide source such as sodium azide in a suitable solvent such as N,N- dimethylformamide, optionally in presence of a salt such as ammonium chloride and/or lithium chloride preferably at 95 °C, as previously described in WO2018165520.
  • an azide source such as sodium azide
  • a suitable solvent such as N,N- dimethylformamide
  • a salt such as ammonium chloride and/or lithium chloride preferably at 95 °C, as previously described in WO2018165520.
  • Compounds of formula (XV) can be prepared, according to process P15, by reacting a compound of formula (XVI) wherein LG5 is a leaving group by nucleophilic substitution such as chlorine with a compound of formula (VI) (as previously described in WO2018165520) optionally in presence of a base (like for example triethylamine) or an acid (like for example p-toluenesulfonic acid) in a solvent such as for example ethanol, dichloromethane or 1,4-dioxane.
  • a base like for example triethylamine
  • an acid like for example p-toluenesulfonic acid
  • processes P1 to P15 can be performed if appropriate in the presence of a solvent and if appropriate in the presence of a base.
  • Suitable solvents for carrying out processes P1 to P15 according to the invention are customary inert organic solvents. Preference is given to using optionally halogenated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin ; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane ; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran
  • N -methyl- pyrrolidone or hexamethylphosphoric triamide N -methyl- pyrrolidone or hexamethylphosphoric triamide ; esters, such as methyl acetate or ethyl acetate, sulfoxides, such as dimethyl sulfoxide or sulfones, such as sulfolane.
  • Suitable bases for carrying out processes P1 to P15 according to the invention are inorganic and organic bases which are customary for such reactions.
  • pyridine N -methylpiperidine. N ,N -dimethyl- aminopyridine, l,4-diazabicyclo[2.2.2]octane (DABCO), l,5-diazabicyclo[4.3.0]non-5-ene (DBN) or 1 , 8 -diazabicyclo [5.4.0]undec-7 -ene (DBU) .
  • DABCO l,4-diazabicyclo[2.2.2]octane
  • DBN l,5-diazabicyclo[4.3.0]non-5-ene
  • DBU 8 -diazabicyclo [5.4.0]undec-7 -ene
  • the reaction temperature can independently be varied within a relatively wide range.
  • processes according to the invention are carried out at temperatures between -20°C and 160°C.
  • a way to control the temperature for the processes is to use microwave technology.
  • Processes P1 to P15 according to the invention are generally independently carried out under atmospheric pressure. However, it is also possible to operate under elevated or reduced pressure.
  • reaction mixture is treated with water and the organic phase is separated off and, after drying, concentrated under reduced pressure. If appropriate, the remaining residue can be freed by customary methods, such as chromatography or recrystallization, from any impurities that can still be present.
  • compositions and formulations may be further understood in light of the following examples, which should not be construed as limiting the scope of the present teaching in any way.
  • the present invention further relates to a composition, in particular a composition for controlling unwanted phytopathogenic microorganisms.
  • the compositions may be applied to the microorganisms and/or in their habitat.
  • composition comprises at least one compound of the invention and at least one agriculturally suitable auxiliary, e.g. carrier(s) and/or surfactant(s).
  • agriculturally suitable auxiliary e.g. carrier(s) and/or surfactant(s).
  • a carrier is a solid or liquid, natural or synthetic, organic or inorganic substance that is generally inert.
  • the carrier generally improves the application of the compounds, for instance, to plants, plants parts or seeds.
  • suitable solid carriers include, but are not limited to, ammonium salts, in particular ammonium sulfates, ammonium phosphates and ammonium nitrates, natural rock flours, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite and diatomaceous earth, silica gel and synthetic rock flours, such as finely divided silica, alumina and silicates.
  • typically useful solid carriers for preparing granules include, but are not limited to crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, synthetic granules of inorganic and organic flours and granules of organic material such as paper, sawdust, coconut shells, maize cobs and tobacco stalks.
  • suitable liquid carriers include, but are not limited to, water, organic solvents and combinations thereof.
  • suitable solvents include polar and nonpolar organic chemical liquids, for example from the classes of aromatic and nonaromatic hydrocarbons (such as cyclohexane, paraffins, alkylbenzenes, xylene, toluene, tetrahydronaphthalene, alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride), alcohols and polyols (which may optionally also be substituted, etherified and/or esterified, such as ethanol, propanol, butanol, benzylalcohol, cyclohexanol or glycol), ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amide
  • the carrier may also be a liquefied gaseous extender, i.e. liquid which is gaseous at standard temperature and under standard pressure, for example aerosol propellants such as halohydrocarbons, butane, propane, nitrogen and carbon dioxide.
  • a liquefied gaseous extender i.e. liquid which is gaseous at standard temperature and under standard pressure
  • aerosol propellants such as halohydrocarbons, butane, propane, nitrogen and carbon dioxide.
  • Preferred solid carriers are selected from clays, talc and silica.
  • Preferred liquid carriers are selected from water, fatty acid amides and esters thereof, aromatic and nonaromatic hydrocarbons, lactams and carbonic acid esters.
  • the amount of carrier typically ranges from 1 to 99.99%, preferably from 5 to 99.9%, more preferably from 10 to 99.5%, and most preferably from 20 to 99% by weight of the composition.
  • Liquid carriers are typically present in a range of from 20 to 90%, for example 30 to 80% by weight of the composition.
  • Solid carriers are typically present in a range of from 0 to 50%, preferably 5 to 45%, for example 10 to 30% by weight of the composition.
  • composition comprises two or more carriers, the outlined ranges refer to the total amount of carriers.
  • the surfactant can be an ionic (cationic or anionic), amphoteric or non-ionic surfactant, such as ionic or non-ionic emulsifier(s), foam former(s), dispersant(s), wetting agent(s), penetration enhancer(s) and any mixtures thereof.
  • surfactants include, but are not limited to, salts of polyacrylic acid, salts of lignosulfonic acid (such as sodium lignosulfonate), salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene oxide and/or propylene oxide with fatty alcohols, fatty acids or fatty amines (for example, polyoxyethylene fatty acid esters such as castor oil ethoxylate, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols) and ethoxylates thereof (such as tristyrylphenol ethoxylate), salts of sulfosuccinic esters, taurine derivatives (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phenols, fatty esters of polyols (such a fatty acid esters of g,
  • Preferred surfactants are selected from polyoxyethylene fatty alcohol ethers, polyoxyethylene fatty acid esters, alkylbenzene sulfonates, such as calcium dodecylbenzenesulfonate, castor oil ethoxylate, sodium lignosulfonate and arylphenol ethoxylates, such as tristyrylphenol ethoxylate.
  • the amount of surfactants typically ranges from 5 to 40%, for example 10 to 20%, by weight of the composition.
  • auxiliaries include water repellents, siccatives, binders (adhesive, tackifier, fixing agent, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural phospholipids such as cephalins and lecithins and synthetic phospholipids, polyvinylpyrrolidone and tylose), thickeners and secondary thickeners (such as cellulose ethers, acrylic acid derivatives, xanthan gum, modified clays, e.g. the products available under the name Bentone, and finely divided silica), stabilizers (e.g.
  • cold stabilizers preservatives (e.g. dichlorophene and benzyl alcohol hemiformal), antioxidants, light stabilizers, in particular UV stabilizers, or other agents which improve chemical and/or physical stability), dyes or pigments (such as inorganic pigments, e.g. iron oxide, titanium oxide and Prussian Blue; organic dyes, e.g. alizarin, azo and metal phthalocyanine dyes), antifoams (e.g.
  • silicone antifoams and magnesium stearate silicone antifoams and magnesium stearate
  • antifreezes stickers, gibberellins and processing auxiliaries, mineral and vegetable oils, perfumes, waxes, nutrients (including trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc), protective colloids, thixotropic substances, penetrants, sequestering agents and complex formers.
  • auxiliaries depends on the intended mode of application of the compound of the invention and/or on the physical properties of the compound(s). Furthermore, the auxiliaries may be chosen to impart particular properties (technical, physical and/or biological properties) to the compositions or use forms prepared therefrom. The choice of auxiliaries may allow customizing the compositions to specific needs.
  • composition of the invention may be provided to the end user as ready-for-use formulation, i.e. the compositions may be directly applied to the plants or seeds by a suitable device, such as a spraying or dusting device.
  • a suitable device such as a spraying or dusting device.
  • the compositions may be provided to the end user in the form of concentrates which have to be diluted, preferably with water, prior to use.
  • composition of the invention can be prepared in conventional manners, for example by mixing the compound of the invention with one or more suitable auxiliaries, such as disclosed herein above.
  • the composition comprises a fungicidally effective amount of the compound(s) of the invention.
  • effective amount denotes an amount, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound of the invention used.
  • the composition according to the invention contains from 0.01 to 99% by weight, preferably from 0.05 to 98% by weight, more preferred from 0.1 to 95% by weight, even more preferably from 0.5 to 90% by weight, most preferably from 1 to 80% by weight of the compound of the invention. It is possible that a composition comprises two or more compounds of the invention. In such case the outlined ranges refer to the total amount of compounds of the present invention.
  • composition of the invention may be in any customary composition type such as solutions (e.g. aqueous solutions), emulsions, water- and oil-based suspensions, powders (e.g. wettable powders, soluble powders), dusts, pastes, granules (e.g. soluble granules, granules for broadcasting), suspoemulsion concentrates, natural or synthetic products impregnated with the compound of the invention, fertilizers and also microencapsulations in polymeric substances.
  • the compound of the invention may be present in a suspended, emulsified or dissolved form. Examples of particular suitable composition types are solutions, water-soluble concentrates (e.g.
  • SL LS
  • dispersible concentrates DC
  • suspensions and suspension concentrates e.g. SC, OD, OF, FS
  • emulsifiable concentrates e.g. EC
  • emulsions e.g. EW, EO, ES, ME, SE
  • capsules e.g. CS, ZC
  • pastes pastilles
  • wettable powders or dusts e.g. WP, SP, WS, DP, DS
  • pressings e.g. BR, TB, DT
  • granules e.g. WG, SG, GR, FG, GG, MG
  • insecticidal articles e.g.
  • compositions types are defined by the Food and Agriculture Organization of the United Nations (FAO). An overview is given in the "Catalogue of pesticide formulation types and international coding system", Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.
  • the composition of the invention is in form of one of the following types: EC, SC, FS, SE, OD and WG, more preferred EC, SC, OD and WG.
  • composition types and their preparation are given below. If two or more compounds of the invention are present, the outlined amount of compound of the invention refers to the total amount of compounds of the present invention. This applies mutatis mutandis for any further component of the composition, if two or more representatives of such component, e.g. wetting agent, binder, are present.
  • SL, LS Water-soluble concentrates
  • ком ⁇ онент 5-40 % by weight of at least one compound of the invention and 1-10 % by weight surfactant (e.g. amixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 % by weight water- insoluble organic solvent (e.g. aromatic hydrocarbon).
  • surfactant e.g. amixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate
  • water- insoluble organic solvent e.g. aromatic hydrocarbon
  • This mixture is added to such amount of water by means of an emulsifying machine to result in a total amount of 100 % by weight.
  • the resulting composition is a homogeneous emulsion. Before application the emulsion may be further diluted with water.
  • an agitated ball mill 20-60 % by weight of at least one compound of the invention are comminuted with addition of 2-10 % by weight surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1 -2 % by weight thickener (e.g. xanthan gum) and water to give a fine active substance suspension.
  • surfactant e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether
  • thickener e.g. xanthan gum
  • water e.g. xanthan gum
  • the water is added in such amount to result in a total amount of 100 % by weight. Dilution with water gives a stable suspension of the active substance.
  • binder e.g. polyvinylalcohol
  • a suitable grinding equipment e.g. an agitated ball mill
  • 20-60 % by weight of at least one compound of the invention are comminuted with addition of 2-10 % by weight surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2 % by weight thickener (e.g. modified clay, in particular Bentone, or silica) and an organic carrier to give a fine active substance oil suspension.
  • the organic carrier is added in such amount to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion of the active substance.
  • 50-80 % by weight of at least one compound of the invention are ground finely with addition of surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether) and converted to water-dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed).
  • surfactant e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether
  • the surfactant is used in such amount to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion or solution of the active substance.
  • WP, SP, WS Water-dispersible powders and water-soluble powders
  • % by weight of at least one compound of the invention are ground in a rotor-stator mill with addition of 1-8 % by weight surfactant (e.g. sodium lignosulfonate, polyoxyethylene fatty alcohol ether) and such amount of solid carrier, e.g. silica gel, to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion or solution of the active substance.
  • surfactant e.g. sodium lignosulfonate, polyoxyethylene fatty alcohol ether
  • solid carrier e.g. silica gel
  • agitated ball mill 5-25 % by weight of at least one compound of the invention are comminuted with addition of 3-10 % by weight surfactant (e.g. sodium lignosulfonate), 1-5 % by weight binder (e.g. carboxymethylcellulose) and such amount of water to result in a total amount of 100 % by weight.
  • surfactant e.g. sodium lignosulfonate
  • binder e.g. carboxymethylcellulose
  • 5-20 % by weight of at least one compound of the invention are added to 5-30 % by weight organic solvent blend (e.g. fatty acid dimethylamide and cyclohexanone), 10-25 % by weight surfactant blend (e.g. polyoxyethylene fatty alcohol ether and arylphenol ethoxylate), and such amount of water to result in a total amount of 100 % by weight.
  • organic solvent blend e.g. fatty acid dimethylamide and cyclohexanone
  • surfactant blend e.g. polyoxyethylene fatty alcohol ether and arylphenol ethoxylate
  • An oil phase comprising 5-50 % by weight of at least one compound of the invention, 0-40 % by weight water-insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 % by weight acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules.
  • an oil phase comprising 5-50 % by weight of at least one compound of the invention, 0-40 % by weight water-insoluble organic solvent (e.g.
  • At least one compound of the invention are ground finely and associated with such amount of solid carrier (e.g. silicate) to result in atotal amount of 100 % by weight.
  • Granulation is achieved by extrusion, spray-drying or the fluidized bed.
  • compositions types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 % by weight preservatives, 0.1-1 % by weight antifoams, 0.1-1 % by weight dyes and/or pigments, and 5-10% by weight antifreezes.
  • the compound and the composition of the invention can be mixed with other active ingredients like fungicides, bactericides, acaricides, nematicides, insecticides, biological control agents or herbicides. Mixtures with fertilizers, growth regulators, safeners, nitrification inhibitors, semiochemicals and/or other agriculturally beneficial agents are also possible. This may allow to broaden the activity spectrum or to prevent development of resistance. Examples of known fungicides, insecticides, acaricides, nematicides and bactericides are disclosed in the Pesticide Manual, 17th Edition. Examples of fungicides which could be mixed with the compound of formula (I) used according to the invention and the composition of the invention are:
  • Inhibitors of the ergosterol biosynthesis for example (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenhexamid, (1.005) fenpropidin, (1.006) fenpropimorph, (1.007) fenpyrazamine, (1.008) fluquinconazole, (1.009) flutriafol, (1.010) imazalil, (1.011) imazalil sulfate, (1.012) ipconazole, (1.013) metconazole, (1.014) myclobutanil, (1.015) paclobutrazol, (1.016) prochloraz, (1.017) propiconazole, (1.018) prothioconazole, (1.019) pyrisoxazole, (1.020) spiroxamine, (1.021) tebuconazole, (1.022) tetraconazole, (1.023) t
  • Inhibitors of the respiratory chain at complex I or II for example (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) fluopyram, (2.006) flutolanil, (2.007) fluxapyroxad, (2.008) furametpyr, (2.009) Isofetamid, (2.010) isopyrazam (anti-epimeric enantiomer 1R,4S,9S), (2.011) isopyrazam (anti-epimeric enantiomer 1S,4R,9R), (2.012) isopyrazam (anti-epimeric racemate 1RS,4SR,9SR), (2.013) isopyrazam (mixture of syn-epimeric racemate 1RS,4SR,9RS and anti-epimeric racemate 1RS,4SR,9SR), (2.014) isopyrazam (syn-epimeric enantiomer 1R,4S
  • Inhibitors of the respiratory chain at complex III for example (3.001) ametoctradin, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) coumethoxystrobin, (3.005) coumoxystrobin, (3.006) cyazofamid, (3.007) dimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadone, (3.010) fenamidone, (3.011) flufenoxystrobin, (3.012) fluoxastrobin, (3.013) kresoxim-methyl, (3.014) metominostrobin, (3.015) orysastrobin, (3.016) picoxystrobin, (3.017) pyraclostrobin, (3.018) pyrametostrobin, (3.019) pyraoxystrobin, (3.020) trifloxystrobin, (3.021) (2E)-2- ⁇ 2-[( ⁇ [(lE)-l-(3- ⁇ [((l
  • Inhibitors of the amino acid and/or protein biosynthesis for example (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracy cline, (7.005) pyrimethanil, (7.006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-l-yl)quinoline.
  • Inhibitors of the ATP production for example (8.001) silthiofam.
  • Inhibitors of the cell wall synthesis for example (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamid, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3 -(4-tert-butylphenyl)-3 -(2-chloropyridin-4-yl)- 1 -(morpholin-4-yl)prop-2-en- 1 -one, (9.009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one.
  • Inhibitors of the lipid and membrane synthesis for example (10.001) propamocarb, (10.002) propamocarb hydrochloride, (10.003) tolclofos-methyl.
  • Inhibitors of the melanin biosynthesis for example (11.001) tricyclazole, (11.002) tolprocarb.
  • Inhibitors of the nucleic acid synthesis for example (12.001) benalaxyl, (12.002) benalaxyl-M (kiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam).
  • Inhibitors of the signal transduction for example (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazid, (13.005) quinoxyfen, (13.006) vinclozolin.
  • fungicides selected from the group consisting of (15.001) abscisic acid, (15.002) benthiazole, (15.003) bethoxazin, (15.004) capsimycin, (15.005) carvone, (15.006) chinomethionat, (15.007) cufraneb, (15.008) cyflufenamid, (15.009) cymoxanil, (15.010) cyprosulfamide, (15.011) flutianil, (15.012) fosetyl- aluminium, (15.013) fosetyl-calcium, (15.014) fosetyl-sodium, (15.015) methyl isothiocyanate, (15.016) metrafenone, (15.017) mildiomycin, (15.018) natamycin, (15.019) nickel dimethyldithiocarbamate, (15.020) nitrothal-isopropyl, (15.021) oxamocarb, (15.022) oxathiapiprolin, (15.023)
  • the compound of formula (I) used according to the invention and the composition of the invention may also be combined with one or more biological control agents.
  • biological control is defined as control of harmful organisms such as a phytopathogenic fungi and/or insects and/or acarids and/or nematodes by the use or employment of a biological control agent.
  • biological control agent is defined as an organism other than the harmful organisms and / or proteins or secondary metabolites produced by such an organism for the purpose of biological control. Mutants of the second organism shall be included within the definition of the biological control agent.
  • mutant refers to a variant of the parental strain as well as methods for obtaining a mutant or variant in which the pesticidal activity is greater than that expressed by the parental strain.
  • the ’’parent strain“ is defined herein as the original strain before mutagenesis.
  • the parental strain may be treated with a chemical such as N-methyl-N'-nitro-N-nitrosoguanidine, ethylmethanesulfone, or by irradiation using gamma, x-ray, or UV-irradiation, or by other means well known to those skilled in the art.
  • a chemical such as N-methyl-N'-nitro-N-nitrosoguanidine, ethylmethanesulfone, or by irradiation using gamma, x-ray, or UV-irradiation, or by other means well known to those skilled in the art.
  • Known mechanisms of biological control agents comprise enteric bacteria that control root rot by out-competing fungi for space on the surface of the root.
  • Bacterial toxins, such as antibiotics have been used to control pathogens.
  • the toxin can be isolated and applied directly to the plant or the bacterial species may be administered so it produces the toxin in situ.
  • a ’’variant is a strain having all the identifying characteristics of the NRRL or ATCC Accession Numbers as indicated in this text and can be identified as having a genome that hybridizes under conditions of high stringency to the genome of the NRRL or ATCC Accession Numbers.
  • Hybridization refers to a reaction in which one or more polynucleotides react to form a complex that is stabilized via hydrogen bonding between the bases of the nucleotide residues.
  • the hydrogen bonding may occur by Watson-Crick base pairing, Hoogstein binding, or in any other sequence-specific manner.
  • the complex may comprise two strands forming a duplex structure, three or more strands forming a multi- stranded complex, a single self-hybridizing strand, or any combination of these.
  • Hybridization reactions can be performed under conditions of different “stringency”. In general, a low stringency hybridization reaction is carried out at about 40 °C in 10 X SSC or a solution of equivalent ionic strength/temperature. A moderate stringency hybridization is typically performed at about 50 °C in 6 X SSC, and a high stringency hybridization reaction is generally performed at about 60 °C in 1 X SSC.
  • a variant of the indicated NRRL or ATCC Accession Number may also be defined as a strain having a genomic sequence that is greater than 85%, more preferably greater than 90% or more preferably greater than 95% sequence identity to the genome of the indicated NRRL or ATCC Accession Number.
  • a polynucleotide or polynucleotide region (or a polypeptide or polypeptide region) has a certain percentage (for example, 80%, 85%, 90%, or 95%) of “sequence identity” to another sequence means that, when aligned, that percentage of bases (or amino acids) are the same in comparing the two sequences. This alignment and the percent homology or sequence identity can be determined using software programs known in the art, for example, those described in Current Protocols in Molecular Biology (F. M. Ausubel et al., eds., 1987).
  • NRRL is the abbreviation for the Agricultural Research Service Culture Collection, an international depositary authority for the purposes of deposing microorganism strains under the Budapest treaty on the international recognition of the deposit of microorganisms for the purposes of patent procedure, having the address National Center for Agricultural Utilization Research, Agricultural Research service, U.S. Department of Agriculture, 1815 North university Street, Peroira, Illinois 61604 USA.
  • ATCC is the abbreviation for the American Type Culture Collection, an international depositary authority for the purposes of deposing microorganism strains under the Budapest treaty on the international recognition of the deposit of microorganisms for the purposes of patent procedure, having the address ATCC Patent Depository, 10801 University Boulevard., Manassas, VA 10110 USA.
  • biological control agents which may be combined with the compound and the composition of the invention are:
  • Antibacterial agents selected from the group of:
  • (Al) bacteria such as (ATI) Bacillus subtilis, in particular strain QST713/AQ713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP, US, having NRRL Accession No. B21661, U.S. Patent No. 6,060,051);
  • Bacillus subtilis strain BU1814 (available as VELONDIS ® PLUS, VELONDIS ® FLEX and VELONDIS ® EXTRA from BASF SE);
  • Bacillus mojavensis strain R3B (Accession No. NCAIM (P) B001389) (WO 2013/034938) from Certis USA LLC, a subsidiary of Mitsui & Co.;
  • Paenibacillus polymyxa in particular strain AC-1 (e.g.
  • Pseudomonas proradix e.g. PRORADIX ® from Sourcon Padena
  • Al.l l Pantoea agglomerans, in particular strain E325 (Accession No. NRRL B-21856) (available as BLOOMTIME BIOLOGICALTM LD BIOPESTICIDE from Northwest Agri Products); and
  • (A2) fungi such as (A2.1) Aureobasidium pullulans, in particular blastospores of strain DSM14940, blastospores of strain DSM 14941 ormixtures of blastospores of strains DSM14940 and DSM14941 (e.g., BOTECTOR ® and BLOSSOM PROTECT ® from bio-ferm, CH); (A2.2) Pseudozyma aphidis (as disclosed in WO2011/151819 by Yissum Research Development Company of the Hebrew University of Jerusalem); (A2.3) Saccharomyces cerevisiae, in particular strains CNCM No. 1-3936, CNCM No. 1-3937, CNCM No. 1-3938 or CNCM No. 1-3939 (WO 2010/086790) from Lesaffre et Compagnie, FR;
  • (Bl) bacteria for example (Bl.l) Bacillus subtilis, in particular strain QST713/AQ713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP, US, having NRRL Accession No. B21661 and described in U.S. Patent No. 6,060,051); (B1.2) Bacillus pumilus, in particular strain QST2808 (available as SONATA® from Bayer CropScience LP, US, having Accession No. NRRL B- 30087 and described in U.S. Patent No.
  • Bacillus pumilus in particular strain GB34 (available as Yield Shield® from Bayer AG, DE);
  • Bacillus amyloliquefaciens in particular strain D747 (available as Double NickelTM from Kumiai Chemical Industry Co., Ltd., having accession number FERM BP-8234, US Patent No.
  • Bacillus subtilis Y1336 (available as BIOBAC ® WP from Bion-Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Nos. 4764, 5454, 5096 and 5277); (B 1.7) Bacillus subtilis strain MBI 600 (available as SUBTILEX from BASF SE), having Accession Number NRRL B-50595, U.S. Patent No. 5,061,495; (B1.8) Bacillus subtilis strain GB03 (available as Kodiak® from Bayer AG, DE); (B 1.9) Bacillus subtilis var. amyloliquefaciens strain FZB24 having Accession No.
  • DSM 10271 (available from Novozymes as TAEGRO ® or TAEGRO ® ECO (EPA Registration No. 70127- 5)); (B1.10) Bacillus mycoides, isolate J , having Accession No. B-30890 (available as BMJ TGAI ® or WG and LifeGardTM from Certis USA LLC, a subsidiary of Mitsui & Co.); (Bl.l 1) Bacillus licheniformis, in particular strain SB3086 , having Accession No. ATCC 55406, WO 2003/000051 (available as ECOGUARD ® Biofungicide and GREEN RELEAFTM from Novozymes); (B1.12) a Paenibacillus sp. strain having Accession No.
  • Bacillus amyloliquefaciens strain FZB42 Bacillus amyloliquefaciens strain FZB42, Accession No. DSM 23117 (available as RHIZOVITAL ® from ABiTEP, DE); (B1.17) Bacillus licheniformis FMCHOOl and Bacillus subtilis FMCH002 (QUARTZO ® (WG) and PRESENCE ® (WP) from FMC Corporation); (Bl.18) Bacillus mojavensis strain R3B (Accession No.
  • NCAIM (P) B001389) (WO 2013/034938) from Certis USA LLC, a subsidiary of Mitsui & Co.; (B1.19) Paenibacillus polymyxa ssp. plantarum (WO 2016/020371) from BASF SE; (B1.20) Paenibacillus epiphyticus (WO 2016/020371) from BASF SE; (B.1.21) Pseudomonas chlororaphis strain AFS009, having Accession No.
  • NRRL B-50897, WO 2017/019448 e.g., HOWLERTM and ZIO ® from AgBiome Innovations, US
  • B1.22 Pseudomonas chlororaphis, in particular strain MA342 (e.g. CEDOMON ® , CERALL ® , and CEDRESS ® by Bioagri and Koppert);
  • B1.23 Streptomyces lydicus strain WYEC108 (also known as Streptomyces lydicus strain WYCD108US) (ACTINO-IRON ® and ACTINOVATE ® from Novozymes);
  • B1.24 Agrobacterium radiobacter strain K84 (e.g.
  • (B2) fungi for example: (B2.1) Coniothyrium minitans, in particular strain CON/M/91-8 (Accession No. DSM-9660; e.g. Contans ® from Bayer CropScience Biologies GmbH); (B2.2) Metschnikowia fructicola, in particular strain NRRL Y-30752; (B2.3) Microsphaeropsis ochracea; (B2.5) Trichoderma atroviride, in particular strain SCI (having Accession No. CBS 122089, WO 2009/116106 and U.S. Patent No. 8,431,120 (from Bi-PA)), strain 77B (T77 from Andermatt Biocontrol) or strain LU132 (e.g.
  • Trichoderma harzianum strain T-22 e.g. Trianum-P from Andermatt Biocontrol or Koppert
  • strain Cepa Simb-T5 from Simbiose Agro
  • Gliocladium roseum also known as Clonostachys rosea f. rosea
  • strain 321U from Adjuvants Plus
  • strain ACM941 as disclosed in Xue (Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling the root tot complex of field pea, Can Jour Plant Sci 83(3): 519-524), or strain IK726 (Jensen DF, et al.
  • Trichoderma atroviride strain ATCC 20476 (IMI 206040); (B2.45) Trichoderma atroviride, strain Til (IMI352941/ CECT20498); (B2.46) Trichoderma harmatum, (B2.47) Trichoderma harzianum, (B2.48) Trichoderma harzianum rifai T39 (e.g. Trichodex® from Makhteshim, US); (B2.49) Trichoderma asperellum, in particular, strain kd (e.g. T-Gro from Andermatt Biocontrol); (B2.50) Trichoderma harzianum, strain ITEM 908 (e.g.
  • Trianum-P Trianum-P from Koppert
  • B2.51 Trichoderma harzianum, strain TH35 (e.g. Root-Pro by Mycontrol);
  • Trichoderma virens also known as Gliocladium virens), in particular strain GL-21 (e.g. SoilGard by Certis, US);
  • B2.53 Trichoderma viride, strain TVl(e.g. Trianum-P by Koppert);
  • Ampelomyces quisqualis in particular strain AQ 10 (e.g.
  • NM 99/06216 e.g., BOTRY- ZEN ® by Botry-Zen Ltd, New Zealand and BOTRYSTOP ® from BioWorks, Inc.
  • Verticillium albo-atrum (formerly V dahliae), strain WCS850 having Accession No. WCS850, deposited at the Central Bureau for Fungi Cultures (e.g., DUTCH TRIG ® by Tree Care Innovations);
  • Verticillium chlamydosporium B2.87) mixtures of Trichoderma asperellum strain ICC 012 (also known as Trichoderma harzianum ICC012), having Accession No.
  • CABI 353812 (e.g. BIOKUPRUMTM by AgriLife); (B2.91) Saccharomyces cerevisiae, in particular strain LASO2 (from Agro-Levures et Derives), strain LAS 117 cell walls (CEREVISANE ® from Lesaffre; ROMEO ® from BASF SE), strains CNCM No. I- 3936, CNCM No. 1-3937, CNCM No. 1-3938, CNCM No. 1-3939 (WO 2010/086790) from Lesaffre et Compagnie, FR; (B2.92) Trichoderma virens strain G-41, formerly known as Gliocladium virens (Accession No.
  • ATCC 20906 (e.g., ROOTSHIELD ® PLUS WP and TURFSHIELD ® PLUS WP from BioWorks, US); (B2.93) Trichoderma hamatum, having Accession No. ATCC 28012; (B2.94) Ampelomyces quisqualis strain AQ 10, having Accession No.
  • CNCMI-807 e.g., AQ 10 ® by IntrachemBio Italia
  • B2.95 Phlebiopsis gigantea strain VRA 1992 (ROTSTOP ® C from Danstar Ferment);
  • B2.96 Penicillium steckii (DSM 27859; WO 2015/067800) from BASF SE;
  • B2.97 Chaetomium glohosum (available as RIVADIOM ® by Rivale);
  • B2.101 Fusarium oxysporum, strain Fo47 (available as FUSACLEAN ® by Natural Plant Protection);
  • B2.102 Pseudozyma flocculosa, strain PF-A22 UL (available as SPORODEX ® L by
  • strain ICC 080 IMI CC 392151 CABI
  • BIODERMA ® AGROBIOSOL DE MEXICO, S .A. DE C.V.
  • B2.104 Trichoderma fertile (e.g. product TrichoPlus from BASF);
  • B2.105 Muscodor roseus, in particular strain A3-5 (Accession No. NRRL 30548);
  • B2.106 Simplicillium lanosoniveum; biological control agents having an effect for improving plant growth and/or plant health which may be combined in the compound combinations according to the invention including
  • (Cl) bacteria selected from the group consisting of Bacillus pumilus, in particular strain QST2808 (having Accession No. NRRL No. B-30087); Bacillus suhtilis, in particular strain QST713/AQ713 (having NRRL Accession No. B-21661and described in U.S. Patent No. 6,060,051; available as SERENADE ® OPTI or SERENADE ® ASO from Bayer CropScience LP, US); Bacillus suhtilis, in particular strain AQ30002 (having Accession Nos. NRRL B-50421 and described in U.S. Patent Application No.
  • Bacillus mycoides EE118 (NRRL No. B-50918), Bacillus mycoides EE141 (NRRL No. B-50916), Bacillus mycoides BT46-3 (NRRL No. B-50922), Bacillus cereus family member EE128 (NRRL No. B-50917), Bacillus thuringiensis BT013A (NRRL No. B-50924) also known as Bacillus thuringiensis 4Q7, Bacillus cereus family member EE349 (NRRL No.
  • Bacillus amyloliquefaciens SB3281 ATCC # PTA- 7542; WO 2017/205258
  • Bacillus amyloliquefaciens TJ1000 available as QUIKROOTS ® from Novozymes
  • Bacillus firmus in particular strain CNMC 1-1582 (e.g. VOTIVO ® from BASF SE)
  • Bacillus pumilus in particular strain GB34 (e.g. YIELD SHIELD ® from Bayer Crop Science, DE); Bacillus amyloliquefaciens, in particular strain IN937a; Bacillus amyloliquefaciens, in particular strain FZB42 (e.g.
  • RHIZOVITAL ® from ABiTEP, DE
  • Bacillus amyloliquefaciens BS27 (Accession No. NRRL B-5015); a mixture of Bacillus licheniformis FMCHOOl and Bacillus subtilis FMCH002 (available as QUARTZO ® (WG), PRESENCE ® (WP) from FMC Corporation); Bacillus cereus, in particular strain BP01 (ATCC 55675; e.g. MEP1CHLOR ® from Arysta Lifescience, US); Bacillus subtilis, in particular strain MBI 600 (e.g. SUBTILEX ® from BASF SE); Bradyrhizobium japonicum (e.g.
  • OPTIMIZE ® from Novozymes Mesorhizobium cicer (e.g., NODULATOR from BASF SE); Rhizobium leguminosarium biovar viciae (e.g., NODULATOR from BASF SE); Delftia acidovorans, in particular strain RAY209 (e.g. BIOBOOST ® from Brett Young Seeds); Lactobacillus sp. (e.g. LACTOPLANT ® from LactoPAFI); Paenibacillus polymyxa, in particular strain AC-1 (e.g. TOPSEED ® from Green Biotech Company Ltd.); Pseudomonas proradix (e.g.
  • PRORADIX ® from Sourcon Padena
  • Azospirillum brasilense e.g., VIGOR ® from KALO, Inc.
  • Azospirillum lipoferum e.g., VERTEX-IFTM from TerraMax, Inc.
  • a mixture of Azotobacter vinelandii and Clostridium pasteurianum available as INVIGORATE ® from Agrinos
  • Pseudomonas aeruginosa in particular strain PN 1 ; Rhizobium leguminosarum, in particular bv. viceae strain Z25 (Accession No.
  • C2 fungi selected from the group consisting of Purpureoci Ilium lilacinum (previously known as Paecilomyces lilacinus) strain 251 (AGAL 89/030550; e.g. BioAct from Bayer CropScience Biologies GmbH)Penicillium bilaii, strain ATCC 22348 (e.g. JumpStart ® from Acceleron BioAg), Talaromyces flavus, strain VI 17b; Trichoderma atroviride strain CNCM 1-1237 (e.g. Esquive® WP from Agrauxine, FR), Trichoderma viride, e.g.
  • Trichoderma atroviride strain LC52 also known as Trichoderma atroviride strain LU132; e.g. Sentinel from Agrimm Technologies Limited
  • Trichoderma asperellum strain kd e.g. T-Gro from Andermatt Biocontrol
  • Trichoderma asperellum strain Eco-T Plantt Health Products, ZA
  • Trichoderma harzianum strain T-22 e.g.
  • Trianum-P from Andermatt Biocontrol or Koppert Myrothecium verrucaria strain AARC-0255 (e.g. DiTeraTM from Valent Biosciences); Penicillium bilaii strain ATCC ATCC20851; Pythium oligandrum strain Ml (ATCC 38472; e.g. Polyversum from Bioprepraty, CZ); Trichoderma virens strain GL-21 (e.g. SoilGard® from Certis, USA); Verticillium albo-atrum (formerly V dahliae) strain WCS850 (CBS 276.92; e.g. Dutch Trig from Tree Care Innovations); Trichoderma atroviride, in particular strain no.
  • AARC-0255 e.g. DiTeraTM from Valent Biosciences
  • Penicillium bilaii strain ATCC ATCC20851 e.g. Polyversum from Bioprepraty, CZ
  • (Dl) bacteria selected from the group consisting of Bacillus thuringiensis suhsp. aizawai, in particular strain ABTS-1857 (SD-1372; e.g. XENTARI ® from Valent BioSciences); Bacillus mycoides, isolate J. (e.g. BmJ from Certis USA LLC, a subsidiary of Mitsui & Co.); Bacillus sphaericus, in particular Serotype H5a5b strain 2362 (strain ABTS-1743) (e.g. VECTOLEX ® from Valent BioSciences, US); Bacillus thuringiensis suhsp.
  • israelensis strain BMP 144 (e.g.
  • Burkholderia spp. in particular Burkholderia rinojensis strain A396 (also known as Burkholderia rinojensis strain MBI 305) (Accession No. NRRL B-50319; WO 2011/106491 and WO 2013/032693; e.g. MBI-206 TGAI and ZELTO ® from Marrone Bio Innovations); Chromobacterium subtsugae, in particular strain PRAA4-1T (MBI-203; e.g.
  • GRANDEVO GRANDEVO ® from Marrone Bio Innovations
  • Paenibacillus popilliae (formerly Bacillus popilliae, ⁇ e.g. MILKY SPORE POWDERTM and MILKY SPORE GRANULARTM from St. Gabriel Laboratories);
  • Bacillus thuringiensis subsp. israelensis (serotype H-14) strain AM65-52 (Accession No. ATCC 1276) (e.g. VECTOBAC ® by Valent BioSciences, US); Bacillus thuringiensis var. kurstaki strain EVB-113-19 (e.g., BIOPROTEC ® from AEF Global); Bacillus thuringiensis subsp.
  • tenebrionis strain NB 176 (SD-5428; e.g. NOVODOR ® FC from BioFa DE); Bacillus thuringiensis var. japonensis strain Buibui; Bacillus thuringiensis suhsp. kurstaki strain ABTS 351; Bacillus thuringiensis suhsp. kurstaki strain PB 54; Bacillus thuringiensis subsp. kurstaki strain SA 11; Bacillus thuringiensis subsp. kurstaki strain SA 12; Bacillus thuringiensis suhsp. kurstaki strain EG 2348; Bacillus thuringiensis var. Colmeri (e.g.
  • (D2) fungi selected from the group consisting of Isaria fumosorosea (previously known as Paecilomyces fumosoroseus ) strain apopka 97; Beauveria bassiana strain ATCC 74040 (e.g. NATURALIS ® from Intrachem Bio Italia); Beauveria bassiana strain GHA (Accession No. ATCC74250; e.g.
  • viruses selected from the group consisting of Adoxophyes orana (summer fruit tortrix) granulosis virus (GV), Cydia pomonella (codling moth) granulosis virus (GV), Helicoverpa armigera (cotton bollworm) nuclear polyhedrosis virus (NPV), Spodoptera exigua (beet armyworm) mNPV, Spodoptera frugiperda (fall armyworm) mNPV, and Spodoptera littoralis (African cotton leafworm) NPV;
  • (F) bacteria and fungi which can be added as 'inoculanf to plants or plant parts or plant organs and which, by virtue of their particular properties, promote plant growth and plant health.
  • Agrobacterium spp. Azorhizobium caulinodans, Azospirillum spp., Azotobacter spp., Bradyrhizobium spp., Burkholderia spp., in particular Burkholderia cepacia (formerly known as Pseudomonas cepacia), Gigaspora spp., or Gigaspora monosporum, Glomus spp., Laccaria spp., Lactobacillus buchneri, Paraglomus spp., Pisolithus tinctorus, Pseudomonas spp., Rhizobium spp., in particular Rhizobium trifolii, Rhizopogon spp., Scleroderma spp., Suill
  • G plant extracts and products formed by microorganisms including proteins and secondary metabolites which can be used as biological control agents, such as Allium sativum, Artemisia absinthium, azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum, chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up ( Chenopodium quinoa saponin extract), Pyrethrum/Pyrethrins , Quassia amara, Quercus, Quillaja, Regalia, "Requiem TM Insecticide", rotenone, mr/mr/ryanodine.
  • Allium sativum Artemisia absinthium, azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelm
  • Symphytum officinale Tanacetum vulgare, thymol, Triact 70, TriCon, Tropaeulum majus, Urtica dioica, Veratrin, Viscum album, Brassicaceae extract, in particular oilseed rape powder or mustard powder, as well as bioinsecticidal / acaricidal active substances obtained from olive oil, in particular unsaturated fatty/carboxylic acids having carbon chain lengths C16-C20 as active ingredients, such as, for example, contained in the product with the trade name FLiPPER®.
  • the compound and the composition of the invention may be combined with one or more active ingredients selected from insecticides, acaricides and nematicides.
  • Insecticides as well as the term “insecticidal” refers to the ability of a substance to increase mortality or inhibit growth rate of insects. As used herein, the term “insects” comprises all organisms in the class “Insecta”. “Nematicide” and “nematicidal” refers to the ability of a substance to increase mortality or inhibit the growth rate of nematodes. In general, the term “nematode” comprises eggs, larvae, juvenile and mature forms of said organism.
  • Acaricide and “acaricidal” refers to the ability of a substance to increase mortality or inhibit growth rate of ectoparasites belonging to the class Arachnida, sub-class Acari.
  • insecticides examples include insecticides, acaricides and nematicides, respectively, which could be mixed with the compound and the composition of the invention are:
  • Acetylcholinesterase (AChE) inhibitors such as, for example, carbamates, for example alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC and xylylcarb; or organophosphates, for example acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifo
  • GABA-gated chloride channel blockers such as, for example, cyclodiene-organochlorines, for example chlordane and endosulfan or phenylpyrazoles (fiproles), for example ethiprole and fipronil.
  • Sodium channel modulators such as, for example, pyrethroids, e.g. acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(lR)-trans-isomer], deltamethrin, empenthrin [(EZ)-(lR)-i
  • Nicotinic acetylcholine receptor (nAChR) competitive modulators such as, for example, neonicotinoids, e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam or nicotine or sulfoxaflor or flupyradifurone.
  • Nicotinic acetylcholine receptor (nAChR) allosteric modulators such as, for example, spinosyns, e.g. spinetoram and spinosad.
  • Glutamate -gated chloride channel (GluCl) allosteric modulators such as, for example, avermectins/milbemycins, for example abamectin, emamectin benzoate, lepimectin and milbemectin.
  • Juvenile hormone mimics such as, for example, juvenile hormone analogues, e.g. hydroprene, kinoprene and methoprene or fenoxycarb or pyriproxyfen.
  • Miscellaneous non-specific (multi-site) inhibitors such as, for example, alkyl halides, e.g. methyl bromide and other alkyl halides; or chloropicrine or sulphuryl fluoride or borax or tartar emetic or methyl isocyanate generators, e.g. diazomet and metam.
  • Modulators of Chordotonal Organs such as, for example pymetrozine or flonicamid.
  • Mite growth inhibitors such as, for example clofentezine, hexythiazox and diflovidazin or etoxazole.
  • Microbial disruptors of the insect gut membrane such as, for example Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenehrionis, and B.t. plant proteins: CrylAb, CrylAc, CrylFa, CrylA.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Abl/35Abl.
  • Inhibitors of mitochondrial ATP synthase such as, ATP disruptors such as, for example, diafenthiuron or organotin compounds, for example azocyclotin, cyhexatin and fenbutatin oxide or propargite ortetradifon.
  • ATP disruptors such as, for example, diafenthiuron or organotin compounds, for example azocyclotin, cyhexatin and fenbutatin oxide or propargite ortetradifon.
  • Nicotinic acetylcholine receptor channel blockers such as, for example, bensultap, cartap hydrochloride, thiocylam, and thiosultap-sodium.
  • Inhibitors of chitin biosynthesis type 0, such as, for example, bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron.
  • Inhibitors of chitin biosynthesis type 1, for example buprofezin.
  • Moulting disruptor in particular for Diptera, i.e. dipterans, such as, for example, cyromazine.
  • Ecdysone receptor agonists such as, for example, chromafenozide, halofenozide, methoxyfenozide and tebufenozide.
  • Octopamine receptor agonists such as, for example, amitraz.
  • Mitochondrial complex III electron transport inhibitors such as, for example, hydramethylnone or acequinocyl or fluacrypyrim.
  • Mitochondrial complex I electron transport inhibitors such as, for example from the group of the METI acaricides, e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad or rotenone (Derris).
  • METI acaricides e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad or rotenone (Derris).
  • Voltage-dependent sodium channel blockers such as, for example indoxacarb or metaflumizone.
  • Inhibitors of acetyl CoA carboxylase such as, for example, tetronic and tetramic acid derivatives, e.g. spirodiclofen, spiromesifen and spirotetramat.
  • Mitochondrial complex IV electron transport inhibitors such as, for example, phosphines, e.g. aluminium phosphide, calcium phosphide, phosphine and zinc phosphide or cyanides, e.g. calcium cyanide, potassium cyanide and sodium cyanide.
  • Mitochondrial complex II electron transport inhibitors such as, for example, beta-ketonitrile derivatives, e.g. cyenopyrafen and cyflumetofen and carboxanilides, such as, for example, pyflubumide.
  • Ryanodine receptor modulators such as, for example, diamides, e.g. chlorantraniliprole, cyantraniliprole and flubendiamide, further active compounds such as, for example, Afidopyropen, Afoxolaner, Azadirachtin, Benclothiaz, Benzoximate, Bifenazate, Broflanilide, Bromopropylate, Chinomethionat, Chloroprallethrin, Cryolite, Cyclaniliprole, Cycloxaprid, Cyhalodiamide, Dicloromezotiaz, Dicofol, epsilon-Metofluthrin, epsilon- Momfluthrin, Flometoquin, Fluazaindolizine, Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprole, Fluhexafon, Fluopyram, Fluralaner, Fluxamet
  • herbicides which could be mixed with the compound and the composition of the invention are:
  • plant growth regulators are:
  • safeners which could be mixed with the compound and the composition of the invention are, for example, benoxacor, cloquintocet (-mexyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole (- ethyl), fenclorim, flurazole, fluxofenim, furilazole, isoxadifen (-ethyl), mefenpyr (-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-( ⁇ 4-[(methylcarbamoyl)amino]phenyl ⁇ - sulphonyl)benzamide (CAS 129531-12-0), 4-(dichloroacetyl)-l-oxa-4-azaspiro[4.5]decane (CAS 71526- 07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-l,3-oxazolidine (
  • nitrification inhibitors which can be mixed with the compound and the composition of the invention are selected from the group consisting of 2-(3, 4-dimethyl- 1 H-pyrazol-1 -yl)succinic acid, 2- (4,5-dimethyl-l H-pyrazol-1 -yl)succinic acid, 3,4-dimethyl pyrazolium glycolate, 3,4-dimethyl pyrazolium citrate, 3,4-dimethyl pyrazolium lactate, 3,4-dimethyl pyrazolium mandelate, 1 ,2,4-triazole, 4-Chloro-3-methylpyrazole, N-((3(5)-methyl-1H-pyrazole-l-yl)methyl)acetamide, N-((3(5)-methyl-1 H- pyrazole-l-yl)methyl)formamide, N-((3(5),4-dimethylpyrazole-l-yl)methyl)formamide, N-((4-chloro- 3(5)-methyl-pyrazo
  • the compound and the composition of the invention may be combined with one or more agriculturally beneficial agents.
  • agriculturally beneficial agents include biostimulants, plant growth regulators, plant signal molecules, growth enhancers, microbial stimulating molecules, biomolecules, soil amendments, nutrients, plant nutrient enhancers, etc., such as lipo-chitooligosaccharides (LCO), chitooligosaccharides (CO), chitinous compounds, flavonoids, jasmonic acid or derivatives thereof (e.g., jasmonates), cytokinins, auxins, gibberellins, absiscic acid, ethylene, brassinosteroids, salicylates, macro- and micro-nutrients, linoleic acid or derivatives thereof, linolenic acid or derivatives thereof, karrikins, and beneficial microorganisms (e.g., Rhizobium spp., Bradyrhizobium spp., Sinorhizobium spp., Azorhizobium spp., Glomus spp., Gigaspora
  • Arlhrobacler spp. Arthrobotrys spp., Aspergillus spp., Azospirillum spp., Bacillus spp., Burkholderia spp., Candida spp., Chryseomonas spp., Enterobacter spp., Eupenicillium spp., Exiguobacterium spp., Klebsiella spp., Kluyvera spp., Microbacterium spp., Mucor spp., Paecilomyces spp., Paenibacillus spp., Penicillium spp., Pseudomonas spp., Serratia spp., Stenotrophomonas spp., Streptomyces spp., Streptosporangium spp., Swaminathania spp., Thiobacillus spp., Torulospora
  • the compound and the composition of the invention have potent microbicidal activity and/or plant defense modulating potential. They can be used for controlling unwanted microorganisms, such as unwanted fungi and bacteria, on plants. They can be particularly useful in crop protection (they control microorganisms that cause plants diseases) or for protecting materials (e.g. industrial materials, timber, storage goods) as described in more details herein below. More specifically, the compound and the composition of the invention can be used to protect seeds, germinating seeds, emerged seedlings, plants, plant parts, fruits, harvest goods and/or the soil in which the plants grow from unwanted microorganisms.
  • Control or controlling as used herein encompasses protective, curative and eradicative treatment of unwanted microorganisms.
  • Unwanted microorganisms may be pathogenic bacteria, pathogenic virus, pathogenic oomycetes or pathogenic fungi, more specifically phytopathogenic bacteria, phytopathogenic virus, phytopathogenic oomycetes or phytopathogenic fungi. As detailed herein below, these phytopathogenic microorganims are the causal agents of a broad spectrum of plants diseases.
  • the compound and the composition of the invention can be used as fungicides.
  • fungicide refers to a compound or composition that can be used in crop protection for the control of unwanted fungi, such as Plasmodiophoromycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes and/or for the control of Oomycetes.
  • the compound and the composition of the invention may also be used as antibacterial agent.
  • they may be used in crop protection, for example for the control of unwanted bacteria, such as Pseudomonadaceae, Rhizobiaceae, Xanthomonadaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae .
  • the compound and the composition of the invention may also be used as antiviral agent in crop protection.
  • the compound and the composition of the invention may have effects on diseases from plant viruses, such as the tobacco mosaic virus (TMV), tobacco rattle virus, tobacco stunt virus (TStuV), tobacco leaf curl virus (VLCV), tobacco nervilia mosaic virus (TVBMV), tobacco necrotic dwarf virus (TNDV), tobacco streak virus (TSV), potato virus X (PVX), potato viruses Y, S, M, and A, potato acuba mosaic virus (PAMV), potato mop-top virus (PMTV), potato leaf-roll virus (PLRV), alfalfa mosaic virus (AMV), cucumber mosaic virus (CMV), cucumber green mottlemosaic virus (CGMMV), cucumber yellows virus (CuYV), watermelon mosaic virus (WMV), tomato spotted wilt virus (TSWV), tomato ringspot virus (TomRSV), sugarcane mosaic virus (SCMV), rice drawf virus, rice stripe virus, rice black- streaked drawf virus, strawberry mo
  • the present invention also relates to a method for controlling unwanted microorganisms, such as unwanted fungi, oomycetes and bacteria, on plants comprising the step of applying at least one compound of the formula (I) or at least one composition of the invention to the microorganisms and/or their habitat (to the plants, plant parts, seeds, fruits or to the soil in which the plants grow).
  • unwanted microorganisms such as unwanted fungi, oomycetes and bacteria
  • Suitable substrates that may be used for cultivating plants include inorganic based substrates, such as mineral wool, in particular stone wool, perlite, sand or gravel; organic substrates, such as peat, pine bark or sawdust; and petroleum based substrates such as polymeric foams or plastic beads.
  • Effective and plant-compatible amount means an amount that is sufficient to control or destroy the fungi present or liable to appear on the cropland and that does not entail any appreciable symptom of phytotoxicity for said crops. Such an amount can vary within a wide range depending on the f mgus to be controlled, the type of crop, the crop growth stage, the climatic conditions and the respective compound or composition of the invention used. This amount can be determined by systematic field trials that are within the capabilities of a person skilled in the art.
  • the compound and the composition of the invention may be applied to any plants or plant parts.
  • Plants mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants).
  • Crop plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the genetically modified plants (GMO or transgenic plants) and the plant cultivars which are protectable and non-protectable by plant breeders’ rights.
  • Plant cultivars are understood to mean plants which have new properties ("traits”) and have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can be cultivars, varieties, bio- or genotypes.
  • Plant parts are understood to mean all parts and organs of plants above and below the ground, such as shoots, leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes.
  • the plant parts also include harvested material and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, slips and seeds.
  • Plants which may be treated in accordance with the methods of the invention include the following: cotton, flax, grapevine, fruit, vegetables, such as Rosaceae sp. (for example pome fruits such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries), Ribesioidae sp. , Juglandaceae sp., Betulaceae sp. , Anacardiaceae sp., Fagaceae sp.,Moraceae sp., Oleaceae sp. , Actinidaceae sp. , Lauraceae sp. , Musaceae sp.
  • Rosaceae sp. for example pome fruits such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries
  • Rosaceae sp. for example pome fruits such as apples
  • Rubiaceae sp. for example coffee
  • Theaceae sp. Sterculiceae sp.
  • Rutaceae sp. for example lemons, oranges and grapefruit
  • Solanaceae sp. for example tomatoes
  • Liliaceae sp. for example lettuce
  • Umbelliferae sp. for example lettuce
  • Alliaceae sp. for example leek, onion
  • peas for example peas
  • major crop plants such as Gramineae sp. (for example maize, turf, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (for example sunflower), Brassicaceae sp. (for example white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, pak choi, kohlrabi, radishes, and oilseed rape, mustard, horseradish and cress), Fabacae sp. (for example bean, peanuts), Papilionaceae sp. (for example soya bean), Solanaceae sp. (for example potatoes), Chenopodiaceae sp.
  • Gramineae sp. for example maize, turf, cereals such as wheat, rye, rice, barley, oats, millet and triticale
  • Asteraceae sp. for example sunflower
  • Plants and plant cultivars which may be treated by the above disclosed methods include plants and plant cultivars which are resistant against one or more biotic stresses, i.e. said plants show a better defense against animal and microbial pests, such as against nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and/or viroids.
  • Plants and plant cultivars which may be treated by the above disclosed methods include those plants which are resistant to one or more abiotic stresses.
  • Abiotic stress conditions may include, for example, drought, cold temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozone exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, shade avoidance.
  • Plants and plant cultivars which may be treated by the above disclosed methods include those plants characterized by enhanced yield characteristics. Increased yield in said plants may be the result of, for example, improved plant physiology, growth and development, such as water use efficiency, water retention efficiency, improved nitrogen use, enhanced carbon assimilation, improved photosynthesis, increased germination efficiency and accelerated maturation. Yield may furthermore be affected by improved plant architecture (under stress and non-stress conditions), including but not limited to, early flowering, flowering control for hybrid seed production, seedling vigor, plant size, intemode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, seed number per pod or ear, seed mass, enhanced seed filling, reduced seed dispersal, reduced pod dehiscence and lodging resistance. Further yield traits include seed composition, such as carbohydrate content and composition for example cotton or starch, protein content, oil content and composition, nutritional value, reduction in anti-nutritional compounds, improved processability and better storage stability.
  • Plants and plant cultivars which may be treated by the above disclosed methods include plants and plant cultivars which are hybrid plants that already express the characteristic of heterosis or hybrid vigor which results in generally higher yield, vigor, health and resistance towards biotic and abiotic stresses.
  • the compound according to the invention can be advantageously used to treat transgenic plants, plant cultivars or plant parts that received genetic material which imparts advantageous and/or useful properties (traits) to these plants, plant cultivars or plant parts. Therefore, it is contemplated that the present invention may be combined with one or more recombinant traits or transgenic event(s) or a combination thereof.
  • a transgenic event is created by the insertion of a specific recombinant DNA molecule into a specific position (locus) within the chromosome of the plant genome.
  • the insertion creates a novel DNA sequence referred to as an “event” and is characterized by the inserted recombinant DNA molecule and some amount of genomic DNA immediately adjacent to/flanking both ends of the inserted DNA.
  • trait(s) or transgenic event(s) include, but are not limited to, pest resistance, water use efficiency, yield performance, drought tolerance, seed quality, improved nutritional quality, hybrid seed production, and herbicide tolerance, in which the trait is measured with respect to a plant lacking such trait or transgenic event.
  • Such advantageous and/or useful properties are better plant growth, vigor, stress tolerance, standability, lodging resistance, nutrient uptake, plant nutrition, and/or yield, in particular improved growth, increased tolerance to high or low temperatures, increased tolerance to drought or to levels of water or soil salinity, enhanced flowering performance, easier harvesting, accelerated ripening, higher yields, higher quality and/or a higher nutritional value of the harvested products, better storage life and/or processability of the harvested products, and increased resistance against animal and microbial pests, such as against insects, arachnids, nematodes, mites, slugs and snails.
  • Bt Cry or VIP proteins which include the CrylA, CrylAb, CrylAc, CryllA, CrylllA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CrylF proteins or toxic fragments thereof and also hybrids or combinations thereof, especially the CrylF protein or hybrids derived from a CrylF protein (e.g. hybrid CrylA-CrylF proteins or toxic fragments thereof), the CrylA-type proteins or toxic fragments thereof, preferably the CrylAc protein or hybrids derived from the CrylAc protein (e.g.
  • hybrid CrylAb-CrylAc proteins or the CrylAb or Bt2 protein or toxic fragments thereof, the Cry2Ae, Cry2Af or Cry2Ag proteins or toxic fragments thereof, the CrylA.105 protein or a toxic fragment thereof, the VIP3Aal9 protein, the VIP3Aa20 protein, the VIP3A proteins produced in the COT202 or COT203 cotton events, the VIP3Aa protein ora toxic fragment thereof as described in Estruch et al. (1996), Proc Natl Acad Sci US A.
  • Another and particularly emphasized example of such properties is conferred tolerance to one or more herbicides, for example imidazolinones, sulphonylureas, glyphosate or phosphinothricin.
  • herbicides for example imidazolinones, sulphonylureas, glyphosate or phosphinothricin.
  • DNA sequences encoding proteins which confer properties of tolerance to certain herbicides on the transformed plant cells and plants mention will be particularly be made to the bar or PAT gene or the Streptomyces coelicolor gene described in WO2009/152359 which confers tolerance to glufosinate herbicides, a gene encoding a suitable EPSPS (5-Enolpyruvylshikimat-3-phosphat-svnthase) which confers tolerance to herbicides having EPSPS as a target, especially herbicides such as glyphosate and its salts, a gene encoding glyphosate-n
  • herbicide tolerance traits include at least one ALS (acetolactate synthase) inhibitor (e.g. WO2007/024782), a mutated Arabidopsis ALS/AHAS gene (e.g. U.S. Patent 6,855,533), genes encoding 2,4-D- monooxygenases conferring tolerance to 2,4-D (2,4- dichlorophenoxyacetic acid) and genes encoding Dicamba monooxygenases conferring tolerance to dicamba (3,6-dichloro-2- methoxybenzoic acid).
  • ALS acetolactate synthase
  • a mutated Arabidopsis ALS/AHAS gene e.g. U.S. Patent 6,855,533
  • Yet another example of such properties is resistance to one or more phytopathogenic fungi, for example Asian Soybean Rust.
  • phytopathogenic fungi for example Asian Soybean Rust.
  • DNA sequences encoding proteins which confer properties of resistance to such diseases mention will particularly be made of the genetic material from glycine tomentella, for example from any one of publically available accession lines P1441001 , P1483224, P1583970, P1446958, P1499939, P1505220, P1499933, P1441008, P1505256 or P1446961 as described in WO2019/103918.
  • SAR systemic acquired resistance
  • phytoalexins phytoalexins
  • elicitors resistance genes and correspondingly expressed proteins and toxins.
  • Particularly useful transgenic events in transgenic plants or plant cultivars which can be treated with preference in accordance with the invention include Event 531/ PV-GHBK04 (cotton, insect control, described in WO2002/040677), Event 1143-14A (cotton, insect control, not deposited, described in WO2006/128569); Event 1143-5 IB (cotton, insect control, not deposited, described in WO2006/128570); Event 1445 (cotton, herbicide tolerance, not deposited, described in US-A 2002- 120964 or WO2002/034946); Event 17053 (rice, herbicide tolerance, deposited as PTA-9843, described in WO2010/117737); Event 17314 (rice, herbicide tolerance, deposited as PTA-9844, described in WO2010/117735); Event 281-24-236 (cotton, insect control - herbicide tolerance, deposited as PTA-6233, described in WO2005/103266 or US-A 2005-216969); Event 3006-210-23 (cotton, insect control - herb
  • Event BLR1 (oilseed rape, restoration of male sterility, deposited as NCIMB 41193, described in WO2005/074671), Event CE43-67B (cotton, insect control, deposited as DSM ACC2724, described in US-A 2009-217423 or WO2006/128573); Event CE44-69D (cotton, insect control, not deposited, described in US-A 2010- 0024077); Event CE44-69D (cotton, insect control, not deposited, described in WO2006/128571); Event CE46-02A (cotton, insect control, not deposited, described in WO2006/128572); Event COT102 (cotton, insect control, not deposited, described in US-A 2006-130175 or WO2004/039986); Event COT202 (cotton, insect control, not deposited, described in US-A 2007-067868 or WO2005/054479); Event COT203 (cotton, insect control, not deposited, described, described in US-A 2007-067868 or
  • event DP-040416-8 (com, insect control, ATCC Accession N° PTA-11508, WO2011/075593A1), event DP-043A47-3 (com, insect control, ATCC Accession N° PTA-11509, WO2011/075595A1), event DP- 004114-3 (com, insect control, ATCC Accession N° PTA-11506, WO2011/084621A1), event DP-032316-8 (com, insect control, ATCC Accession N° PTA-11507, WO2011/084632A1), event MON-88302-9 (oilseed rape, herbicide tolerance, ATCC Accession N° PTA-10955, WO2011/153186A1), event DAS-21606-3 (soybean, herbicide tolerance, ATCC Accession No.
  • transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice, triticale, barley, rye, oats), maize, soya beans, potatoes, sugar beet, sugar cane, tomatoes, peas and other types of vegetable, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), with particular emphasis being given to maize, soya beans, wheat, rice, potatoes, cotton, sugar cane, tobacco and oilseed rape.
  • Traits which are particularly emphasized are the increased resistance of the plants to insects, arachnids, nematodes and slugs and snails, as well as the increased resistance of the plants to one or more herbicides.
  • Non-limiting examples of pathogens of fungal diseases which may be treated in accordance with the invention include: diseases caused by powdery mildew pathogens, for example Blumeria species, for example Blumeria graminis,' Podosphaera species, for example Podosphaera leucotricha; Sphaerotheca species, for example Sphaerotheca fuliginea ; Uncinula species, for example Uncinula necator ; diseases caused by rust disease pathogens, for example Gymnosporangium species, for example Gymnosporangium sabinae; Hemileia species, for example Hemileia vastatrix; Phakopsora species, for example Phakopsora pachyrhizi or Phakopsora meibomiae; Puccinia species, for example Puccinia recondita, Puccinia graminis oder Puccinia striiformis ; Uromyces species, for example Uromyces
  • Pseudomonas species for example Pseudomonas syringae pv. lachrymans ; Erwinia species, for example Erwinia amylovora ; Liberibacter species, for example Liberibacter asiaticus; Xyella species, for example Xylella fastidiosa ; Ralstonia species, for example Ralstonia solanacearum; Dickeya species, for example Dickeya solani,' Clavibacter species, for example Clavibacter michiganensis; Streptomyces species, for example Streptomyces scabies. diseases of soya beans:
  • Rhizoctonia solani sclerotinia stem decay ( Sclerotinia sclerotiorum), sclerotinia southern blight (i Sclerotinia rolfsii), thielaviopsis root rot ( Thielaviopsis basicola).
  • the compound and the composition of the invention may reduce the mycotoxin content in the harvested material and the foods and feeds prepared therefrom.
  • Mycotoxins include particularly, but not exclusively, the following: deoxynivalenol (DON), nivalenol, 15-Ac-DON, 3-Ac-DON, T2- and HT2- toxin, fumonisins, zearalenon, moniliformin, fusarin, diaceotoxyscirpenol (DAS), beauvericin, enniatin, fusaroproliferin, fusarenol, ochratoxins, patulin, ergot alkaloids and aflatoxins which can be produced, for example, by the following fungi: Fusarium spec., such as F.
  • verticillioides and also by Aspergillus spec., such as A.flavus, A. parasiticus, A. nomius,A. ochraceus, A. clavatus,A. terreus,A. versicolor, Penicillium spec., such as P. verrucosum,P. viridicatum,P. citrinum, P. expansum, P. claviforme,P. roqueforti, Claviceps spec., such as C. purpurea, C. fusiformis, C. paspali, C. africana, Stachybotrys spec and others.
  • Aspergillus spec. such as A.flavus, A. parasiticus, A. nomius,A. ochraceus, A. clavatus,A. terreus,A. versicolor
  • Penicillium spec. such as P. verrucosum,P. viridicatum,P. cit
  • the compound and the composition of the invention may also be used in the protection of materials, especially for the protection of industrial materials against attack and destruction by phytopathogenic fungi.
  • the compound and the composition of the invention may be used as antifouling compositions, alone or in combinations with other active ingredients.
  • Industrial materials in the present context are understood to mean inanimate materials which have been prepared for use in industry.
  • industrial materials which are to be protected from microbial alteration or destruction may be adhesives, glues, paper, wallpaper and board/cardboard, textiles, carpets, leather, wood, fibers and tissues, paints and plastic articles, cooling lubricants and other materials which can be infected with or destroyed by microorganisms.
  • Parts of production plants and buildings, for example cooling-water circuits, cooling and heating systems and ventilation and air-conditioning units, which may be impaired by the proliferation of microorganisms may also be mentioned within the scope of the materials to be protected.
  • Industrial materials within the scope of the present invention preferably include adhesives, sizes, paper and card, leather, wood, paints, cooling lubricants and heat transfer fluids, more preferably wood.
  • the compound and the composition of the invention may prevent adverse effects, such as rotting, decay, discoloration, decoloration or formation of mould.
  • the compound and the composition of the invention may also be used against fungal diseases liable to grow on or inside timber.
  • Timber means all types of species of wood, and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood, and plywood.
  • the compound and the composition of the invention may be used to protect objects which come into contact with saltwater or brackish water, especially hulls, screens, nets, buildings, moorings and signalling systems, from fouling.
  • Storage goods are understood to mean natural substances of vegetable or animal origin or processed products thereof which are of natural origin, and for which long-term protection is desired.
  • Storage goods of vegetable origin for example plants or plant parts, such as stems, leaves, tubers, seeds, fruits, grains, may be protected freshly harvested or after processing by (pre)drying, moistening, comminuting, grinding, pressing or roasting.
  • Storage goods also include timber, both unprocessed, such as construction timber, electricity poles and barriers, or in the form of finished products, such as furniture.
  • Storage goods of animal origin are, for example, hides, leather, furs and hairs.
  • the compound and the composition of the invention may prevent adverse effects, such as rotting, decay, discoloration, decoloration or formation of mould.
  • Microorganisms capable of degrading or altering industrial materials include, for example, bacteria, fungi, yeasts, algae and slime organisms.
  • the compound and the composition of the invention preferably act against fungi, especially moulds, wood-discoloring and wood-destroying fungi (Ascomycetes, Basidiomycetes, Deuteromycetes and Zygomycetes), and against slime organisms and algae.
  • microorganisms of the following genera Alternaria, such as Alternaria tenuis,' Aspergillus, such as Aspergillus niger; Chaetomium, such as Chaetomium globosum; Coniophora, such as Coniophora puetana; Lentinus, such as Lentinus tigrinus; Penicillium, such as Penicillium glaucum; Polyporus, such as Polyporus versicolor, Aureobasidium, such as Aureobasidium pullulans,' Sclerophoma, such as Sclerophoma pityophila; Trichoderma, such as Trichoderma viride; Ophiostoma spp., Ceratocystis spp., Humicola spp., Petriella spp., Trichurus spp., Coriolus spp., Gloeophyllum spp., Pleurotus spp., Por
  • the compound and the composition of the invention may also be used to protect seeds from unwanted microorganisms, such as phytopathogenic microorganisms, for instance phytopathogenic fungi or phytopathogenic oomycetes.
  • seedfsl as used herein include dormant seeds, primed seeds, pregerminated seeds and seeds with emerged roots and leaves.
  • the present invention also relates to a method for protecting seeds from unwanted microorganisms which comprises the step of treating the seeds with the compound or the composition of the invention.
  • the treatment of seeds with the compound or the composition of the invention protects the seeds from phytopathogenic microorganisms, but also protects the germinating seeds, the emerging seedlings and the plants after emergence from the treated seeds. Therefore, the present invention also relates to a method for protecting seeds, germinating seeds and emerging seedlings.
  • the seeds treatment may be performed prior to sowing, at the time of sowing or shortly thereafter.
  • the seeds treatment may be performed as follows: the seeds may be placed into a mixer with a desired amount of the compound or the composition of the invention, the seeds and the compound or the composition of the invention are mixed until an homogeneous distribution on seeds is achieved. If appropriate, the seeds may then be dried.
  • the invention also relates to seeds coated with the compound or the composition of the invention.
  • the seeds are treated in a state in which it is sufficiently stable for no damage to occur in the course of treatment.
  • seeds can be treated at any time between harvest and shortly after sowing. It is customary to use seeds which have been separated from the plant and freed from cobs, shells, stalks, coats, hairs or the flesh of the fruits. For example, it is possible to use seeds which have been harvested, cleaned and dried down to a moisture content of less than 15% by weight. Alternatively, it is also possible to use seeds which, after drying, for example, have been treated with water and then dried again, or seeds just after priming, or seeds stored in primed conditions or pre -germinated seeds, or seeds sown on nursery trays, tapes or paper.
  • the amount of the compound of formula (I) or the composition of the invention applied to the seeds is typically such that the germination of the seed is not impaired, or that the resulting plant is not damaged. This must be ensured particularly in case the compound of formula (I) would exhibit phytotoxic effects at certain application rates.
  • the intrinsic phenotypes of transgenic plants should also be taken into consideration when determining the amount of the compound of formula (I) to be applied to the seed in order to achieve optimum seed and germinating plant protection with a minimum amount of compound being employed.
  • the compound of formula (I) can be applied as such, directly to the seeds, i.e. without the use of any other components and without having been diluted. Also the composition of the invention can be applied to the seeds.
  • the compound of formula (I) and the composition of the invention are suitable for protecting seeds of any plant variety.
  • Preferred seeds are that of cereals (such as wheat, barley, rye, millet, triticale, and oats), oilseed rape, maize, cotton, soybean, rice, potatoes, sunflower, beans, coffee, peas, beet (e.g. sugar beet and fodder beet), peanut, vegetables (such as tomato, cucumber, onions and lettuce), lawns and ornamental plants. More preferred are seeds of wheat, soybean, oilseed rape, maize and rice.
  • the compound of formula (I) and the composition of the invention may be used for treating transgenic seeds, in particular seeds of plants capable of expressing a polypeptide or protein which acts against pests, herbicidal damage or abiotic stress, thereby increasing the protective effect.
  • Seeds of plants capable of expressing a polypeptide or protein which acts against pests, herbicidal damage or abiotic stress may contain at least one heterologous gene which allows the expression of said polypeptide or protein.
  • These heterologous genes in transgenic seeds may originate, for example, from microorganisms of the species Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus or Gliocladium.
  • heterologous genes preferably originate from Bacillus sp., in which case the gene product is effective against the European com borer and/or the Western com rootworm. Particularly preferably, the heterologous genes originate from Bacillus thuringiensis.
  • the compound of formula (I) can be applied as such, or for example in the form of as ready-to-use solutions, emulsions, water- or oil-based suspensions, powders, wettable powders, pastes, soluble powders, dusts, soluble granules, granules for broadcasting, suspoemulsion concentrates, natural products impregnated with the compound of formula (I), synthetic substances impregnated with the compound of formula (I), fertilizers or microencapsulations in polymeric substances.
  • Application is accomplished in a customary manner, for example by watering, spraying, atomizing, broadcasting, dusting, foaming or spreading-on. It is also possible to deploy the compound of formula (I) by the ultra-low volume method, via a drip irrigation system or drench application, to apply it in-furrow or to inject it into the soil stem or trunk. It is further possible to apply the compound of formula (I) by means of a wound seal, paint or other wound dressing.
  • the effective and plant-compatible amount of the compound of formula (I) which is applied to the plants, plant parts, fruits, seeds or soil will depend on various factors, such as the compound/composition employed, the subject of the treatment (plant, plant part, fruit, seed or soil), the type of treatment (dusting, spraying, seed dressing), the purpose of the treatment (curative and protective), the type of microorganisms, the development stage of the microorganisms, the sensitivity of the microorganisms, the crop growth stage and the environmental conditions.
  • the application rates can vary within a relatively wide range, depending on the kind of application.
  • the application rate may range from 0.1 to 10 000 g/ha, preferably from 10 to 1000 g/ha, more preferably from 50 to 300 g/ha (in the case of application by watering or dripping, it is even possible to reduce the application rate, especially when inert substrates such as rockwool or perlite are used).
  • the application rate may range from 0.1 to 200 g per 100 kg of seeds, preferably from 1 to 150 g per 100 kg of seeds, more preferably from 2.5 to 25 g per 100 kg of seeds, even more preferably from 2.5 to 12.5 g per 100 kg of seeds.
  • the application rate may range from 0.1 to 10 000 g/ha, preferably from 1 to 5000 g/ha.
  • the compound and the composition of the invention can be used in combination with models e.g. embedded in computer programs for site specific crop management, satellite farming, precision farming or precision agriculture.
  • models support the site specific management of agricultural sites with data from various sources such as soils, weather, crops (e.g. type, growth stage, plant health), weeds (e.g. type, growth stage), diseases, pests, nutrients, water, moisture, biomass, satellite data, yield etc. with the purpose to optimize profitability, sustainability and protection of the environment.
  • crops e.g. type, growth stage, plant health
  • weeds e.g. type, growth stage
  • diseases, pests, nutrients, water, moisture, biomass, satellite data, yield etc. with the purpose to optimize profitability, sustainability and protection of the environment.
  • such models can help to optimize agronomical decisions, control the precision of pesticide applications and record the work performed.
  • the compound of formula (I) can be applied to a crop plant according to appropriate dose regime if a model models the development of a fungal disease and calculates that a threshold has been reached for which it is recommendable to apply the compound of formula (I) to the crop plant.
  • the compound of formula (I) can also be used in combination with smart spraying equipment such as e.g. spot spraying or precision spraying equipment attached to or housed within a farm vehicle such as a tractor, robot, helicopter, airplane, unmanned aerial vehicle (UAV) such as a drone, etc.
  • smart spraying equipment such as e.g. spot spraying or precision spraying equipment attached to or housed within a farm vehicle such as a tractor, robot, helicopter, airplane, unmanned aerial vehicle (UAV) such as a drone, etc.
  • Such an equipment usually includes input sensors (such as e.g. a camera) and a processing unit configured to analyze the input data and configured to provide a decision based on the analysis of the input data to apply the compound of formula (I) to the crop plants (respectively the weeds) in a specific and precise manner.
  • the use of such smart spraying equipment usually also requires positions systems (e.g. GPS receivers) to localize recorded data and to guide or to control farm vehicles; geographic information systems (GIS) to
  • fungal diseases can be detected from imagery acquired by a camera.
  • fungal diseases can be identified and/or classified based on that imagery.
  • identification and/ classification can make use of image processing algorithms.
  • image processing algorithms can utilize machine learning algorithms, such as trained neutral networks, decision trees and utilize artificial intelligence algorithms. In this manner, the compounds described herein can be applied only where needed.
  • LogP value is determined by measurement of LC-UV, in an acidic range, with 0.1% formic acid in water and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile).
  • LogP value is determined by measurement of LC-UV, in a neutral range, with 0.001 molar ammonium acetate solution in water and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile).
  • LogP value is determined by measurement of LC-UV, in an acidic range, with 0.1% phosphoric acid and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile).
  • 'H-NMR data of selected examples as provided herein are written in form of 'H-NMR- peak lists. To each signal peak are listed the d-value in ppm and the signal intensity in round brackets. Between the d-value - signal intensity pairs are semicolons as delimiters.
  • the peak list of an example has therefore the form: ⁇ 1 (intensity 1 ); ⁇ 2 (intensity 2 ); . ; ⁇ ⁇ (intensity i ); . ; ⁇ n (intensity n )
  • Intensity of sharp signals correlates with the height of the signals in a printed example of a NMR spectrum in cm and shows the real relations of signal intensities. Prom broad signals several peaks or the middle of the signal and their relative intensity in comparison to the most intensive signal in the spectrum can be shown.
  • the peaks of stereoisomers of the target compounds and/or peaks of impurities have usually on average a lower intensity than the peaks of target compounds (for example with a purity >90%).
  • Such stereoisomers and/or impurities can be typical for the specific preparation process. Therefore their peaks can help to recognize the reproduction of our preparation process via “side-products-fmgerprints”.
  • An expert who calculates the peaks of the target compounds with known methods (MestreC, ACD- simulation, but also with empirically evaluated expectation values) can isolate the peaks of the target compounds as needed optionally using additional intensity filters. This isolation would be similar to relevant peak picking at classical 'H-NMR interpretation.
  • Tables 1 and 2 illustrates in a non-limiting manner examples of compounds of formula (I) according to the invention :
  • (**) 1.031 is a mixture of stereoisomers.
  • (**) 1.046 is a mixture of stereoisomers
  • Table 2 Table 3 illustrates in a non-limiting manner examples of intermediates of formula (II) according to the invention :
  • the intermediates of formula (II) which are mentioned in table 3 herein below were prepared in accordance with the procedures detailed herein below in connection with specific examples and with the general description of the processes herein disclosed.
  • Table 4 provides the NMR data ( 1 H) of a selected number of compounds from tables 1, 2 and 3.
  • Step 2 preparation of 2-chloro-5-[5-(difluoromethyl)-1.3.4-oxadiazol-2-yl]-pyrimidine
  • Step 3 preparation of 5-[5-(difluoromethyl)-1.3.4-oxadiazol-2-yl]-N-[l-(2-fluorophenyl)-2- methylpropyl]pyrimidin-2-amine (compound 1.007)
  • Step 1 Preparation of 5-[5-(difluoromethyl)-1.3.4-oxadiazol-2-yl]pyrimidin-2-amine
  • 2-chloro-5-[5-(difluoromethyl)-1.3.4-oxadiazol-2-yl]-pyrimidine 64.5 mmol
  • a 4 M ammonia solution in THF (193.5 mmol)
  • the reaction mixture was warmed up to 0 °C and stirred for 2.5 hours.
  • the reaction mixture was concentrated under reduced pressure.
  • Step 2 Preparation of 5-[5-(difluoromethyl)-1.3.4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)but-2-yn-l- yl]pyrimidin-2 -amine (compound 1.004)
  • Step 1 Preparation of 2-[(2-amino-l-phenylethyl)amino]-N'-(difluoroacetyl)pyrimidine-5- carbohydrazide (compound II.001)
  • Step 2 Preparation of N-[2-( ⁇ 5-[5-(difluoromethyl)-1.3.4-oxadiazol-2-yl]pyrimidin-2-yl ⁇ amino)-2- phenylethyl]-4-methylbenzenesulfonamide (compound 1.025)
  • UV stability reported with the half-life time of the photo degradation was performed by irradiating the samples for 24h with the full UV/VIS Spectrum as available on a SUNTEST XLS+ going from 250nm to 800nm, followed by an analysis of the analyte and its possible degradation products via reversed phase liquid chromatography with UV-detection coupled to a single quadrupole mass spectrometer using the following method:
  • the analyte is determined by measurement of LC-UV-MS , with 0.085% (v/v) formic acid in water and 0.1% (v/v) formic acid acetonitrile as eluent (linear gradient from 5% acetonitrile to 95% acetonitrile).
  • the analyte is identified and determined via UV and MS-spectrum.
  • the half-life time is determined over the course of 5 time points at Oh, 2h, 4h, 6h and 24h in triplicates each time point. All time points are normalized on detector responses received at Oh.
  • the half-life time is determined fitting the results to a 1 st order degradation function and is returned with the unit [h] .
  • Table 5 provides the half-life times of a selected number of compounds from table 1 and some reference compounds known from WO2019/122323.
  • the following compounds were used as reference examples: ref. 1: N-[1-(2-pyridyl)cyclobutyl]-5-[5-(triiluoromethyl)-1.2.4-oxadiazol-3-yl]pyrimidin-2-amine ref. 2: N-(1-phenylcyclopropyl)-5-[5-(trifluoromethyl)-1.2.4-oxadiazol-3-yl]pyrimidin-2-amine
  • Emulsifier 1 m ⁇ of polyoxyethylene sorbitan monooleate (Tween ® 80) per mg of active ingredient
  • the active ingredients were made soluble and homogenized in a mixture of Dimethyl sulfoxide/Acetone/ /Tween ® 80 and then diluted in water to the desired concentration.
  • the young plants of wheat were treated by spraying the active ingredient prepared as described above. Control plants were treated only with an aqueous solution of Acetone/Dimethyl sulfoxide/ Tween ® 80.
  • the plants were contaminated by spraying the leaves with an aqueous suspension of Puccinia recondita spores.
  • the contaminated wheat plants were incubated for 24 hours at 20°C and at 100% relative humidity and then for 9 days at 20°C and at 70-80% relative humidity.
  • the test was evaluated 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control plants while an efficacy of 100% means that no disease was observed.
  • Emulsifier 1 pi of polyoxyethylene sorbitan monooleate (Tween ® 80) per mg of active ingredient
  • the active ingredients were made soluble and homogenized in a mixture of Dimethyl sulfoxide/Acetone/ /Tween ® 80 and then diluted in water to the desired concentration.
  • the young plants of soybean were treated by spraying the active ingredient prepared as described above. Control plants were treated only with an aqueous solution of Acetone/Dimethyl sulfoxide/ Tween® 80.
  • the plants were contaminated by spraying the leaves with an aqueous suspension of Phakospora pachyrhizi spores.
  • the contaminated soybean plants were incubated for 24 hours at 24°C and at 100% relative humidity and then for 10 days at 24°C and at 70-80% relative humidity.
  • the active ingredients were made soluble and homogenized in a mixture of Dimethyl sulfoxide/Acetone/ /Tween ® 80 and then diluted in water to the desired concentration.
  • the young plants of bean were treated by spraying the active ingredient prepared as described above. Control plants were treated only with an aqueous solution of Acetone/Dimethyl sulfoxide/ Tween ® 80.
  • the plants were contaminated by spraying the leaves with an aqueous suspension of Colletotrichum lindemuthianum spores.
  • the contaminated bean plants were incubated for 24 hours at 20°C and at 100% relative humidity and then for 6 days at 20°C and at 90% relative humidity.
  • the test was evaluated 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control plants while an efficacy of 100% means that no disease was observed.
  • Culture medium 14.6g anhydrous D-glucose (VWR), 7.1g Mycological Peptone (Oxoid), 1.4g granulated Yeast Extract (Merck), QSP 1 liter Inoculum: spores suspension
  • Fungicides were solubilized in DMSO and the solution used to prepare the required range of concentrations.
  • the final concentration of DMSO used in the assay was ⁇ 1%.
  • a spore suspension of C. lindemuthianum was prepared and diluted to the desired spore density.
  • Fungicides were evaluated for their ability to inhibit spores germination and mycelium growth in liquid culture assay.
  • the compounds were added in the desired concentration to the culture medium with spores. After 6 days incubation, fiingi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without fungicides.
  • the plants remained in the incubation cabinet at approximately 24 °C and a relative atmospheric humidity of approximately 80% and a day / night interval of 12 hours.
  • Emulsifier 1 part by weight of polyoxyethylene sorbitan monooleate To produce a suitable preparation of active compound, 1 part by weight of active compound was mixed with the stated amounts of solvent and emulsifier, and the concentrate was diluted with water to the desired concentration.
  • the plants remained in the incubation cabinet at approximately 24°C and a relative atmospheric humidity of approximately 80 % and a day / night interval of 12h.
  • the plants remained in the incubation cabinet at approximately 24°C and a relative atmospheric humidity of approximately 80 % and a day / night interval of 12h.
  • Emulsifier 1 part by weight of polyoxyethylene sorbitan monooleate To produce a suitable preparation of active compound, 1 part by weight of active compound or active compound combination was mixed with the stated amounts of solvent and emulsifier, and the concentrate was diluted with water to the desired concentration.
  • the plants were placed in the greenhouse at a temperature of approximately 20°C and a relative atmospheric humidity of approximately 80%.
  • the test was evaluated 8 days after the inoculation. 0% means an efficacy which corresponds to that of the untreated control, while an efficacy of 100% means that no disease is observed.

Abstract

La présente invention concerne l'utilisation de composés de 1,3,4-oxadiazol-2-ylpyrimidine pour lutter contre des micro-organismes phytopathogènes, en particulier des champignons phytopathogènes, dans la protection des cultures.
PCT/EP2021/066410 2020-06-19 2021-06-17 1,3,4-oxadiazole pyrimidines en tant que fongicides WO2021255170A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR112022025755A BR112022025755A2 (pt) 2020-06-19 2021-06-17 1,3,4-oxadiazol pirimidinas como fungicidas

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20181239 2020-06-19
EP20181239.3 2020-06-19

Publications (1)

Publication Number Publication Date
WO2021255170A1 true WO2021255170A1 (fr) 2021-12-23

Family

ID=71119990

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2021/066410 WO2021255170A1 (fr) 2020-06-19 2021-06-17 1,3,4-oxadiazole pyrimidines en tant que fongicides

Country Status (5)

Country Link
AR (1) AR122685A1 (fr)
BR (1) BR112022025755A2 (fr)
TW (1) TW202216699A (fr)
UY (1) UY39276A (fr)
WO (1) WO2021255170A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024013106A1 (fr) * 2022-07-11 2024-01-18 Syngenta Crop Protection Ag Compositions fongicides

Citations (174)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010A (en) 1841-03-18 Machine foe
US2009A (en) 1841-03-18 Improvement in machines for boring war-rockets
US24077A (en) 1859-05-17 Window-sash supporter
US137395A (en) 1873-04-01 Improvement in nuts
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
US5061495A (en) 1988-03-07 1991-10-29 Agricultural Genetics Company Limited Antibiotic derived from b. subtilis
WO1997017432A1 (fr) 1995-11-06 1997-05-15 Wisconsin Alumni Research Foundation Toxines proteiques insecticides provenant de photorhabdus
WO1998008932A1 (fr) 1996-08-29 1998-03-05 Dow Agrosciences Llc TOXINES PROTEINIQUES INSECTICIDES ISOLEES A PARTIR DE $i(PHOTORHABDUS)
WO1998044140A1 (fr) 1997-04-03 1998-10-08 Dekalb Genetics Corporation Lignees de mais resistantes aux glyphosates
WO1998050427A1 (fr) 1997-05-05 1998-11-12 Dow Agrosciences Llc TOXINES PROTEIQUES INSECTICIDES ISSUES DE $i(XENORHABDUS)
JPH11253151A (ja) 1997-11-13 1999-09-21 Kumiai Chem Ind Co Ltd イネの育苗時病害防除剤
WO2000015637A1 (fr) 1998-09-16 2000-03-23 Dow Agrosciences Llc 2-methoxyimino -2-(pyridinyloxymethyle) phenyle acetamides comprenant des heterocycles a 5 chainons sur le cycle pyridine, utilises comme fongicides
US6060051A (en) 1997-05-09 2000-05-09 Agraquest, Inc. Strain of bacillus for controlling plant diseases and corn rootworm
WO2000026345A1 (fr) 1998-11-03 2000-05-11 Aventis Cropscience N.V. Riz tolerant au glufosinate
WO2000026356A1 (fr) 1998-11-03 2000-05-11 Aventis Cropscience N. V. Riz tolerant au glufosinate
WO2000068198A2 (fr) 1999-05-05 2000-11-16 Merck Frosst Canada & Co. Derives de pyridine heterosubstitues utilises comme inhibiteurs de pde 4
WO2001031042A2 (fr) 1999-10-29 2001-05-03 Aventis Cropscience N.V. Plantes brassica male sterile et procedes de production de ces plantes
US6245551B1 (en) 1999-03-30 2001-06-12 Agraquest, Inc. Strain of Bacillus pumilus for controlling plant diseases caused by fungi
WO2001041558A1 (fr) 1999-12-08 2001-06-14 Aventis Cropscience N.V. Colza oleagineux d'hiver hybrides et son procede de production
WO2001047952A2 (fr) 1999-12-28 2001-07-05 Bayer Cropscience N.V. Proteines insecticides provenant de bacillus thuringiensis
WO2001051654A2 (fr) 2000-01-11 2001-07-19 Bayer Cropscience N.V. Procedes et assortiments de materiel permettant d'identifier l'evenement elite gat-zm1 dans les echantillons biologiques
WO2002027004A2 (fr) 2000-09-29 2002-04-04 Monsanto Technology Llc Plante de ble 33391 resistante au glyphosate et compositions et procedes de detection de celle-ci
WO2002034946A2 (fr) 2000-10-25 2002-05-02 Monsanto Technology Llc Mecanisme biochimique de plant de coton pv-ghgt07(1445), compositions et techniques de detection de celui-ci
WO2002036831A2 (fr) 2000-10-30 2002-05-10 Monsanto Technology Llc Colza canola pv-bngt(rt73), compositions et procedes de detection correspondants
WO2002040677A2 (fr) 2000-11-20 2002-05-23 Monsanto Technology Llc Evenement du coton pv-ghbk04 (531) et compositions et procedes permettant de detecter la presence de ce dernier
WO2002044407A2 (fr) 2000-11-30 2002-06-06 Ses Europe N.V. Séquence des flancs de t227-1
US20020102582A1 (en) 2000-09-13 2002-08-01 Levine Elaine B. Corn event MON810 and compositions and methods for detection thereof
WO2002069901A2 (fr) 2001-03-02 2002-09-12 Merck Frosst Canada & Co. Inhibiteurs de cathepsines de la cysteine protease
WO2002100163A2 (fr) 2001-06-11 2002-12-19 Monsanto Technology Llc Evenement mon15985 du coton et compositions et procedes servant a sa detection
WO2003000051A2 (fr) 2001-06-22 2003-01-03 Drahos David J Nouveau biofongicide
WO2003013224A2 (fr) 2001-08-06 2003-02-20 Bayer Bioscience N.V. Cotonniers avec tolerance aux herbicides et procedes de production et d'identification de ces cotonniers
WO2003052073A2 (fr) 2001-12-17 2003-06-26 Syngenta Participations Ag Nouvel evenement du mais
US20030126634A1 (en) 1990-08-09 2003-07-03 Dekalb Genetics Corporation Methods and compositions for the increase of yield in plants
WO2003106457A1 (fr) 2002-06-14 2003-12-24 Syngenta Limited Derives de spiroindolinepiperidine
WO2004011601A2 (fr) 2002-07-29 2004-02-05 Monsanto Technology, Llc Mais pv-zmir13 designe mon863, composition et procedes de detection
WO2004039986A1 (fr) 2002-10-29 2004-05-13 Syngenta Participations Ag Coton insecticide cot102
WO2004053062A2 (fr) 2002-12-05 2004-06-24 Monsanto Technology Llc Evenement associe a l'agrostide asr-368 et compositions et procedes de detection de la presence de celle-ci
WO2004072235A2 (fr) 2003-02-12 2004-08-26 Monsanto Technology Llc Evenement mon 88913 de plant de coton et procedes de detection correspondants
WO2004074492A1 (fr) 2003-02-20 2004-09-02 Kws Saat Ag Betteraves sucrieres tolerant le glyphosate
US20040172669A1 (en) 2003-02-28 2004-09-02 Josef Kraus Glyphosate tolerant sugar beet
WO2004099447A2 (fr) 2003-05-02 2004-11-18 Dow Agrosciences Llc Mais tc1507 et procedes de detection de celui-ci
WO2004099160A1 (fr) 2003-05-12 2004-11-18 Sumitomo Chemical Company, Limited Composes de pyrimidine et compostion de lutte contre les animaux nuisibles contenant ces composes
US6855533B2 (en) 1995-04-20 2005-02-15 Basf Corporation Structure-based designed herbicide resistant products
WO2005054480A2 (fr) 2003-12-01 2005-06-16 Syngenta Participations Ag Plants de coton resistant aux insectes et procedes de detection de ces derniers
WO2005054479A1 (fr) 2003-12-01 2005-06-16 Syngenta Participations Ag Cotonnier resistant aux insectes et procedes pour detecter celui-ci
WO2005059103A2 (fr) 2003-12-15 2005-06-30 Monsanto Technology Llc Plant de mais mon88017, compositions et procedes de detection associes
WO2005061720A2 (fr) 2003-12-11 2005-07-07 Monsanto Technology Llc Compositions de mais a haute teneur en lysine et methodes de detection correspondantes
WO2005074671A1 (fr) 2004-01-30 2005-08-18 Syngenta Participations Ag Restauration amelioree de la fertilite pour le systeme ogura d'androsterilite cytoplasmique du brassica, et procede correspondant
US20050216969A1 (en) 2004-03-26 2005-09-29 Dow Agrosciences Llc Cry1F and Cry1AC transgenic cotton lines and event-specific identification thereof
WO2005103301A2 (fr) 2004-03-25 2005-11-03 Syngenta Participations Ag Mais mir604
WO2006003494A2 (fr) 2004-06-28 2006-01-12 Syngenta Participations Ag Composes chimiques
US20060070139A1 (en) 2004-09-29 2006-03-30 Pioneer Hi-Bred International, Inc. Corn event DAS-59122-7 and methods for detection thereof
WO2006043635A1 (fr) 2004-10-20 2006-04-27 Kumiai Chemical Industry Co., Ltd. Dérivé de 3-triazolylphénylsulfide et insecticide/acaricide/nématicide incluant ledit dérivé au titre de principe actif
US7094592B2 (en) 2001-11-26 2006-08-22 Kumiai Chemical Industry Co., Ltd. Bacillus sp. D747 strain, plant disease controlling agents and insect pest controlling agents using the same and control method using the agents
WO2006098952A2 (fr) 2005-03-16 2006-09-21 Syngenta Participations Ag Mais 3272 et procedes pour le detecter
WO2006108675A2 (fr) 2005-04-11 2006-10-19 Bayer Bioscience N.V. Evenement elite a5547-127 et procedes et trousses pour l'identification d'un tel evenement dans des echantillons biologiques
WO2006108674A2 (fr) 2005-04-08 2006-10-19 Bayer Bioscience N.V. Evenement elite a2704-12 et procedes et trousses permettant d'identifier cet evenement dans des prelevements biologiques
WO2006128570A1 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide 1143-51b
WO2006128572A1 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide ce46-02a
WO2006128569A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide 1143-14a
WO2006128573A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide ce43-67b
WO2006128568A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide t342-142
WO2006130436A2 (fr) 2005-05-27 2006-12-07 Monsanto Technology Llc Evenement de soja mon89788 et procedes de detection de celui-ci
WO2006128571A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide ce44-69d
WO2007017186A1 (fr) 2005-08-08 2007-02-15 Bayer Bioscience N.V. Cotonniers tolerants aux herbicides et leurs procedes d'identification
WO2007024782A2 (fr) 2005-08-24 2007-03-01 Pioneer Hi-Bred International, Inc. Compositions assurant une tolerance a de multiples herbicides et methodes d'utilisation
WO2007040280A1 (fr) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Cyclic amine compound and pest control agent
WO2007091277A2 (fr) 2006-02-10 2007-08-16 Maharashtra Hybrid Seeds Company Limited (Mahyco) Aubergine transgenique (solanum melongena) comprenant un evenement ee-i
WO2007090852A1 (fr) 2006-02-10 2007-08-16 Cellzome Limited Composés d'amino pyrimidine destinés à traiter des troubles inflammatoires
WO2007140256A1 (fr) 2006-05-26 2007-12-06 Monsanto Technology, Llc Plant et semence de maïs correspondant au produit transgénique mon89034, procédés de détection et utilisation associés
WO2007142840A2 (fr) 2006-06-03 2007-12-13 Syngenta Participations Ag Événement de transformation de maïs mir162
US20070292854A1 (en) 2000-06-22 2007-12-20 Behr Carl F Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof
WO2008002872A2 (fr) 2006-06-28 2008-01-03 Pioneer Hi-Bred International, Inc. Événement de soja 3560.4.3.5 et compositions et procedes d'identification et/ou de détection de celui-ci
US20080064032A1 (en) 2006-09-13 2008-03-13 Syngenta Participations Ag Polynucleotides and uses thereof
WO2008054747A2 (fr) 2006-10-31 2008-05-08 E. I. Du Pont De Nemours And Company Événement de soja dp-305423-1, leurs compositions et leurs procédés d'identification et/ou de détection
WO2008112019A2 (fr) 2006-10-30 2008-09-18 Pioneer Hi-Bred International, Inc. Evènement dp-098140-6 du maïs et compositions et procédés pour son identification et/ou sa détection
WO2008114282A2 (fr) 2007-03-19 2008-09-25 Maharashtra Hybrid Seeds Company Limited Riz transgénique (oryza sativa) comprenant l'événement pe-7 et son procédé de détection
WO2008122406A1 (fr) 2007-04-05 2008-10-16 Bayer Bioscience N.V. Plants de coton résistant aux insectes et leurs procédés d'identification
US20080289060A1 (en) 2006-08-24 2008-11-20 Bayer Bioscience N.V. Herbicide tolerant rice plants and methods for identifying same
WO2008151780A1 (fr) 2007-06-11 2008-12-18 Bayer Bioscience N.V. Cotonniers résistant aux insectes comprenant un événement élite ee-gh6 et leurs procédés d'identification
CN101337937A (zh) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-3-取代氨基吡唑类化合物
CN101337940A (zh) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
US20090130071A1 (en) 2007-11-15 2009-05-21 Ai-Guo Gao Soybean Plant And Seed Corresponding To Transgenic Event MON87701 And Methods For Detection Thereof
WO2009100188A2 (fr) 2008-02-08 2009-08-13 Dow Agrosciences Llc Procédés de détection de l’événement de maïs das-59132
US20090210970A1 (en) 2008-02-14 2009-08-20 Pioneer Hi-Bred International, Inc. Plant Genomic DNA Flanking SPT Event and Methods for Identifying SPT Event
WO2009102873A1 (fr) 2008-02-15 2009-08-20 Monsanto Technology Llc Plante de soja et graine correspondant à l’évènement transgénique mon87769 et leurs procédés de détection
US7579183B1 (en) 2006-12-01 2009-08-25 The United States Of America As Represented By The Secretary Of Agriculture Saprophytic yeast, Pichia anomala
WO2009111263A1 (fr) 2008-02-29 2009-09-11 Monsanto Technology Llc Plant de maïs correspondant au produit transgénique mon87460 et compositions et procédés de détection associés
WO2009116106A1 (fr) 2008-03-21 2009-09-24 Trentino Sviluppo S.P.A. Trichoderma atroviride sc1 pour la lutte biologique contre les maladies fongiques des végétaux
WO2009152359A2 (fr) 2008-06-11 2009-12-17 Dow Agrosciences Llc Produits de recombinaison pour l’expression de gènes de tolérance aux herbicides, plantes associées, et combinaisons de caractères associées
JP2010018586A (ja) 2008-07-14 2010-01-28 Meiji Seika Kaisha Ltd Ｐｆ１３６４物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
WO2010024976A1 (fr) 2008-08-29 2010-03-04 Monsanto Technology Llc Plante et semences de soja correspondant à l’événement transgénique mon87754 et procédés pour détection de celui-ci
WO2010037016A1 (fr) 2008-09-29 2010-04-01 Monsanto Technology Llc Événement transgénique de soja t mon87705 et procédés pour la détection de celui-ci
WO2010052161A2 (fr) 2008-11-06 2010-05-14 Syngenta Participations Ag Compositions herbicides
WO2010051926A2 (fr) 2008-11-05 2010-05-14 Bayer Cropscience Aktiengesellschaft Nouveaux composés substitués par halogène
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
WO2010066780A1 (fr) 2008-12-12 2010-06-17 Syngenta Participations Ag N-oxypipéridines spirohétérocycliques utilisées comme pesticides
WO2010076212A1 (fr) 2008-12-19 2010-07-08 Syngenta Participations Ag Événement de betterave sucrière transgénique gm rz13
WO2010077816A1 (fr) 2008-12-16 2010-07-08 Syngenta Participations Ag Evénement transgénique du maïs 5307
WO2010080829A1 (fr) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Évènement de soja 127 et procédés apparentés
WO2010086790A1 (fr) 2009-01-27 2010-08-05 Lesaffre Et Compagnie Souches de saccharomyces cerevisiae a aptitudes phytosanitaires
WO2010117735A1 (fr) 2009-03-30 2010-10-14 Monsanto Technology Llc Évènement 17314 de riz transgénique et ses procédés d'utilisation
WO2010117737A1 (fr) 2009-03-30 2010-10-14 Monsanto Technology Llc Evénement de riz transgénique 17053 et ses procédés d'utilisation
US20100291039A1 (en) 2007-12-14 2010-11-18 Kohl Jurgen Anton Novel micro-organisms controlling plant pathogens
WO2011022469A2 (fr) 2009-08-19 2011-02-24 Dow Agrosciences Llc Événement das-40278-9 d'aad-1, lignées transgéniques de maïs connexes et identification spécifique d'événement de celui-ci
WO2011034704A1 (fr) 2009-09-17 2011-03-24 Monsanto Technology Llc Variété transgénique mon 87708 du soja et ses méthodes d'utilisation
WO2011062904A1 (fr) 2009-11-23 2011-05-26 Monsanto Technology Llc Événement du maïs transgénique mon 87427 et échelle de développement relative
WO2011063413A2 (fr) 2009-11-23 2011-05-26 Bayer Bioscience N.V. Plantes de soja tolérant un herbicide et leurs procédés d'identification
WO2011066360A1 (fr) 2009-11-24 2011-06-03 Dow Agrosciences Llc Détection de l'événement 416 du soja aad-12
WO2011066384A1 (fr) 2009-11-24 2011-06-03 Dow Agrosciences Llc Événement 416 de la transformation aad-12, lignées de soja transgéniques associées, et leur identification spécifique à l'événement
WO2011075595A1 (fr) 2009-12-17 2011-06-23 Pioneer Hi-Bred International, Inc. Maïs dp-043a47-3 et procédés de détection associés
WO2011075593A1 (fr) 2009-12-17 2011-06-23 Pioneer Hi-Bred International, Inc. Maïs dp-040416-8 et procédés de détection associés
WO2011077043A2 (fr) 2009-12-23 2011-06-30 Galderma Research & Development Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
WO2011084632A1 (fr) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Evénement de maïs dp-032316-8 et ses procédés de détection
WO2011084621A1 (fr) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Evénement de transformation dp-004114-3 du maïs et son procédé de détection
WO2011085575A1 (fr) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Composés de formanilide hétérocyclique, leurs procédés de synthèse et leur utilisation
WO2011105506A1 (fr) 2010-02-25 2011-09-01 日本曹達株式会社 Composé amine cyclique et acaricide
WO2011106491A2 (fr) 2010-02-25 2011-09-01 Marrone Bio Innovations, Inc. Souche bactérienne isolée du genre burkholderia et métabolites pesticides issus de cette souche
WO2011151819A2 (fr) 2010-06-01 2011-12-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Pseudozyma aphidis en tant qu'agent de biocontrôle contre différents pathogènes de plantes
WO2011153186A1 (fr) 2010-06-04 2011-12-08 Monsanto Technology Llc Evénement mon 88032 d'une plante transgénique du genre brassica et ses procédés d'utilisation
WO2011151146A1 (fr) 2010-05-31 2011-12-08 Syngenta Participations Ag Procédé d'amélioration du rendement d'un produit cultivé
WO2012029672A1 (fr) 2010-08-31 2012-03-08 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Agent de lutte contre des organismes nuisibles
WO2012033794A2 (fr) 2010-09-08 2012-03-15 Dow Agrosciences Llc Événement 1606 d'aad-12 et lignées de soja transgénique associées
WO2012034403A1 (fr) 2010-09-14 2012-03-22 中化蓝天集团有限公司 Composés de fluorométhoxypyrazole et d'anthranilamide, leurs procédés de synthèse et leurs utilisations
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
WO2012051199A2 (fr) 2010-10-12 2012-04-19 Monsanto Technology Llc Plante et semence de soja correspondant à l'événement transgénique mon87712 et procédé pour les détecter
US20120131692A1 (en) 2010-11-24 2012-05-24 Pioneer Hi-Bred International, Inc. Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof
WO2012071039A1 (fr) 2010-11-24 2012-05-31 Pioner Hi-Bred International, Inc. Événement dp-061061-7 de brassica gat et compositions et procédés pour l'identifier et/ou le détecter
WO2012075429A1 (fr) 2010-12-03 2012-06-07 Dow Agrosciences Llc Événement 8291.45.36.2 de tolérance aux herbicides empilé, lignées de soja transgéniques apparentées, et sa détection
WO2012075426A1 (fr) 2010-12-03 2012-06-07 Dow Agrosciences Llc Événement 8264.44.06.1 de tolérance aux herbicides empilé, lignées de soja transgéniques apparentées, et sa détection
WO2012082548A2 (fr) 2010-12-15 2012-06-21 Syngenta Participations Ag Soja comprenant le mécanisme de transformation syht04r, et compositions et procédés de détection de ce mécanisme
WO2012134808A1 (fr) 2011-03-30 2012-10-04 Monsanto Technology Llc Événement transgénique mon 88701 du coton et ses procédés d'utilisation
WO2012143415A1 (fr) 2011-04-21 2012-10-26 Glaxosmithkline Llc Dérivés de tétrahydroquinoline utiles comme inhibiteurs de bromodomaine
WO2013003558A1 (fr) 2011-06-30 2013-01-03 Monsanto Technology Llc Plante et graine de luzerne correspondant à l'événement transgénique kk 179-2 et procédés pour la détection de celui-ci
WO2013010094A1 (fr) 2011-07-13 2013-01-17 Dow Agrosciences Llc Événement 8264.42.32.1 « empilé » de tolérance aux herbicides, lignées de soja transgénique associées et détection dudit événément
WO2013012775A1 (fr) 2011-07-15 2013-01-24 Syngenta Participations Ag Événement mzdt09y dans le maïs
WO2013032693A2 (fr) 2011-08-27 2013-03-07 Marrone Bio Innovations, Inc. Souche bactérienne isolée du gène burkholderia et métabolites pesticides dérivés de cette souche, formulations et utilisations
WO2013034938A2 (fr) 2011-09-08 2013-03-14 Szegedi Tudományegyetem Souche de bacillus mojavensis produisant de la fengycine résistante au cuivre pour réguler les pathogènes des légumes, utilisations de cette souche et composition la contenant
WO2013050317A1 (fr) 2011-10-03 2013-04-11 Syngenta Limited Formes polymorphes d'un dérivé d'isoxazoline
CN103109816A (zh) 2013-01-25 2013-05-22 青岛科技大学 硫代苯甲酰胺类化合物及其应用
CN103232431A (zh) 2013-01-25 2013-08-07 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
WO2013115391A1 (fr) 2012-02-01 2013-08-08 日本農薬株式会社 Dérivé d'arylalkyloxy pyrimidine, pesticide à usage agricole et horticole contenant le dérivé d'arylalkyloxy pyrimidine comme ingrédient actif, et son utilisation
CN103265527A (zh) 2013-06-07 2013-08-28 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
WO2013144213A1 (fr) 2012-03-30 2013-10-03 Basf Se Composés de pyridylidène n-substitués et dérivés destinés à lutter contre les animaux nuisibles
EP2647626A1 (fr) 2012-04-03 2013-10-09 Syngenta Participations AG. Dérivés de 1-aza-spiro[4.5]déc-3-ène and 1,8-diaza-spiro[4.5]déc-3-ène en tant que pesticides
WO2013162715A2 (fr) 2012-04-27 2013-10-31 Dow Agrosciences Llc Compositions pesticides et procédés correspondants
CN103524422A (zh) 2013-10-11 2014-01-22 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
WO2014028521A1 (fr) 2012-08-14 2014-02-20 Marrone Bio Innovations, Inc. Souche de bacillus sp. avec activité antifongique, antibactérienne et de stimulation de la croissance
WO2014058685A1 (fr) 2012-10-08 2014-04-17 Merck Sharp & Dohme Corp. Inhibiteurs de l'activité de l'irak4
US20140213448A1 (en) 2012-04-27 2014-07-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
WO2014187846A1 (fr) 2013-05-23 2014-11-27 Syngenta Participations Ag Formulations de mélange en cuve
WO2015058021A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de de composés pesticides
WO2015058028A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de composés pesticides
WO2015067800A1 (fr) 2013-11-11 2015-05-14 Basf Se Souches de penicillium antifongiques, extrolites fongicides de celles-ci, et leur utilisation
WO2016005276A1 (fr) 2014-07-07 2016-01-14 Bayer Cropscience Aktiengesellschaft Procédé de préparation de composés fluorés d'iminopyridine
WO2016020371A1 (fr) 2014-08-04 2016-02-11 Basf Se Souches de paenibacillus anti-fongiques, composés de type fusaricidine et leur utilisation
WO2016133011A1 (fr) 2015-02-17 2016-08-25 日本曹達株式会社 Composition agrochimique
WO2016154297A1 (fr) 2015-03-26 2016-09-29 Bayer Cropscience Lp Nouvelle souche de paenibacillus, composés antifongiques et procédés d'utilisation associés
WO2017019448A1 (fr) 2015-07-24 2017-02-02 AgBiome, Inc. Agents de lutte biologique modifiés et leurs utilisations
WO2017023133A2 (fr) 2015-08-04 2017-02-09 Chong Kun Dang Pharmaceutical Corp. Composés dérivés de 1,3,4-oxadiazole utilisés en tant qu'inhibiteur de l'histone désacétylase 6, et composition pharmaceutique les comprenant
WO2017066094A1 (fr) 2015-10-12 2017-04-20 Pioneer Hi-Bred International, Inc. Produits biologiques et leur utilisation dans des plantes
WO2017065473A1 (fr) 2015-10-12 2017-04-20 Chong Kun Dang Pharmaceutical Corp. Composés dérivés d'oxadiazole amine utilisés en tant qu'inhibiteur de l'histone désacétylase 6, et composition pharmaceutique les comprenant
WO2017205258A1 (fr) 2016-05-26 2017-11-30 Novozymes Bioag A/S Bacillus et lipo-chito-oligosaccharide pour améliorer la croissance de plantes
WO2018080859A1 (fr) 2016-10-24 2018-05-03 E. I. Du Pont De Nemours And Company Oxadiazoles fongicides
WO2018106667A1 (fr) 2016-12-05 2018-06-14 Microbiotix, Inc. Inhibiteurs à large spectre de filovirus
WO2018118781A1 (fr) 2016-12-20 2018-06-28 Fmc Corporation Oxadiazoles à activité fongicide
WO2018165520A1 (fr) 2017-03-10 2018-09-13 Vps-3, Inc. Composés inhibiteurs de métalloenzymes
US20180317490A1 (en) 2015-11-04 2018-11-08 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2018233633A1 (fr) 2017-06-20 2018-12-27 南京明德新药研发股份有限公司 Inhibiteur de ssao
WO2019063748A1 (fr) 2017-09-30 2019-04-04 Glaxosmithkline Intellectual Property Development Limited Inhibiteurs de ror-gamma
WO2019103918A1 (fr) 2017-11-21 2019-05-31 Syngenta Participations Ag Nouveaux gènes de résistance associés à la résistance aux maladies du soja
WO2019122323A1 (fr) 2017-12-22 2019-06-27 Bayer Aktiengesellschaft Oxadiazoles fongicides
WO2020127974A1 (fr) 2018-12-21 2020-06-25 Bayer Aktiengesellschaft 1,3,4-oxadiazoles et leurs dérivés en tant que nouveaux agents antifongiques

Patent Citations (215)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009A (en) 1841-03-18 Improvement in machines for boring war-rockets
US24077A (en) 1859-05-17 Window-sash supporter
US137395A (en) 1873-04-01 Improvement in nuts
US2010A (en) 1841-03-18 Machine foe
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
US5061495A (en) 1988-03-07 1991-10-29 Agricultural Genetics Company Limited Antibiotic derived from b. subtilis
US20030126634A1 (en) 1990-08-09 2003-07-03 Dekalb Genetics Corporation Methods and compositions for the increase of yield in plants
US6855533B2 (en) 1995-04-20 2005-02-15 Basf Corporation Structure-based designed herbicide resistant products
WO1997017432A1 (fr) 1995-11-06 1997-05-15 Wisconsin Alumni Research Foundation Toxines proteiques insecticides provenant de photorhabdus
WO1998008932A1 (fr) 1996-08-29 1998-03-05 Dow Agrosciences Llc TOXINES PROTEINIQUES INSECTICIDES ISOLEES A PARTIR DE $i(PHOTORHABDUS)
WO1998044140A1 (fr) 1997-04-03 1998-10-08 Dekalb Genetics Corporation Lignees de mais resistantes aux glyphosates
US20050086719A1 (en) 1997-04-03 2005-04-21 Michael Spencer Glyphosate resistant maize lines
US20050188434A1 (en) 1997-04-03 2005-08-25 Michael Spencer Method for plant breeding
US20060059581A1 (en) 1997-04-03 2006-03-16 Dekalb Genetics Corporation Method of breeding glyphosate resistant plants
WO1998050427A1 (fr) 1997-05-05 1998-11-12 Dow Agrosciences Llc TOXINES PROTEIQUES INSECTICIDES ISSUES DE $i(XENORHABDUS)
US6060051A (en) 1997-05-09 2000-05-09 Agraquest, Inc. Strain of bacillus for controlling plant diseases and corn rootworm
JPH11253151A (ja) 1997-11-13 1999-09-21 Kumiai Chem Ind Co Ltd イネの育苗時病害防除剤
WO2000015637A1 (fr) 1998-09-16 2000-03-23 Dow Agrosciences Llc 2-methoxyimino -2-(pyridinyloxymethyle) phenyle acetamides comprenant des heterocycles a 5 chainons sur le cycle pyridine, utilises comme fongicides
US6468747B1 (en) 1998-11-03 2002-10-22 Plant Genetic System, N.V. Glufosinate tolerant rice
WO2000026345A1 (fr) 1998-11-03 2000-05-11 Aventis Cropscience N.V. Riz tolerant au glufosinate
WO2000026356A1 (fr) 1998-11-03 2000-05-11 Aventis Cropscience N. V. Riz tolerant au glufosinate
US6245551B1 (en) 1999-03-30 2001-06-12 Agraquest, Inc. Strain of Bacillus pumilus for controlling plant diseases caused by fungi
WO2000068198A2 (fr) 1999-05-05 2000-11-16 Merck Frosst Canada & Co. Derives de pyridine heterosubstitues utilises comme inhibiteurs de pde 4
WO2001031042A2 (fr) 1999-10-29 2001-05-03 Aventis Cropscience N.V. Plantes brassica male sterile et procedes de production de ces plantes
US20030188347A1 (en) 1999-12-08 2003-10-02 Both Greta De Hybrid winter oilseed rape and methods for producing same
WO2001041558A1 (fr) 1999-12-08 2001-06-14 Aventis Cropscience N.V. Colza oleagineux d'hiver hybrides et son procede de production
WO2001047952A2 (fr) 1999-12-28 2001-07-05 Bayer Cropscience N.V. Proteines insecticides provenant de bacillus thuringiensis
WO2001051654A2 (fr) 2000-01-11 2001-07-19 Bayer Cropscience N.V. Procedes et assortiments de materiel permettant d'identifier l'evenement elite gat-zm1 dans les echantillons biologiques
US20010029014A1 (en) 2000-01-11 2001-10-11 Beuckeleer Marc De Methods and kits for identifying elite event GAT-ZM1 in biological samples
US20070292854A1 (en) 2000-06-22 2007-12-20 Behr Carl F Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof
US20020102582A1 (en) 2000-09-13 2002-08-01 Levine Elaine B. Corn event MON810 and compositions and methods for detection thereof
WO2002027004A2 (fr) 2000-09-29 2002-04-04 Monsanto Technology Llc Plante de ble 33391 resistante au glyphosate et compositions et procedes de detection de celle-ci
US20020120964A1 (en) 2000-10-25 2002-08-29 Rangwala Tasneem S. Cotton event PV-GHGT07(1445) and compositions and methods for detection thereof
WO2002034946A2 (fr) 2000-10-25 2002-05-02 Monsanto Technology Llc Mecanisme biochimique de plant de coton pv-ghgt07(1445), compositions et techniques de detection de celui-ci
WO2002036831A2 (fr) 2000-10-30 2002-05-10 Monsanto Technology Llc Colza canola pv-bngt(rt73), compositions et procedes de detection correspondants
US20080070260A1 (en) 2000-10-30 2008-03-20 Rachel Krieb Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof
WO2002040677A2 (fr) 2000-11-20 2002-05-23 Monsanto Technology Llc Evenement du coton pv-ghbk04 (531) et compositions et procedes permettant de detecter la presence de ce dernier
WO2002044407A2 (fr) 2000-11-30 2002-06-06 Ses Europe N.V. Séquence des flancs de t227-1
US20090265817A1 (en) 2000-11-30 2009-10-22 Ses Europe N.V./S.A. T227-1 flanking sequence
WO2002069901A2 (fr) 2001-03-02 2002-09-12 Merck Frosst Canada & Co. Inhibiteurs de cathepsines de la cysteine protease
US20040250317A1 (en) 2001-06-11 2004-12-09 Huber Scott A Cotton event moni5985 and compositions and methods for detection thereof
WO2002100163A2 (fr) 2001-06-11 2002-12-19 Monsanto Technology Llc Evenement mon15985 du coton et compositions et procedes servant a sa detection
WO2003000051A2 (fr) 2001-06-22 2003-01-03 Drahos David J Nouveau biofongicide
WO2003013224A2 (fr) 2001-08-06 2003-02-20 Bayer Bioscience N.V. Cotonniers avec tolerance aux herbicides et procedes de production et d'identification de ces cotonniers
US20030097687A1 (en) 2001-08-06 2003-05-22 Linda Trolinder Herbicide tolerant cotton plants and methods for producing and identifying same
US7094592B2 (en) 2001-11-26 2006-08-22 Kumiai Chemical Industry Co., Ltd. Bacillus sp. D747 strain, plant disease controlling agents and insect pest controlling agents using the same and control method using the agents
WO2003052073A2 (fr) 2001-12-17 2003-06-26 Syngenta Participations Ag Nouvel evenement du mais
WO2003106457A1 (fr) 2002-06-14 2003-12-24 Syngenta Limited Derives de spiroindolinepiperidine
WO2004011601A2 (fr) 2002-07-29 2004-02-05 Monsanto Technology, Llc Mais pv-zmir13 designe mon863, composition et procedes de detection
US20060095986A1 (en) 2002-07-29 2006-05-04 Cavato Tracey A Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof
US20060130175A1 (en) 2002-10-29 2006-06-15 Ellis Daniel M Cot102 insecticidal cotton
WO2004039986A1 (fr) 2002-10-29 2004-05-13 Syngenta Participations Ag Coton insecticide cot102
WO2004053062A2 (fr) 2002-12-05 2004-06-24 Monsanto Technology Llc Evenement associe a l'agrostide asr-368 et compositions et procedes de detection de la presence de celle-ci
US20060162007A1 (en) 2002-12-05 2006-07-20 Monsanto Technology Llc Bentgrass event asr-368 and compositions and methods for detection thereof
WO2004072235A2 (fr) 2003-02-12 2004-08-26 Monsanto Technology Llc Evenement mon 88913 de plant de coton et procedes de detection correspondants
US20060059590A1 (en) 2003-02-12 2006-03-16 Monsanto Technology Llc Cotton event mon 88913 and compositions and methods for detection thereof
WO2004074492A1 (fr) 2003-02-20 2004-09-02 Kws Saat Ag Betteraves sucrieres tolerant le glyphosate
US20040172669A1 (en) 2003-02-28 2004-09-02 Josef Kraus Glyphosate tolerant sugar beet
US20050039226A1 (en) 2003-05-02 2005-02-17 Dow Agrosciences Llc Corn event TC1507 and methods for detection thereof
WO2004099447A2 (fr) 2003-05-02 2004-11-18 Dow Agrosciences Llc Mais tc1507 et procedes de detection de celui-ci
WO2004099160A1 (fr) 2003-05-12 2004-11-18 Sumitomo Chemical Company, Limited Composes de pyrimidine et compostion de lutte contre les animaux nuisibles contenant ces composes
US20070067868A1 (en) 2003-12-01 2007-03-22 Negrotto David V Insect resistant cotton plants and methods of detecting the same
WO2005054480A2 (fr) 2003-12-01 2005-06-16 Syngenta Participations Ag Plants de coton resistant aux insectes et procedes de detection de ces derniers
WO2005054479A1 (fr) 2003-12-01 2005-06-16 Syngenta Participations Ag Cotonnier resistant aux insectes et procedes pour detecter celui-ci
WO2005061720A2 (fr) 2003-12-11 2005-07-07 Monsanto Technology Llc Compositions de mais a haute teneur en lysine et methodes de detection correspondantes
US20070028322A1 (en) 2003-12-11 2007-02-01 Dizigan Mark A High lysine maize compositions and methods for detection thereof
WO2005059103A2 (fr) 2003-12-15 2005-06-30 Monsanto Technology Llc Plant de mais mon88017, compositions et procedes de detection associes
US20080028482A1 (en) 2003-12-15 2008-01-31 Beazley Kim A Corn Plant Mon88017 and Compositions and Methods for Detection Thereof
WO2005074671A1 (fr) 2004-01-30 2005-08-18 Syngenta Participations Ag Restauration amelioree de la fertilite pour le systeme ogura d'androsterilite cytoplasmique du brassica, et procede correspondant
WO2005103301A2 (fr) 2004-03-25 2005-11-03 Syngenta Participations Ag Mais mir604
US20080167456A1 (en) 2004-03-25 2008-07-10 Syngenta Participations Ag Corn Event MIR604
US20070143876A1 (en) 2004-03-26 2007-06-21 Dow Agrosciences Llc Cry1F and Cry1Ac transgenic cotton lines and event-specific identification thereof
US20050216969A1 (en) 2004-03-26 2005-09-29 Dow Agrosciences Llc Cry1F and Cry1AC transgenic cotton lines and event-specific identification thereof
WO2005103266A1 (fr) 2004-03-26 2005-11-03 Dow Agrosciences Llc Lignees de coton transgeniques cry1f et cry1ac et leur identification specifique a l'evenement
WO2006003494A2 (fr) 2004-06-28 2006-01-12 Syngenta Participations Ag Composes chimiques
US20060070139A1 (en) 2004-09-29 2006-03-30 Pioneer Hi-Bred International, Inc. Corn event DAS-59122-7 and methods for detection thereof
WO2006043635A1 (fr) 2004-10-20 2006-04-27 Kumiai Chemical Industry Co., Ltd. Dérivé de 3-triazolylphénylsulfide et insecticide/acaricide/nématicide incluant ledit dérivé au titre de principe actif
US20060230473A1 (en) 2005-03-16 2006-10-12 Syngenta Participations Ag Corn event 3272 and methods for detection thereof
WO2006098952A2 (fr) 2005-03-16 2006-09-21 Syngenta Participations Ag Mais 3272 et procedes pour le detecter
US20080320616A1 (en) 2005-04-08 2008-12-25 Bayer Bioscience N.V. Elite Event A2407-12 and Methods and Kits for Identifying Such Event in Biological Samples
WO2006108674A2 (fr) 2005-04-08 2006-10-19 Bayer Bioscience N.V. Evenement elite a2704-12 et procedes et trousses permettant d'identifier cet evenement dans des prelevements biologiques
WO2006108675A2 (fr) 2005-04-11 2006-10-19 Bayer Bioscience N.V. Evenement elite a5547-127 et procedes et trousses pour l'identification d'un tel evenement dans des echantillons biologiques
US20080196127A1 (en) 2005-04-11 2008-08-14 Bayer Bioscience N.V. Elite Event A5547-127 and Methods and Kits For Identifying Such Event in Biological Samples
US20060282915A1 (en) 2005-05-27 2006-12-14 Monsanto Technology Llc Soybean event MON89788 and methods for detection thereof
WO2006130436A2 (fr) 2005-05-27 2006-12-07 Monsanto Technology Llc Evenement de soja mon89788 et procedes de detection de celui-ci
WO2006128568A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide t342-142
WO2006128571A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide ce44-69d
WO2006128570A1 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide 1143-51b
US20090217423A1 (en) 2005-06-02 2009-08-27 Cayley Patricia J Ce43-67b insecticidal cotton
WO2006128572A1 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide ce46-02a
WO2006128569A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide 1143-14a
WO2006128573A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide ce43-67b
US20100050282A1 (en) 2005-08-08 2010-02-25 Bayer Bioscience N.V. Herbicide Tolerant Cotton Plants and Methods for Identifying the Same
WO2007017186A1 (fr) 2005-08-08 2007-02-15 Bayer Bioscience N.V. Cotonniers tolerants aux herbicides et leurs procedes d'identification
WO2007024782A2 (fr) 2005-08-24 2007-03-01 Pioneer Hi-Bred International, Inc. Compositions assurant une tolerance a de multiples herbicides et methodes d'utilisation
WO2007040282A1 (fr) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Compose d'amine cyclique et agent pesticide
WO2007040280A1 (fr) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Cyclic amine compound and pest control agent
WO2007091277A2 (fr) 2006-02-10 2007-08-16 Maharashtra Hybrid Seeds Company Limited (Mahyco) Aubergine transgenique (solanum melongena) comprenant un evenement ee-i
WO2007090852A1 (fr) 2006-02-10 2007-08-16 Cellzome Limited Composés d'amino pyrimidine destinés à traiter des troubles inflammatoires
WO2007140256A1 (fr) 2006-05-26 2007-12-06 Monsanto Technology, Llc Plant et semence de maïs correspondant au produit transgénique mon89034, procédés de détection et utilisation associés
US20080260932A1 (en) 2006-05-26 2008-10-23 Anderson Heather M Corn Plant and Seed Corresponding to Transgenic Event MON89034 and Methods For Detection and Use Thereof
US20090300784A1 (en) 2006-06-03 2009-12-03 Syngenta Participations Ag Corn event mir162
WO2007142840A2 (fr) 2006-06-03 2007-12-13 Syngenta Participations Ag Événement de transformation de maïs mir162
WO2008002872A2 (fr) 2006-06-28 2008-01-03 Pioneer Hi-Bred International, Inc. Événement de soja 3560.4.3.5 et compositions et procedes d'identification et/ou de détection de celui-ci
US20100184079A1 (en) 2006-06-28 2010-07-22 Pioneer Hi-Bred International, Inc. Soybean event 3560.4.3.5 and compositions and methods for the identification and detection thereof
US20080289060A1 (en) 2006-08-24 2008-11-20 Bayer Bioscience N.V. Herbicide tolerant rice plants and methods for identifying same
US20080064032A1 (en) 2006-09-13 2008-03-13 Syngenta Participations Ag Polynucleotides and uses thereof
WO2008112019A2 (fr) 2006-10-30 2008-09-18 Pioneer Hi-Bred International, Inc. Evènement dp-098140-6 du maïs et compositions et procédés pour son identification et/ou sa détection
US20080312082A1 (en) 2006-10-31 2008-12-18 Kinney Anthony J Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
WO2008054747A2 (fr) 2006-10-31 2008-05-08 E. I. Du Pont De Nemours And Company Événement de soja dp-305423-1, leurs compositions et leurs procédés d'identification et/ou de détection
US7579183B1 (en) 2006-12-01 2009-08-25 The United States Of America As Represented By The Secretary Of Agriculture Saprophytic yeast, Pichia anomala
WO2008114282A2 (fr) 2007-03-19 2008-09-25 Maharashtra Hybrid Seeds Company Limited Riz transgénique (oryza sativa) comprenant l'événement pe-7 et son procédé de détection
US20100077501A1 (en) 2007-04-05 2010-03-25 Bayer Bioscience N.V. Insect resistant cotton plants and methods for identifying same
WO2008122406A1 (fr) 2007-04-05 2008-10-16 Bayer Bioscience N.V. Plants de coton résistant aux insectes et leurs procédés d'identification
WO2008151780A1 (fr) 2007-06-11 2008-12-18 Bayer Bioscience N.V. Cotonniers résistant aux insectes comprenant un événement élite ee-gh6 et leurs procédés d'identification
US20090130071A1 (en) 2007-11-15 2009-05-21 Ai-Guo Gao Soybean Plant And Seed Corresponding To Transgenic Event MON87701 And Methods For Detection Thereof
WO2009064652A1 (fr) 2007-11-15 2009-05-22 Monsanto Technology Llc Plante et graine de soja correspondant à l'événement transgénique mon87701 et procédés pour les détecter
US20100291039A1 (en) 2007-12-14 2010-11-18 Kohl Jurgen Anton Novel micro-organisms controlling plant pathogens
WO2009100188A2 (fr) 2008-02-08 2009-08-13 Dow Agrosciences Llc Procédés de détection de l’événement de maïs das-59132
US20090210970A1 (en) 2008-02-14 2009-08-20 Pioneer Hi-Bred International, Inc. Plant Genomic DNA Flanking SPT Event and Methods for Identifying SPT Event
WO2009103049A2 (fr) 2008-02-14 2009-08-20 Pioneer Hi-Bred International, Inc. Evénement spt flanquant l'adn génomique végétal et procédés d'identification de l'événement spt
US20110067141A1 (en) 2008-02-15 2011-03-17 Byron Froman Soybean plant and seed corresponding to transgenic event mon87769 and methods for detection thereof
WO2009102873A1 (fr) 2008-02-15 2009-08-20 Monsanto Technology Llc Plante de soja et graine correspondant à l’évènement transgénique mon87769 et leurs procédés de détection
WO2009111263A1 (fr) 2008-02-29 2009-09-11 Monsanto Technology Llc Plant de maïs correspondant au produit transgénique mon87460 et compositions et procédés de détection associés
US20110138504A1 (en) 2008-02-29 2011-06-09 Monsanto Technology Llc Corn plant event mon87460 and compositions and methods for detection thereof
WO2009116106A1 (fr) 2008-03-21 2009-09-24 Trentino Sviluppo S.P.A. Trichoderma atroviride sc1 pour la lutte biologique contre les maladies fongiques des végétaux
US8431120B2 (en) 2008-03-21 2013-04-30 Trentino Sviluppo S.P.A. Trichoderma atroviride SC1 for biocontrol of fungal diseases in plants
WO2009152359A2 (fr) 2008-06-11 2009-12-17 Dow Agrosciences Llc Produits de recombinaison pour l’expression de gènes de tolérance aux herbicides, plantes associées, et combinaisons de caractères associées
JP2010018586A (ja) 2008-07-14 2010-01-28 Meiji Seika Kaisha Ltd Ｐｆ１３６４物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
CN101337940A (zh) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
CN101337937A (zh) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-3-取代氨基吡唑类化合物
WO2010024976A1 (fr) 2008-08-29 2010-03-04 Monsanto Technology Llc Plante et semences de soja correspondant à l’événement transgénique mon87754 et procédés pour détection de celui-ci
US20100080887A1 (en) 2008-09-29 2010-04-01 Monsanto Technology Llc Soybean Transgenic Event MON87705 and Methods for Detection Thereof
WO2010037016A1 (fr) 2008-09-29 2010-04-01 Monsanto Technology Llc Événement transgénique de soja t mon87705 et procédés pour la détection de celui-ci
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
WO2010051926A2 (fr) 2008-11-05 2010-05-14 Bayer Cropscience Aktiengesellschaft Nouveaux composés substitués par halogène
WO2010052161A2 (fr) 2008-11-06 2010-05-14 Syngenta Participations Ag Compositions herbicides
WO2010066780A1 (fr) 2008-12-12 2010-06-17 Syngenta Participations Ag N-oxypipéridines spirohétérocycliques utilisées comme pesticides
WO2010077816A1 (fr) 2008-12-16 2010-07-08 Syngenta Participations Ag Evénement transgénique du maïs 5307
WO2010076212A1 (fr) 2008-12-19 2010-07-08 Syngenta Participations Ag Événement de betterave sucrière transgénique gm rz13
WO2010080829A1 (fr) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Évènement de soja 127 et procédés apparentés
WO2010086790A1 (fr) 2009-01-27 2010-08-05 Lesaffre Et Compagnie Souches de saccharomyces cerevisiae a aptitudes phytosanitaires
WO2010117735A1 (fr) 2009-03-30 2010-10-14 Monsanto Technology Llc Évènement 17314 de riz transgénique et ses procédés d'utilisation
WO2010117737A1 (fr) 2009-03-30 2010-10-14 Monsanto Technology Llc Evénement de riz transgénique 17053 et ses procédés d'utilisation
WO2011022469A2 (fr) 2009-08-19 2011-02-24 Dow Agrosciences Llc Événement das-40278-9 d'aad-1, lignées transgéniques de maïs connexes et identification spécifique d'événement de celui-ci
WO2011034704A1 (fr) 2009-09-17 2011-03-24 Monsanto Technology Llc Variété transgénique mon 87708 du soja et ses méthodes d'utilisation
WO2011062904A1 (fr) 2009-11-23 2011-05-26 Monsanto Technology Llc Événement du maïs transgénique mon 87427 et échelle de développement relative
WO2011063413A2 (fr) 2009-11-23 2011-05-26 Bayer Bioscience N.V. Plantes de soja tolérant un herbicide et leurs procédés d'identification
WO2011066360A1 (fr) 2009-11-24 2011-06-03 Dow Agrosciences Llc Détection de l'événement 416 du soja aad-12
WO2011066384A1 (fr) 2009-11-24 2011-06-03 Dow Agrosciences Llc Événement 416 de la transformation aad-12, lignées de soja transgéniques associées, et leur identification spécifique à l'événement
WO2011075595A1 (fr) 2009-12-17 2011-06-23 Pioneer Hi-Bred International, Inc. Maïs dp-043a47-3 et procédés de détection associés
WO2011084632A1 (fr) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Evénement de maïs dp-032316-8 et ses procédés de détection
WO2011084621A1 (fr) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Evénement de transformation dp-004114-3 du maïs et son procédé de détection
WO2011075593A1 (fr) 2009-12-17 2011-06-23 Pioneer Hi-Bred International, Inc. Maïs dp-040416-8 et procédés de détection associés
WO2011077043A2 (fr) 2009-12-23 2011-06-30 Galderma Research & Development Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
WO2011085575A1 (fr) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Composés de formanilide hétérocyclique, leurs procédés de synthèse et leur utilisation
WO2011105506A1 (fr) 2010-02-25 2011-09-01 日本曹達株式会社 Composé amine cyclique et acaricide
WO2011106491A2 (fr) 2010-02-25 2011-09-01 Marrone Bio Innovations, Inc. Souche bactérienne isolée du genre burkholderia et métabolites pesticides issus de cette souche
WO2011151146A1 (fr) 2010-05-31 2011-12-08 Syngenta Participations Ag Procédé d'amélioration du rendement d'un produit cultivé
WO2011151819A2 (fr) 2010-06-01 2011-12-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Pseudozyma aphidis en tant qu'agent de biocontrôle contre différents pathogènes de plantes
WO2011153186A1 (fr) 2010-06-04 2011-12-08 Monsanto Technology Llc Evénement mon 88032 d'une plante transgénique du genre brassica et ses procédés d'utilisation
WO2012029672A1 (fr) 2010-08-31 2012-03-08 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Agent de lutte contre des organismes nuisibles
WO2012033794A2 (fr) 2010-09-08 2012-03-15 Dow Agrosciences Llc Événement 1606 d'aad-12 et lignées de soja transgénique associées
WO2012034403A1 (fr) 2010-09-14 2012-03-22 中化蓝天集团有限公司 Composés de fluorométhoxypyrazole et d'anthranilamide, leurs procédés de synthèse et leurs utilisations
WO2012051199A2 (fr) 2010-10-12 2012-04-19 Monsanto Technology Llc Plante et semence de soja correspondant à l'événement transgénique mon87712 et procédé pour les détecter
US20120131692A1 (en) 2010-11-24 2012-05-24 Pioneer Hi-Bred International, Inc. Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof
WO2012071039A1 (fr) 2010-11-24 2012-05-31 Pioner Hi-Bred International, Inc. Événement dp-061061-7 de brassica gat et compositions et procédés pour l'identifier et/ou le détecter
WO2012075426A1 (fr) 2010-12-03 2012-06-07 Dow Agrosciences Llc Événement 8264.44.06.1 de tolérance aux herbicides empilé, lignées de soja transgéniques apparentées, et sa détection
WO2012075429A1 (fr) 2010-12-03 2012-06-07 Dow Agrosciences Llc Événement 8291.45.36.2 de tolérance aux herbicides empilé, lignées de soja transgéniques apparentées, et sa détection
WO2012082548A2 (fr) 2010-12-15 2012-06-21 Syngenta Participations Ag Soja comprenant le mécanisme de transformation syht04r, et compositions et procédés de détection de ce mécanisme
WO2012134808A1 (fr) 2011-03-30 2012-10-04 Monsanto Technology Llc Événement transgénique mon 88701 du coton et ses procédés d'utilisation
WO2012143415A1 (fr) 2011-04-21 2012-10-26 Glaxosmithkline Llc Dérivés de tétrahydroquinoline utiles comme inhibiteurs de bromodomaine
WO2013003558A1 (fr) 2011-06-30 2013-01-03 Monsanto Technology Llc Plante et graine de luzerne correspondant à l'événement transgénique kk 179-2 et procédés pour la détection de celui-ci
WO2013010094A1 (fr) 2011-07-13 2013-01-17 Dow Agrosciences Llc Événement 8264.42.32.1 « empilé » de tolérance aux herbicides, lignées de soja transgénique associées et détection dudit événément
WO2013012775A1 (fr) 2011-07-15 2013-01-24 Syngenta Participations Ag Événement mzdt09y dans le maïs
WO2013032693A2 (fr) 2011-08-27 2013-03-07 Marrone Bio Innovations, Inc. Souche bactérienne isolée du gène burkholderia et métabolites pesticides dérivés de cette souche, formulations et utilisations
WO2013034938A2 (fr) 2011-09-08 2013-03-14 Szegedi Tudományegyetem Souche de bacillus mojavensis produisant de la fengycine résistante au cuivre pour réguler les pathogènes des légumes, utilisations de cette souche et composition la contenant
WO2013050317A1 (fr) 2011-10-03 2013-04-11 Syngenta Limited Formes polymorphes d'un dérivé d'isoxazoline
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
WO2013115391A1 (fr) 2012-02-01 2013-08-08 日本農薬株式会社 Dérivé d'arylalkyloxy pyrimidine, pesticide à usage agricole et horticole contenant le dérivé d'arylalkyloxy pyrimidine comme ingrédient actif, et son utilisation
WO2013144213A1 (fr) 2012-03-30 2013-10-03 Basf Se Composés de pyridylidène n-substitués et dérivés destinés à lutter contre les animaux nuisibles
EP2647626A1 (fr) 2012-04-03 2013-10-09 Syngenta Participations AG. Dérivés de 1-aza-spiro[4.5]déc-3-ène and 1,8-diaza-spiro[4.5]déc-3-ène en tant que pesticides
WO2013162715A2 (fr) 2012-04-27 2013-10-31 Dow Agrosciences Llc Compositions pesticides et procédés correspondants
US20140213448A1 (en) 2012-04-27 2014-07-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
WO2013162716A2 (fr) 2012-04-27 2013-10-31 Dow Agrosciences Llc Compositions pesticides et procédés correspondants
WO2014028521A1 (fr) 2012-08-14 2014-02-20 Marrone Bio Innovations, Inc. Souche de bacillus sp. avec activité antifongique, antibactérienne et de stimulation de la croissance
WO2014058685A1 (fr) 2012-10-08 2014-04-17 Merck Sharp & Dohme Corp. Inhibiteurs de l'activité de l'irak4
CN103109816A (zh) 2013-01-25 2013-05-22 青岛科技大学 硫代苯甲酰胺类化合物及其应用
CN103232431A (zh) 2013-01-25 2013-08-07 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
WO2014187846A1 (fr) 2013-05-23 2014-11-27 Syngenta Participations Ag Formulations de mélange en cuve
CN103265527A (zh) 2013-06-07 2013-08-28 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
CN103524422A (zh) 2013-10-11 2014-01-22 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
WO2015058021A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de de composés pesticides
WO2015058028A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de composés pesticides
WO2015067800A1 (fr) 2013-11-11 2015-05-14 Basf Se Souches de penicillium antifongiques, extrolites fongicides de celles-ci, et leur utilisation
WO2016005276A1 (fr) 2014-07-07 2016-01-14 Bayer Cropscience Aktiengesellschaft Procédé de préparation de composés fluorés d'iminopyridine
WO2016020371A1 (fr) 2014-08-04 2016-02-11 Basf Se Souches de paenibacillus anti-fongiques, composés de type fusaricidine et leur utilisation
WO2016133011A1 (fr) 2015-02-17 2016-08-25 日本曹達株式会社 Composition agrochimique
WO2016154297A1 (fr) 2015-03-26 2016-09-29 Bayer Cropscience Lp Nouvelle souche de paenibacillus, composés antifongiques et procédés d'utilisation associés
WO2017019448A1 (fr) 2015-07-24 2017-02-02 AgBiome, Inc. Agents de lutte biologique modifiés et leurs utilisations
WO2017023133A2 (fr) 2015-08-04 2017-02-09 Chong Kun Dang Pharmaceutical Corp. Composés dérivés de 1,3,4-oxadiazole utilisés en tant qu'inhibiteur de l'histone désacétylase 6, et composition pharmaceutique les comprenant
WO2017066094A1 (fr) 2015-10-12 2017-04-20 Pioneer Hi-Bred International, Inc. Produits biologiques et leur utilisation dans des plantes
WO2017065473A1 (fr) 2015-10-12 2017-04-20 Chong Kun Dang Pharmaceutical Corp. Composés dérivés d'oxadiazole amine utilisés en tant qu'inhibiteur de l'histone désacétylase 6, et composition pharmaceutique les comprenant
US20180317490A1 (en) 2015-11-04 2018-11-08 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017205258A1 (fr) 2016-05-26 2017-11-30 Novozymes Bioag A/S Bacillus et lipo-chito-oligosaccharide pour améliorer la croissance de plantes
WO2018080859A1 (fr) 2016-10-24 2018-05-03 E. I. Du Pont De Nemours And Company Oxadiazoles fongicides
WO2018106667A1 (fr) 2016-12-05 2018-06-14 Microbiotix, Inc. Inhibiteurs à large spectre de filovirus
WO2018118781A1 (fr) 2016-12-20 2018-06-28 Fmc Corporation Oxadiazoles à activité fongicide
WO2018165520A1 (fr) 2017-03-10 2018-09-13 Vps-3, Inc. Composés inhibiteurs de métalloenzymes
WO2018233633A1 (fr) 2017-06-20 2018-12-27 南京明德新药研发股份有限公司 Inhibiteur de ssao
WO2019063748A1 (fr) 2017-09-30 2019-04-04 Glaxosmithkline Intellectual Property Development Limited Inhibiteurs de ror-gamma
WO2019103918A1 (fr) 2017-11-21 2019-05-31 Syngenta Participations Ag Nouveaux gènes de résistance associés à la résistance aux maladies du soja
WO2019122323A1 (fr) 2017-12-22 2019-06-27 Bayer Aktiengesellschaft Oxadiazoles fongicides
WO2020127974A1 (fr) 2018-12-21 2020-06-25 Bayer Aktiengesellschaft 1,3,4-oxadiazoles et leurs dérivés en tant que nouveaux agents antifongiques

Non-Patent Citations (29)

* Cited by examiner, † Cited by third party
Title
"Current Protocols in Molecular Biology", 1987
"Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling the root tot complex of field pea", CAN JOUR PLANT SCI, vol. 83, no. 3, pages 519 - 524
"Research Disclosure Database", Database accession no. 564025
"Technical Monograph No. 2", May 2008, CROPLIFE INTERNATIONAL, article "Catalogue of pesticide formulation types and international coding system"
ACS CATALYSIS, vol. 3, no. 11, 2013, pages 2536 - 2540
ACS MEDICINAL CHEMISTRY LETTERS, vol. 7, no. 5, 2016, pages 502 - 507
ADVANCED SYNTHESIS & CATALYSIS, vol. 352, no. 16, 2010, pages 2815 - 2824
ANGEWANDTE CHEMIE, INTERNATIONAL EDITION, vol. 53, no. 48, 2014, pages 13049 - 13053
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 18, no. 24, 2008, pages 6482 - 6485
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 20, no. 1, 2012, pages 487 - 497
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 25, no. 17, 2017, pages 4553 - 4559
CAS , no. 1332838-17-1
CAS, no. 1225292-17-0
CHEMISTRY OF HETEROCYCLIC COMPOUNDS (NEW YORK, NY, UNITED STATES, vol. 52, no. 2, 2016, pages 133 - 139
CROP PROTECTION, vol. 25, 2006, pages 468 - 475
ESTRUCH ET AL., PROC NATL ACAD SCI US A., vol. 93, no. 11, 1996, pages 5389 - 94
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 135, 2017, pages 531 - 543
JENSEN DF ET AL.: "Development of a biocontrol agent for plant disease control with special emphasis on the near commercial fungal antagonist Clonostachys rosea strain 'IK726", AUSTRALAS PLANT PATHOL., vol. 36, 2007, pages 95 - 101
JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 24, no. 5, 1987, pages 1305 - 7
JOURNAL OF ORGANIC CHEMISTRY, vol. 68, no. 11, 2003, pages 4527 - 4530
JOURNAL OF ORGANIC CHEMISTRY, vol. 78, no. 16, 2013, pages 8054 - 8064
ORGANIC LETTERS, vol. 15, no. 14, 2013, pages 3734 - 3737
PIETR ET AL., ZESZ. NAUK. A R W SZCZECINIE, vol. 161, 1993, pages 125 - 137
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, vol. 43, no. 11, 2007, pages 1686 - 1695
SYNLETT, vol. 12, 2005, pages 1939 - 1941
TETRAHEDRON LETTERS, vol. 53, no. 9, 2012, pages 1048 - 1050
TETRAHEDRON, vol. 58, no. 27, 2002, pages 5513 - 5523
TETRAHEDRON, vol. 66, no. 25, 2010, pages 4621 - 4632
YINGYONG HUAXUE, vol. 13, no. 5, 1996, pages 5 - 9

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024013106A1 (fr) * 2022-07-11 2024-01-18 Syngenta Crop Protection Ag Compositions fongicides

Also Published As

Publication number Publication date
BR112022025755A2 (pt) 2023-03-07
TW202216699A (zh) 2022-05-01
UY39276A (es) 2022-01-31
AR122685A1 (es) 2022-09-28

Similar Documents

Publication Publication Date Title
EP3897154A1 (fr) 1,3,4-oxadiazoles et leurs dérivés en tant que nouveaux agents antifongiques
EP4165038A1 (fr) Hétérocycles à substitution azabicyclyle utilisés comme fongicides
WO2022129190A1 (fr) 1,2,4-oxadiazoles substitués par (hétéro)aryle utilisés comme fongicides
WO2021224220A1 (fr) Pyridine (thio)amides en tant que composés fongicides
WO2021228734A1 (fr) (thio)amides de triazine et de pyrimidine utilisés comme composés fongicides
WO2021255093A1 (fr) Combinaison de composés actifs
WO2021245083A1 (fr) Hétérocyclyl pyridines en tant que nouveaux fongicides
WO2020182929A1 (fr) Urées et dérivés substitués en tant que nouveaux agents antifongiques
EP3708565A1 (fr) Pyrimidinyloxyphénylamidines et leur utilisation comme fongicides
WO2021255091A1 (fr) 1,3,4-oxadiazoles et leurs dérivés comme fongicides
US20230278994A1 (en) Heterocyclyl pyrimidines and triazines as novel fungicides
WO2021255170A1 (fr) 1,3,4-oxadiazole pyrimidines en tant que fongicides
WO2021255089A1 (fr) 1,3,4-oxadiazole pyrimidines et 1,3,4-oxadiazole pyridines utilisées comme fongicides
US20230354812A1 (en) 3-(pyridazin-4-yl)-5,6-dihydro-4h-1,2,4-oxadiazine derivatives as fungicides for crop protection
WO2021255169A1 (fr) 1,3,4-oxadiazole pyrimidines en tant que fongicides
WO2022129188A1 (fr) 1,2,4-oxadiazol-3-yl pyrimidines en tant que fongicides
WO2022129196A1 (fr) 1,2,4-oxadiazoles substitués par hétérobicycle utilisés en tant que fongicides
WO2021209490A1 (fr) Cyclaminephénylaminoquinoléines utiles en tant que fongicides
WO2022058327A1 (fr) Urées et dérivés substitués en tant que nouveaux agents antifongiques
WO2023099445A1 (fr) Bis(hétéro)aryl thioéther oxadiazines utilisées en tant que composés fongicides
WO2023078915A1 (fr) Bis(hétéro)aryl thioéther (thio)amides utiles en tant que composés fongicides
EP3915971A1 (fr) Phényl-s(o)n-phénylamidines et leur utilisation comme fongicides
EP3986875A1 (fr) Phénoxyphényl hydroxyisoxazolines et analogues utilisés en tant que nouveaux agents antifongiques
EP3986874A1 (fr) Benzylphényl hydroxyisoxazolines et analogues en tant que nouveaux agents antifongiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21731543

Country of ref document: EP

Kind code of ref document: A1

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112022025755

Country of ref document: BR

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 112022025755

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20221216

122 Ep: pct application non-entry in european phase

Ref document number: 21731543

Country of ref document: EP

Kind code of ref document: A1